lipopolysaccharide, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, lipopolysaccharide

Abbate R, Gori AM, Martini F, Brunelli T, Filippini M, Francalanci I, Paniccia R, Prisco D, Gensini GF, Neri Serneri GG. n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prostaglandins Leukot. Essent. Fatty Acids 54: 439-444 (1996).
Abboud PA, Lahni PM, Page K, Giuliano JS Jr, Harmon K, Dunsmore KE, Wong HR, Wheeler DS. The role of endogenously produced extracellular Hsp72 in mononuclear cell reprogramming. Shock 30: 285-292 (2008).
Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, Popa C, van der Meer JW, Netea MG, van den Berg WB. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 56: 2957-2967 (2007). *
Abe M, Shimizu A, Yokoyama Y, Takeuchi Y, Ishikawa O. A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus. Clin. Exp. Dermatol. 33: 759-763 (2008).
Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 40: 414-423 (2004). *
Abe T, Fuse I, Narita M, Takahashi M, Aizawa Y. Combination use of immune complexes and a Ca2 channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells. Clin. Exp. Immunol. 156: 405-412 (2009). *
Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, Depierre JW, Hassan M. Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice. Clin. Exp. Immunol. 141: 238-247 (2005). *
Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K, Bihl F, Ryffel B. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169: 3155-3162 (2002). *
Abeyama K, Maruyama I. Inflammation and its regulatory system. Nippon Rinsho 62: 2229-2235 (2004).
Abraham S, Szabo A, Kaszaki J, Varga R, Eder K, Duda E, Lazar G, Tiszlavicz L, Boros M, Lazar G Jr. Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice. Shock 30: 69-74 (2008).
Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489 (2002).
Abreu MT. Immunologic regulation of Toll-like receptors in gut epithelium. Curr. Opin. Gastroenterol. 19: 559-564 (2003).
Abreu MT, Arditi M. Innate immunity and Toll-like receptors: clinical implications of basic science research. J. Pediatr. 144: 421-429 (2004). *
Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, Arditi M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem. 277: 20431-20437 (2002). *
Abreu MT, Yang H. Is genetic testing in IBD ready for prime time? Am. J. Gastroenterol. 99: 316-318 (2004). *
Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum. Immunol. 68: 901-907 (2007).
Adachi Y, Kamisako T. Intrahepatic cholestasis. Nippon Rinsho 54: 788-793 (1996).
Adams KM, Lucas J, Kapur RP, Stevens AM. LPS induces translocation of TLR4 in amniotic epithelium. Placenta 28: 477-481 (2007).
Addo A, Le J, Li W, Aksentijevich I, Balow J Jr, Lee A, Gregersen PK, Kastner DL, Remmers EF. Analysis of CARD15/NOD2 haplotypes fails to identify common variants associated with rheumatoid arthritis susceptibility. Scand. J. Rheumatol. 34: 198-203 (2005). *
Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients. Crit. Care Med. 34: 2377-2385 (2006).
Adjers K, Karjalainen J, Pessi T, Eklund C, Hurme M. Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females. Int. Arch. Allergy Immunol. 138: 251-256 (2005).
Aggarwal BB, Sethi G, Nair A, Ichikawa H. Nuclear factor-kB: a holy grail in cancer prevention and therapy. Current Signal Transduction Therapy 1: 25-52 (2006). *
Agius LM. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. J. Theor. Biol. 227: 219-228 (2004). *
Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186: 1522-1525 (2002). *
Agou F, Courtois G, Chiaravalli J, Baleux F, Coic YM, Traincard F, Israel A, Veron M. Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (NEMO) oligomerization. J. Biol. Chem. 279: 54248-54257 (2004). *
Ahamed J, Niessen F, Kurokawa T, Lee YK, Bhattacharjee G, Morrissey JH, Ruf W. Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. Blood 109: 5251-5259 (2007). *
Ahmad SM, Haskell MJ, Raqib R, Stephensen CB. Markers of innate immune function are associated with vitamin A stores in men. J. Nutr. 139: 377-385 (2009). *
Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann. N. Y. Acad. Sci. 1056: 218-233 (2005). *
Aihara K, Azuma H, Matsumoto T. Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo. Clin. Calcium 16: 1173-1179 (2006).
Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M. Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J. Leukoc. Biol. 76: 227-236 (2004). *
Akar CA, Feinstein DL. Modulation of inducible nitric oxide synthase expression by sumoylation. J. Neuroinflammation 6: 12 (2009).
Akashi I, Kagami K, Hirano T, Oka K. Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats. J. Pharm. Pharmacol. 61: 473-478 (2009).
Akcan A, Kucuk C, Sozuer E, Esel D, Akyildiz H, Akgun H, Muhtaroglu S, Aritas Y. Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats. World J. Gastroenterol. 14: 918-924 (2008). *
Aki D, Minoda Y, Yoshida H, Watanabe S, Yoshida R, Takaesu G, Chinen T, Inaba T, Hikida M, Kurosaki T, Saeki K, Yoshimura A. Peptidoglycan and lipopolysaccharide activate PLCgamma2, leading to enhanced cytokine production in macrophages and dendritic cells. Genes Cells 13: 199-208 (2008). *
Akira S. Bacterial infections and Toll-like receptors. Kekkaku 76: 593-600 (2001).
Akira S. Toll-like receptors: lessons from knockout mice. Biochem. Soc. Trans. 28: 551-556 (2000). *
Akira S, Hoshino K, Kaisho T. The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin Res. 6: 383-387 (2000). *
Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br. J. Dermatol. 155: 350-356 (2006). *
Aksoy E, Albarani V, Nguyen M, Laes JF, Ruelle JL, De Wit D, Willems F, Goldman M, Goriely S. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 109: 2887-2893 (2007). *
Al-Alem U, Li C, Forey N, Relouzat F, Fondaneche MC, Tavtigian SV, Wang ZQ, Latour S, Yin L. Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap. Blood 106: 2069-2075 (2005). *
Al-Attas OS, Al-Daghri NM, Al-Rubeaan KA, da Silva NF, Sabico SL, Kumar S, McTernan PG, Harte AL. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc. Diabetol. 8: 20 (2009).
Al-Hanbali M, Ali D, Bustami M, Abdel-Malek S, Al-Hanbali R, Alhussainy T, Qadan F, Matalka KZ. Epicatechin suppresses IL-6, IL-8 and enhances IL-10 production with NF-kappaB nuclear translocation in whole blood stimulated system. Neuro. Endocrinol. Lett. 30: 131-138 (2009).
Alabraba EB, Lai V, Boon L, Wigmore SJ, Adams DH, Afford SC. Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion. Hepatology 47: 552-562 (2008). *
Alaish SM, Torres M, Ferlito M, Sun CC, De Maio A. The severity of cholestatic injury is modulated by the genetic background. Shock 24: 412-416 (2005). *
Albillos A, de-la-Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 363: 1608-1610 (2004). *
Albrecht C, Meijer DK, Lebbe C, Sagesser H, Melgert BN, Poelstra K, Reichen J. Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis. Hepatology 26: 1553-1559 (1997). *
Alderson MR, McGowan P, Baldridge JR, Probst P. TLR4 agonists as immunomodulatory agents. J. Endotoxin Res. 12: 313-319 (2006). *
Aldhous MC, Prescott RJ, Roberts S, Samuel K, Waterfall M, Satsangi J. Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease? Inflamm. Bowel Dis. 14: 1469-1482 (2008). *
Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem. Int. 52: 447-456 (2008).
Alexander S, Bramson J, Foley R, Xing Z. Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein. Blood 103: 93-99 (2004). *
Alexis NE, Brickey WJ, Lay JC, Wang Y, Roubey RA, Ting JP, Peden DB. Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals. Ann. Allergy Asthma Immunol. 100: 206-215 (2008).
Alhawi M, Stewart J, Erridge C, Patrick S, Poxton IR. Bacteroides fragilis signals through TLR2 and not TLR4. J. Med. Microbiol. Jun 15 [Epub ahead of print] (2009).
Alipour M, Omri A, Smith MG, Suntres ZE. Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries. J. Endotoxin Res. 13: 297-304 (2007). *
Alipour M, Suntres ZE, Halwani M, Azghani AO, Omri A. Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis. PLoS ONE 4: e5724 (2009). *
Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit. Care Med. 34: 2658-2665 (2006).
Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J. Leukoc. Biol. 71: 677-685 (2002). *
Alsaleh G, Messer L, Semaan N, Boulanger N, Gottenberg JE, Sibilia J, Wachsmann D. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands. Arthritis Rheum. 56: 3202-3214 (2007). *
Altman E, Wang Z, Aaron SD, Liu X, Vandemheen KL, Ferris W, Giesbrecht T, Li J. Epidemiological investigation and glycotyping of clinical Pseudomonas aeruginosa isolates from patients with cystic fibrosis by mass spectrometry: association with multiple drug resistance. J. Microbiol. Methods 76: 204-208 (2009).
Alvarado J, Del Castillo JR, Thomas LE. Modulation of membrane type 1 matrix metalloproteinase by LPS and gamma interferon bound to extracellular matrix in intestinal crypt cells. Cytokine 41: 155-161 (2008).
Alvarez SM, Katsamanis Karavidas M, Coyle SM, Lu SE, Macor M, Oikawa LO, Lehrer PM, Calvano SE, Lowry SF. Low-dose steroid alters in vivo endotoxin-induced systemic inflammation but does not influence autonomic dysfunction. J. Endotoxin Res. 13: 358-368 (2007). *
Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470 (2006).
Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, Cunha TM, Ferreira SH, Cunha FQ, Silva TA, Nicoli JR, Vieira LQ, Souza DG, Teixeira MM. Commensal microbiota is fundamental for the development of inflammatory pain. Proc. Natl. Acad. Sci. U.S.A. 105: 2193-2197 (2008). *
Amat M, Benjamim CF, Williams LM, Prats N, Terricabras E, Beleta J, Kunkel SL, Godessart N. Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo. Br. J. Pharmacol. 149: 666-575 (2006). *
Amati L, Caradonna L, Jirillo E, Caccavo D. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications. Ital. J. Gastroenterol. Hepatol. 31: 313-325 (1999).
Amati L, Caradonna L, Leandro G, Magrone T, Minenna M, Faleo G, Pellegrino NM, Jirillo E, Caccavo D. Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effects. Curr. Pharm. Design 9: 1937-1945 (2003).
Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U.S.A. 93: 14014-14019 (1996). *
Amith SR, Jayanth P, Franchuk S, Siddiqui S, Seyrantepe V, Gee K, Basta S, Beyaert R, Pshezhetsky AV, Szewczuk MR. Dependence of pathogen molecule-induced Toll-like receptor activation and cell function on Neu1 sialidase. Glycoconj. J. May 9 [Epub ahead of print] (2009). *
Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 72: 1100-1116 (2006).
Amoudruz P, Minang JT, Sundstrom Y, Nilsson C, Lilja G, Troye-Blomberg M, Sverremark-Ekstrom E. Pregnancy, but not the allergic status, influences spontaneous and induced interleukin-1beta (IL-1beta), IL-6, IL-10 and IL-12 responses. Immunology 119: 18-26 (2006). *
An GC, Faeder JR. Detailed qualitative dynamic knowledge representation using a BioNetGen model of TLR-4 signaling and preconditioning. Math. Biosci. 217: 53-63 (2009).
An N, Song Y, Zhang X, Ci X, Li H, Cao Y, Zhang M, Cui J, Deng X. Pretreatment of mice with rifampicin prolongs survival of endotoxic shock by modulating the levels of inflammatory cytokines. Immunopharmacol. Immunotoxicol. 30: 437-446 (2008).
Anand P, Kunnumakkara AB, Harikumar KB, Ahn KS, Badmaev V, Aggarwal BB. Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis. Cancer Res. 68: 8861-8870 (2008). *
Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, Wingate A, Monk CE, Toth R, Santos SG, Iversen L, Arthur JS. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat. Immunol. 9: 1028-1036 (2008). *
Anant S, Murmu N, Houchen CW, Mukhopadhyay D, Riehl TE, Young SG, Morrison AR, Stenson WF, Davidson NO. Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 127: 1139-1149 (2004). *
Anders HJ, Zecher D, Pawar RD, Patole PS. Molecular mechanisms of autoimmunity triggered by microbial infection. Arthritis Res. Ther. 7: 215-224 (2005). *
Anderson AD, McNaught CE, Jain PK, MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53: 241-245 (2004). *
Anderson KV. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12: 13-19 (2000).
Anderson P, Phillips K, Stoecklin G, Kedersha N. Post-transcriptional regulation of proinflammatory proteins. J. Leukoc. Biol. 76: 42-47 (2004). *
Andersson LI, Hellman P, Eriksson H. Receptor-mediated endocytosis of particles by peripheral dendritic cells. Hum. Immunol. 69: 625-633 (2008).
Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 72: 1084-1091 (2002). *
Andersson U, Tracey KJ. HMGB1 in sepsis. Scand. J. Infect. Dis. 35: 577-584 (2003).
Ando M, Tu W, Nishijima KI, Iijima S. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem. Biophys. Res. Commun. 369: 878-883 (2008). *
Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4 (TLR4). Blood 106: 2417-2423 (2005). *
Andou A, Hisamatsu T, Okamoto S, Chinen H, Kamada N, Kobayashi T, Hashimoto M, Okutsu T, Shimbo K, Takeda T, Matsumoto H, Sato A, Ohtsu H, Suzuki M, Hibi T. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 136: 564-574.e2 (2009). *
Aneja RK, Tsung A, Sjodin H, Gefter JV, Delude RL, Billiar TR, Fink MP. Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. J. Leukoc. Biol. 84: 1326-1334 (2008). *
Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, Levy O. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr. Res. 60: 205-209 (2006). *
Anspach FB. Endotoxin removal by affinity sorbents. J. Biochem. Biophys. Methods 49: 665-681 (2001). *
Aoki K, Nakajima M, Hoshi Y, Saso N, Kato S, Sugiyama Y, Sato H. Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors. Biol. Pharm. Bull. 31: 412-420 (2008). *
Aomatsu K, Kato T, Fujita H, Hato F, Oshitani N, Kamata N, Tamura T, Arakawa T, Kitagawa S. Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases. Immunology 123: 171-180 (2007). *
Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458: 1180-1184 (2009). *
Apte MV, Pirola RC, Wilson JS. Individual susceptibility to alcoholic pancreatitis. J. Gastroenterol. Hepatol. 23 Suppl. 1: S63-S68 (2008). *
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol. Appl. Pharmacol. 207: 25-38 (2005). *
Aquila S, Rojano B, Recio MC, Giner RM, Schinella GR, Debenedetti SL, Saez J, Rios JL. Anti-inflammatory activity of berenjenol and related compounds. Planta Med. 75: 18-23 (2009).
Ara AI, Xia M, Ramani K, Mato JM, Lu SC. S-Adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology 47: 1655-1666 (2008). *
Armant MA, Fenton MJ. Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol. 3: REVIEWS3011 (2002). *
Arnott ID, Ho GT, Nimmo ER, Satsangi J, Franchimont D, Vermeire S, Deviere J, Rutgeerts PJ. Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe (Author's reply). Gut 54: 308-309 (2005). *
Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martinez C. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4. Peptides 29: 948-956 (2008). *
Arribas B, Rodriguez-Cabezas ME, Camuesco D, Comalada M, Bailon E, Utrilla P, Nieto A, Concha A, Zarzuelo A, Galvez J. A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br. J. Pharmacol. May 22 [Epub ahead of print] (2009).
Asai Y, Makimura Y, Ogawa T. Toll-like receptor 2-mediated dendritic cell activation by a Porphyromonas gingivalis synthetic lipopeptide. J. Med. Microbiol. 56: 459-465 (2007). *
Aschenbach JR, Ahrens F, Schwelberger HG, Furll B, Roesler U, Hensel A, Gabel G. Functional characteristics of the porcine colonic epithelium following transportation stress and Salmonella infection. Scand. J. Gastroenterol. 42: 708-716 (2007). *
Ashino T, Oguro T, Shioda S, Horai R, Asano M, Sekikawa K, Iwakura Y, Numazawa S, Yoshida T. Involvement of interleukin-6 and tumor necrosis factor alpha in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver. Drug Metab. Dispos. 32: 707-714 (2004). *
Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, Rosenthal KL. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190: 1841-1849 (2004). *
Ashwood P, Schauer J, Pessah IN, de Water JV. Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J. Neuroimmunol. 208: 130-135 (2009).
Aslam R, Speck ER, Kim M, Crow AR, Bang KA, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107: 637-641 (2006). *
Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, Vilarem MJ, Pascussi JM. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40: 951-960 (2004). *
Atsumi T, Cho YR, Leng L, McDonald C, Yu T, Danton C, Hong EG, Mitchell RA, Metz C, Niwa H, Takeuchi J, Onodera S, Umino T, Yoshioka N, Koike T, Kim JK, Bucala R. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J. Immunol. 179: 5399-5406 (2007). *
Aue G, Carroll N, Kressel BR, Hardi R, Horne MK 3rd. Disseminated intravascular coagulation in an ambulatory young woman. J. Lab. Clin. Med. 146: 192-196 (2005). *
Aulock SV, Deininger S, Draing C, Gueinzius K, Dehus O, Hermann C. Gender difference in cytokine secretion on immune stimulation with LPS and LTA. J. Interferon Cytokine Res. 26: 887-892 (2006).
Austenaa LM, Carlsen H, Hollung K, Blomhoff HK, Blomhoff R. Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice. J. Nutr. Biochem. Oct 14 [Epub ahead of print] (2008). *
Awomoyi AA, Marchant A, Howson JM, McAdam KP, Blackwell JM, Newport MJ. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J. Infect. Dis. 186: 1808-1814 (2002). *
Aydogan A, Kismet K, Kilicoglu B, Erel S, Ozcan AH, Gollu A, Yildiz E, Akkus MA. Effects of various enteral nutrition solutions on bacterial translocation and intestinal morphology during the postoperative period. Adv. Ther. 24: 41-49 (2007).
Ayoub SS, Botting RM, Joshi AN, Seed MP, Colville-Nash PR. Activation of macrophage peroxisome proliferator-activated receptor-gamma by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines. Mol. Cell. Biochem. 327: 101-110 (2009). *
Azeredo J, Sutherland IW. The use of phages for the removal of infectious biofilms. Curr. Pharm. Biotechnol. 9: 261-266 (2008).
Azuma M, Matsuo A, Fujimoto Y, Fukase K, Hazeki K, Hazeki O, Matsumoto M, Seya T. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI). Biochem. Biophys. Res. Commun. 354: 574-578 (2007). *
Babcock TA, Novak T, Ong E, Jho DH, Helton WS, Espat NJ. Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-alpha production by omega-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J. Surg. Res. 107: 135-139 (2002). *
Babula O, Linhares IM, Bongiovanni AM, Ledger WJ, Witkin SS. Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism. Am. J. Obstet. Gynecol. 198: 101.e1-101.e4 (2008). *
Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view? J. Hepatol. 51: 212-223 (2009).
Bahador M, Cross AS. From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J. Endotoxin Res. 13: 251-279 (2007). *
Bahrun U, Kimoto M, Tsukamoto H, Tsuneyoshi N, Kohara J, Fukudome K. Preparation and characterization of agonistic monoclonal antibodies against Toll-like receptor 4-MD-2 complex. Hybridoma (Larchmt.) 26: 393-400 (2007).
Bai A, Lu N, Guo Y, Chen J, Liu Z. Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin. Exp. Immunol. 156: 353-362 (2009). *
Bai Y, Onuma H, Bai X, Medvedev AV, Misukonis M, Weinberg JB, Cao W, Robidoux J, Floering LM, Daniel KW, Collins S. Persistent NF-kappa B activation in Ucp2-/-mice leads to enhanced nitric oxide and inflammatory cytokine production. J. Biol. Chem. 280: 19062-19069 (2005). *
Bajt ML, Ho YS, Vonderfecht SL, Jaeschke H. Reactive oxygen as modulator of TNF and Fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice. Antioxid. Redox Signal. 4: 733-740 (2002).
Baldassano RN, Schreiber S, Johnston RB Jr, Fu RD, Muraki T, MacDermott RP. Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology 105: 60-66 (1993).
Ballot E, Bandin O, Chazouilleres O, Johanet C, Poupon R. Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases. J. Autoimmun. 22: 153-158 (2004).
Balloy V, Jyot J, Verma A, Si-Tahar M, Ramphal R, Chignard M. Lack of control of Pseudomonas aeruginosa pulmonary infection in the absence of recognition of both lipopolysaccharide and flagellin. Rev. Mal. Respir. 25: 1183 (2008).
Bamford S, Ryley H, Jackson SK. Highly purified lipopolysaccharides from Burkholderia cepacia complex clinical isolates induce inflammatory cytokine responses via TLR4-mediated MAPK signalling pathways and activation of NFkappaB. Cell. Microbiol. 9: 532-543 (2007). *
Bangen JM, Schade FU, Flohe SB. Diverse regulatory activity of human heat shock proteins 60 and 70 on endotoxin-induced inflammation. Biochem. Biophys. Res. Commun. 359: 709-715 (2007). *
Bannerman DD, Eiting KT, Winn RK, Harlan JM. FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide. Am. J. Pathol. 165: 1423-1431 (2004). *
Baranda L, de la Fuente H, Layseca-Espinosa E, Portales-Perez D, Nino-Moreno P, Valencia-Pacheco G, Abud-Mendoza C, Alcocer-Varela J, Gonzalez-Amaro R. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology (Oxford) 44: 1507-1513 (2005). *
Baranek T, Debret R, Antonicelli F, Lamkhioued B, Belaaouaj A, Hornebeck W, Bernard P, Guenounou M, Le Naour R. Elastin receptor (spliced galactosidase) occupancy by elastin peptides counteracts proinflammatory cytokine expression in lipopolysaccharide-stimulated human monocytes through NF-kappaB down-regulation. J. Immunol. 179: 6184-6192 (2007). *
Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am. J. Gastroenterol. 100: 2560-2568 (2005). *
Barber MD, Fearon KC, Ross JA. Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responses. Nutrition 21: 588-593 (2005). *
Barber RC, Maass DL, White DJ, Chang LY, Horton JW. Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction. Shock 30: 705-713 (2008).
Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ, Evans RM. A nuclear receptor atlas: macrophage activation. Mol. Endocrinol. 19: 2466-2477 (2005). *
Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin. Exp. Immunol. 156: 479-487 (2009). *
Barlow AK, He X, Janeway C Jr. Exogenously provided peptides of a self-antigen can be processed into forms that are recognized by self-T cells. J. Exp. Med. 187: 1403-1415 (1998). *
Barnes DS. Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm (2002). *
Bartolome N, Arteta B, Martinez MJ, Chico Y, Ochoa B. Kupffer cell products and interleukin 1beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes. Innate Immun. 14: 255-266 (2008). *
Barton CC, Ganey PE, Roth RA. Lipopolysaccharide augments aflatoxin B(1)-induced liver injury through neutrophil-dependent and -independent mechanisms. Toxicol. Sci. 58: 208-215 (2000). *
Barton CC, Hill DA, Yee SB, Barton EX, Ganey PE, Roth RA. Bacterial lipopolysaccharide exposure augments aflatoxin B(1)-induced liver injury. Toxicol. Sci. 55: 444-452 (2000). *
Basler T, Jeckstadt S, Valentin-Weigand P, Goethe R. Mycobacterium paratuberculosis, Mycobacterium smegmatis, and lipopolysaccharide induce different transcriptional and post-transcriptional regulation of the IRG1 gene in murine macrophages. J. Leukoc. Biol. 79: 628-638 (2006). *
Basu D, Lopez I, Kulkarni A, Sellin JH. Impact of race and ethnicity on inflammatory bowel disease. Am. J. Gastroenterol. 100: 2254-2261 (2005). *
Bates JM, Akerlund J, Mittge E, Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2: 371-382 (2007). *
Bates JM, Mittge E, Kuhlman J, Baden KN, Cheesman SE, Guillemin K. Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation. Dev. Biol. 297: 374-386 (2006). *
Baumgart DC, Metzke D, Schmitz J, Scheffold A, Sturm A, Wiedenmann B, Dignass AU. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 54: 228-236 (2005). *
Baumgart DC, Thomas S, Przesdzing I, Metzke D, Bielecki C, Lehmann SM, Lehnardt S, Dorffel Y, Sturm A, Scheffold A, Schmitz J, Radbruch A. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin. Exp. Immunol. [In Press] (2009). *
Beamer LJ. Structure of human BPI (bactericidal/permeability-increasing protein) and implications for related proteins. Biochem. Soc. Trans. 31: 791-794 (2003). *
Beamer LJ, Carroll SF, Eisenberg D. The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci. 7: 906-914 (1998). *
Beamer LJ, Carroll SF, Eisenberg D. The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions. Biochem. Pharmacol. 57: 225-229 (1999). *
Beamer LJ, Carroll SF, Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276: 1861-1864 (1997). *
Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J, Carr JM, Armit LJ, Clacher C, Malone L, Kollias G, Arthur JS. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25: 10454-10464 (2005). *
Bebo BF Jr, Dehghani B, Foster S, Kurniawan A, Lopez FJ, Sherman LS. Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia 57: 777-790 (2008).
Becker J, Delayre-Orthez C, Frossard N, Pons F. Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation. Pulm. Pharmacol. Ther. 21: 324-330 (2008).
Becker M, Cotena A, Gordon S, Platt N. Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response. Eur. J. Immunol. 36: 950-960 (2006). *
Beckwith J, Cong Y, Sundberg JP, Elson CO, Leiter EH. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 129: 1473-1484 (2005). *
Begni B, Amadori M, Ritelli M, Podavini D. Effects of IFN-alpha on the inflammatory response of swine leukocytes to bacterial endotoxin. J. Interferon. Cytokine Res. 25: 202-208 (2005).
Beier JI, Luyendyk JP, Guo L, von Montfort C, Staunton DE, Arteel GE. Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology 49: 1545-1553 (2009).
Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun. 293: 145-149 (2002). *
Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response is associated with retinoid X receptor repression in rodent liver. J. Biol. Chem. 275: 16390-16399 (2000). *
Beitland S, Opdahl H, Aspelin T, Saetre L, Lyberg T. Blood leucocyte cytokine production after LPS stimulation at different concentrations of glucose and/or insulin. Acta Anaesthesiol. Scand. 53: 183-189 (2009).
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Davies DR, Segal DM. The molecular structure of the TLR3 extracellular domain. J. Endotoxin Res. 12: 375-378 (2006). *
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, Davies DR. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. U.S.A. 102: 10976-10980 (2005). *
Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA. Evaluation of Helicobacter species in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18: 481-486 (2003). *
Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, Dinarello CA, Paul WE. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. U.S.A. 106: 7119-7124 (2009). *
Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336 (2007). *
Benghiat FS, Craciun L, De Wilde V, Dernies T, Kubjak C, Lhomme F, Goldman M, Le Moine A. IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells. Transplantation 85: 943-949 (2008).
Bennouna S, Sukhumavasi W, Denkers EY. Toxoplasma gondii inhibits Toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils. Infect. Immun. 74: 4274-4281 (2006). *
Bentala H, Verweij WR, Huizinga-Van der Vlag A, van Loenen-Weemaes AM, Meijer DK, Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 18: 561-566 (2002). *
Beran O, Lawrence DA, Andersen N, Dzupova O, Kalmusova J, Musilek M, Holub M. Sequential analysis of biomarkers in cerebrospinal fluid and serum during invasive meningococcal disease. Eur. J. Clin. Microbiol. Infect. Dis. Feb 10 [Epub ahead of print] (2009).
Berbaum K, Shanmugam K, Stuchbury G, Wiede F, Korner H, Munch G. Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine 41: 198-203 (2008).
Berclaz PY, Carey B, Fillipi MD, Wernke-Dollries K, Geraci N, Cush S, Richardson T, Kitzmiller J, O'Connor M, Hermoyian C, Korfhagen T, Whitsett JA, Trapnell BC. GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS. Am. J. Respir. Cell. Mol. Biol. 36: 114-121 (2007). *
Bergamini A, Dini L, Baiocchi L, Cappannoli L, Falasca L, Bolacchi F, Capozzi M, Faggioli E, Nistri A, Salanitro A, Ventura L, Rocchi G, Angelico M. Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells. Hepatology 25: 927-933 (1997). *
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *
Berger M. Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc. 23: 19-25 (2002).
Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48: 983-992 (2008).
Bernales I, Fullaondo A, Marin-Vidalled MJ, Ucar E, Martinez-Taboada V, Lopez-Hoyos M, Zubiaga AM. Innate immune response gene expression profiles characterize primary antiphospholipid syndrome. Genes Immun. 9: 38-46 (2008). *
Berres ML, Schnyder B, Yagmur E, Inglis B, Stanzel S, Tischendorf JJ, Koch A, Winograd R, Trautwein C, Wasmuth HE. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int. 29: 536-543 (2009). *
Berstad AE, Hogasen K, Bukholm G, Moran AP, Brandtzaeg P. Complement activation directly induced by Helicobacter pylori. Gastroenterology 120: 1108-1116 (2001). *
Bertok L. Bile acids in physico-chemical host defence. Pathophysiology 11: 139-145 (2004).
Bertok L. Role of endotoxins and bile acids in the pathogenesis of septic circulatory shock. Acta Chir. Hung. 36: 33-36 (1997).
Bettencourt R, Tanji T, Yagi Y, Ip YT. Toll and Toll-9 in Drosophila innate immune response. J. Endotoxin Res. 10: 261-268 (2004). *
Beumer C, Wulferink M, Raaben W, Fiechter D, Brands R, Seinen W. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J. Pharmacol. Exp. Ther. 307: 737-744 (2003). *
Beutler B. Endotoxin, Toll-like receptor 4, and the afferent limb of innate immunity. Curr. Opin. Microbiol. 3: 23-28 (2000).
Beutler B. Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors. Annu. Rev. Pharmacol. Toxicol. 43: 609-628 (2003). *
Beutler B. LPS in microbial pathogenesis: promise and fulfilment. J. Endotoxin Res. 8: 329-335 (2002). *
Beutler B. Innate immune sensing of microbial infection: the mechanism and the therapeutic challenge. Wien. Med. Wochenschr. 152: 547-551 (2002).
Beutler B. Toll-like receptors: how they work and what they do. Curr. Opin. Hematol. 9: 2-10 (2002).
Beutler B. TLR4 as the mammalian endotoxin sensor. Curr. Top. Microbiol. Immunol. 270: 109-120 (2002).
Beutler B, Hoebe K, Georgel P, Tabeta K, Du X. Genetic analysis of innate immunity: TIR adapter proteins in innate and adaptive immune responses. Microbes Infect. 6: 1374-1381 (2004). *
Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24: 353-389 (2006). *
Beutler B, Moresco EM. The forward genetic dissection of afferent innate immunity. Curr. Top. Microbiol. Immunol. 321: 3-26 (2008).
Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3: 169-176 (2003). *
Bhattacharya A, Sun D, Rahman M, Fernandes G. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice. J. Nutr. Biochem. 18: 23-30 (2007). *
Bhattacharyya S, Borthakur A, Pant N, Dudeja PK, Tobacman JK. Bcl10 mediates lipopolysaccharide (LPS)-induced activation of NFkappaB and IL-8 in human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G429-G437 (2007). *
Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ. Macrophage glucocorticoid receptors regulate Toll-like receptor-4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109: 4313-4319 (2007). *
Bickston SJ, Comerford LW, Cominelli F. Future therapies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 518-523 (2003).
Bihl F, Lariviere L, Qureshi ST, Flaherty L, Malo D. LPS-hyporesponsiveness of mnd mice is associated with a mutation in Toll-like receptor 4. Genes Immun. 2: 56-59 (2001). *
Bihl F, Salez L, Beaubier M, Torres D, Lariviere L, Laroche L, Benedetto A, Martel D, Lapointe JM, Ryffel B, Malo D. Overexpression of Toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice. J. Immunol. 170: 6141-6150 (2003). *
Bilej M, De Baetselier P, Van Dijck E, Stijlemans B, Colige A, Beschin A. Distinct carbohydrate recognition domains of an invertebrate defense molecule recognize Gram-negative and Gram-positive bacteria. J. Biol. Chem. 276: 45840-45847 (2001). *
Billack B. Macrophage activation: role of Toll-like receptors, nitric oxide, and nuclear factor kappa B. Am. J. Pharm. Educ. 70: 102 (2006).
Billiar TR, Maddaus MA, West MA, Curran RD, Wells CA, Simmons RL. Intestinal gram-negative bacterial overgrowth in vivo augments the in vitro response of Kupffer cells to endotoxin. Ann. Surg. 208: 532-540 (1988). *
Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 26: 1175-1186 (2006). *
Bingle CD, Craven CJ. Meet the relatives: a family of BPI- and LBP-related proteins. Trends Immunol. 25: 53-55 (2004). *
Bingle CD, Craven CJ. PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11: 937-943 (2002). *
Bingle CD, Gorr SU. Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int. J. Biochem. Cell. Biol. 36: 2144-2152 (2004). *
Bissonnette EY, Proulx LI, Turmel V, Drouin R, Purcell M. PCT-233, a novel modulator of pro- and anti-inflammatory cytokine production. Clin. Exp. Immunol. 135: 440-447 (2004). *
Bissonnette EY, Tremblay GM, Turmel V, Pirotte B, Reboud-Ravaux M. Coumarinic derivatives show anti-inflammatory effects on alveolar macrophages, but their anti-elastase activity is essential to reduce lung inflammation in vivo. Int. Immunopharmacol. 9: 49-54 (2009).
Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, Yamamoto M, Lopez-Collazo E, Akira S, Tergaonkar V. Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J. Immunol. 179: 4083-4092 (2007). *
Biswas SK, Tergaonkar V. Myeloid differentiation factor 88-independent Toll-like receptor pathway: sustaining inflammation or promoting tolerance? Int. J. Biochem. Cell Biol. 39: 1582-1592 (2007).
Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Bottinger EP. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14: 187-197 (2000). *
Blaas SH, Stieber-Gunckel M, Falk W, Obermeier F, Rogler G. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clin. Exp. Immunol. 155: 534-540 (2009). *
Blach-Olszewska Z. Innate immunity: cells, receptors, and signaling pathways. Arch. Immunol. Ther. Exp. (Warsz.) 53: 245-253 (2005).
Black JA, Liu S, Waxman SG. Sodium channel activity modulates multiple functions in microglia. Glia 57: 1072-1081 (2009).
Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ. Res. 99: e88-e99 (2006). *
Bo X, Broome U, Remberger M, Sumitran-Holgersson S. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut 49: 131-141 (2001). *
Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, Weichhart T, Saemann M, Smolen JS. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of Toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum. 56: 1880-1893 (2007). *
Bode C, Bode JC. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin. Exp. Res. 29: 166S-171S (2005).
Bodet C, La VD, Gafner S, Bergeron C, Grenier D. A licorice extract reduces lipopolysaccharide-induced proinflammatory cytokine secretion by macrophages and whole blood. J. Periodontol. 79: 1752-1761 (2008).
Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381-2386 (1998). *
Bogunovic M, Dave SH, Tilstra JS, Chang DT, Harpaz N, Xiong H, Mayer LF, Plevy SE. Enteroendocrine cells express functional Toll-like receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1770-G1783 (2007). *
Bolder U, Jeschke MG, Landmann L, Wolf F, de Sousa C, Schlitt HJ, Przkora R. Heat stress enhances recovery of hepatocyte bile acid and organic anion transporters in endotoxemic rats by multiple mechanisms. Cell Stress Chaperones 11: 89-100 (2006). *
Bolder U, Schmidt A, Landmann L, Kidder V, Tange S, Jauch KW. Heat stress prevents impairment of bile acid transport in endotoxemic rats by a posttranscriptional mechanism. Gastroenterology 122: 963-973 (2002). *
Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 112: 214-225 (1997). *
Bollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE, Gersuk VH, Aderem A, Hawn TR, Nepom GT. The Toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS ONE 4: e5063 (2009). *
Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22: 5551-5560 (2003). *
Bondeva T, Roger T, Wolf G. Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites. Am. J. Nephrol. 27: 308-314 (2007).
Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, Cho JH, Nunez G. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124: 140-146 (2003). *
Bornstein SR, Schumann RR, Rettori V, McCann SM, Zacharowski K. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals. Horm. Metab. Res. 36: 470-473 (2004).
Borra RC, de Mesquita Barros F, de Andrade Lotufo M, Villanova FE, Andrade PM. Toll-like receptor activity in recurrent aphthous ulceration. J. Oral Pathol. Med. 38: 289-298 (2009).
Bosshart H, Heinzelmann M. Targeting bacterial endotoxin: two sides of a coin. Ann. N. Y. Acad. Sci. 1096: 1-17 (2007). *
Botha-Scheepers SA, Watt I, Slagboom E, de Craen AJ, Meulenbelt I, Rosendaal FR, Breedveld FC, Huizinga TW, Kloppenburg M. Innate production of tumor necrosis factor-alpha and interleukin-10 is associated with radiological progression of knee osteoarthritis. Ann. Rheum. Dis. 67: 1165-1169 (2008).
Bottcher A, Gaipl US, Furnrohr BG, Herrmann M, Girkontaite I, Kalden JR, Voll RE. Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum. 54: 927-938 (2006). *
Bouchard C, Page J, Bedard A, Tremblay P, Vallieres L. G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions. Glia 55: 790-800 (2007).
Bouma G, Kaushiva A, Strober W. Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology 123: 554-565 (2002). *
Bourne T, Fossati G, Nesbitt A. A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action. BioDrugs 22: 331-337 (2008).
Boutlis CS, Yeo TW, Anstey NM. Malaria tolerance - for whom the cell tolls? Trends Parasitol. 22: 371-377 (2006). *
Bowdish DM, Hancock RE. Anti-endotoxin properties of cationic host defence peptides and proteins. J. Endotoxin Res. 11: 230-236 (2005). *
Braat H, Stokkers P, Hommes T, Cohn D, Vogels E, Pronk I, Spek A, van Kampen A, van Deventer S, Peppelenbosch M, Hommes D. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J. Mol. Med. 83: 601-609 (2005). *
Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, Dematteo RP, Pamer EG. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455: 804-807 (2008). *
Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25: 5467-5484 (2007). *
Braun D, Longman RS, Albert ML. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106: 2375-2381 (2005). *
Brazova J, Sediva A, Pospisilova D, Vavrova V, Pohunek P, Macek M Jr, Bartunkova J, Lauschmann H. Differential cytokine profile in children with cystic fibrosis. Clin. Immunol. 115: 210-215 (2006). *
Breivik T, Gundersen Y, Gjermo P, von Horsten S, Opstad PK. Nicotinic acetylcholine receptor activation mediates nicotine-induced enhancement of experimental periodontitis. J. Periodontal Res. 44: 110-116 (2009).
Bressan E, De Queiroz Cunha F, Tonussi CR. Contribution of TNFalpha, IL-1beta and CINC-1 for articular incapacitation, edema and cell migration in a model of LPS-induced reactive arthritis. Cytokine 36: 83-89 (2006).
Brett PJ, Burtnick MN, Snyder DS, Shannon JG, Azadi P, Gherardini FC. Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol. Microbiol. 63: 379-390 (2007). *
Brewster JA, Orsi NM, Gopichandran N, Ekbote UV, Cadogan E, Walker JJ. Host inflammatory response profiling in preeclampsia using an in vitro whole blood stimulation model. Hypertens. Pregnancy 27: 1-16 (2008).
Briscoe CP, Looper D, Tran P, Herrera J, McDonnell SR, Bhat BG. LPS-induced biomarkers in mice: a potential model for identifying insulin sensitizers. Biochem. Biophys. Res. Commun. 361: 140-145 (2007). *
Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr. Med. Chem. 13: 2487-2502 (2006).
Brock-Utne JG, Gaffin SL. Endotoxins and anti-endotoxins (their relevance to the anaesthetist and the intensive care specialist). Anaesth. Intensive Care 17: 49-55 (1989).
Brod SA, Hood Z. Ingested (oral) SIRS peptide 1-21 suppresses type 1 diabetes in NOD mice. J. Interferon Cytokine Res. 28: 25-30 (2008).
Brooling JT, Campbell JS, Mitchell C, Yeoh GC, Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology 41: 906-915 (2005). *
Broome U, Eriksson LS, Sundin U, Sundqvist KG. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients. Scand. J. Gastroenterol. 27: 124-128 (1992).
Brown C, Gaspar J, Pettit A, Lee R, Gu X, Wang H, Manning C, Voland C, Goldring SR, Goldring MB, Libermann TA, Gravalllese EM, Oettgen P. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J. Biol. Chem. 279: 12794-12803 (2004). *
Brown KL, Bylund J, Macdonald KL, Song-Zhao GX, Elliott MR, Falsafi R, Hancock RE, Speert DP. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin. Immunol. 129: 90-102 (2008). *
Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ. High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD). Mol. Med. 14: 109-115 (2008). *
Bruey JM, Bruey-Sedano N, Newman R, Chandler S, Reed JC. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kB and caspase-1 activation in macrophages. J. Biol. Chem. 279: 51897-51907 (2004). *
Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu' G, Martines D. Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G518-G525 (2007). *
Brun P, Castagliuolo I, Floreani AR, Buda A, Blasone L, Palu G, Martines D. Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut 55: 1212 (2006). *
Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G571-G578 (2005). *
Brundage SI, Kirilcuk NN, Lam JC, Spain DA, Zautke NA. Insulin increases the release of proinflammatory mediators. J. Trauma 65: 367-372 (2008).
Brunn GJ, Bungum MK, Johnson GB, Platt JL. Conditional signaling by Toll-like receptor 4. FASEB J. 19: 872-874 (2005). *
Brunn GJ, Wijdicks MF, Platt JL. Toward a modern concept of sepsis: new answers to ancient questions. Discov. Med. 6: 11-17 (2006).
Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, Tuck D, Krause DS, Egan ME. Macrophages directly contribute to the exaggerated inflammatory response in CFTR-/- mice. Am. J. Respir. Cell. Mol. Biol. 40: 295-304 (2009). *
Brustolim D, Ribeiro-Dos-Santos R, Kast RE, Altschuler EL, Soares MB. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int. Immunopharmacol. 6: 903-907 (2006).
Buck M, Chojkier M. C/EBPbeta associates with caspase 8 complex proteins and modulates apoptosis in hepatic stellate cells. J. Clin. Gastroenterol. 41: S295-S299 (2007).
Bucki R, Byfield FJ, Janmey PA. Release of the antimicrobial LL37 peptide from DNA/F-actin bundles in CF sputum. Eur. Respir. J. 29: 624-632 (2007). *
Buckland M, Lombardi G. Aspirin and the induction of tolerance by dendritic cells. Handb. Exp. Pharmacol. 188: 197-213 (2009).
Budick-Harmelin N, Dudas J, Demuth J, Madar Z, Ramadori G, Tirosh O. Triglycerides potentiate the inflammatory response in rat Kupffer cells. Antioxid. Redox Signal. 10: 2009-2022 (2008).
Buenafe AC, Bourdette DN. Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182: 32-40 (2007).
Buetler TM. Identification of glutathione S-transferase isozymes and gamma-glutamylcysteine synthetase as negative acute-phase proteins in rat liver. Hepatology 28: 1551-1560 (1998). *
Bulow E, Gullberg U, Olsson I. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein. J. Leukoc. Biol. 68: 669-678 (2000). *
Bunch DO, Silver JS, Majure MC, Sullivan P, Alcorta DA, Chin H, Hogan SL, Lindstrom YI, Clarke SH, Falk RJ, Nachman PH. Maintenance of tolerance by regulation of anti-myeloperoxidase B cells. J. Am. Soc. Nephrol. 19: 1763-1773 (2008).
Burch LH, Picher M. E-NTPDases in human airways: regulation and relevance for chronic lung diseases. Purinergic Signal. 2: 399-408 (2006). *
Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197: 263-268 (2003). *
Butchar JP, Parsa KV, Marsh CB, Tridandapani S. Negative regulators of Toll-like receptor 4-mediated macrophage inflammatory response. Curr. Pharm. Des. 12: 4143-4153 (2006).
Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr. Res. 60: 24-29 (2006). *
Buttari B, Profumo E, Mancinelli R, Cesta Incani U, Tosti ME, Attilia ML, Ceccanti M, Rigano R. Chronic and acute alcohol exposure prevents monocyte-derived dendritic cells from differentiating and maturing. Int. J. Immunopathol. Pharmacol. 21: 929-939 (2008).
Buttenschoen K, Schneider ME, Utz K, Kornmann M, Beger HG, Carli Buttenschoen D. Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4. Langenbecks Arch. Surg. 394: 293-302 (2009). *
Butz DE, Li G, Huebner SM, Cook ME. A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R669-R676 (2007). *
Cairns BA, Barnes CM, Mlot S, Meyer AA, Maile R. Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury. J. Trauma 64: 1069-1077 (2008).
Calafat J, Janssen H, Knol EF, Malm J, Egesten A. The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation. APMIS 108: 201-208 (2000).
Calafat M, Larocca L, Roca V, Perez Leiros C. NOD mice exocrinopathy: towards a neuroimmune link. Neuroimmunomodulation 14: 175-181 (2007).
Calder PC. Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz. J. Med. Biol. Res. 31: 467-490 (1998). *
Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz. J. Med. Biol. Res. 36: 433-446 (2003). *
Calder PC. n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38: 343-352 (2003).
Calder PC. n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann. Nutr. Metab. 41: 203-234 (1997).
Calder PC. Dietary modification of inflammation with lipids. Proc. Nutr. Soc. 61: 345-358 (2002). *
Callejas NA, Castrillo A, Bosca L, Martin-Sanz P. Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators. J. Pharmacol. Exp. Ther. 288: 1235-1241 (1999). *
Calmus Y, Podevin P, Robert A, Poupon R. Differential effects of chenodeoxycholic and ursodeoxycholic acids on expression of procoagulant activity by human monocytes. J. Hepatol. 20: 466-472 (1994).
Calvano SE, Thompson WA, Marra MN, Coyle SM, de Riesthal HF, Trousdale RK, Barie PS, Scott RW, Moldawer LL, Lowry SF. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis. Arch. Surg. 129: 220-226 (1994).
Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF, Large Scale Collab Res Program IA. A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037 (2005). *
Camacho RE, Wnek R, Fischer P, Shah K, Zaller DM, Woods A, La Monica N, Aurisicchio L, Fitzgerald-Bocarsly P, Koo GC. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1( *)01 transgene: a model of SCID-hu mouse for vaccine development. Exp. Hematol. 35: 1219-1230 (2007).
Camargo JF, Correa PA, Castiblanco J, Anaya JM. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 5: 609-614 (2004). *
Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol. Clin. Exp. Res. 29: 1206-1213 (2005). *
Canavan TP, Simhan HN. Innate immune function of the human decidual cell at the maternal-fetal interface. J. Reprod. Immunol. 74: 46-52 (2007).
Cancino-Diaz ME, Perez-Salazar JE, Dominguez-Lopez L, Escobar-Gutierrez A, Granados-Arreola J, Jim�nez-Zamudio L, Burgos-Vargas R, Garc�a-Latorre E. Antibody response to Klebsiella pneumoniae 60 kDa protein in familial and sporadic ankylosing spondylitis: role of HLA-B27 and characterization as a GroEL-like protein. J. Rheumatol. 25: 1756-1764 (1998).
Candia L, Marquez J, Hernandez C, Zea AH, Espinoza LR. Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity? J. Rheumatol. 34: 374-379 (2007).
Cane G, Moal VL, Pages G, Servin AL, Hofman P, Vouret-Craviari V. Up-regulation of intestinal vascular endothelial growth factor by Afa/Dr diffusely adhering Escherichia coli. PLoS ONE 2: e1359 (2007). *
Canny G, Levy O. Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites. Trends Immunol. 29: 541-547 (2008). *
Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc. Natl. Acad. Sci. U.S.A. 99: 3902-3907 (2002). *
Cantorna MT, Mahon BD. D-hormone and the immune system. J. Rheumatol. Suppl. 76: 11-20 (2005). *
Cao H, Kabaroff LC, You Q, Rodriguez A, Boermans HJ, Karrow NA. Characterization of ovine hepatic gene expression profiles in response to Escherichia coli lipopolysaccharide using a bovine cDNA microarray. BMC Vet. Res. 2: 34 (2006). *
Capsoni F, Ongari A, Colombo G, Turcatti F, Catania A. The synthetic melanocortin (CKPV)(2) exerts broad anti-inflammatory effects in human neutrophils. Peptides 28: 2016-2022 (2007). *
Caraceni P, Pertosa A, Giannone F, Domenicali M, Grattagliano I, Perrelli MG, Principe A, Cutrin J, Croci T, Bernardi M. Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. Gut Mar 11 [Epub ahead of print] (2009).
Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am. J. Gastroenterol. 95: 1495-1502 (2000). *
Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 6: 205-214 (2000). *
Carayol N, Chen J, Yang F, Jin T, Jin L, States D, Wang CY. A dominant function of IKK/NF-kappaB signaling in global lipopolysaccharide-induced gene expression. J. Biol. Chem. 281: 31142-31151 (2006). *
Cardarelli G, Anatra GM. Hepcidin: a key peptide in iron metabolism. Minerva Med. 94: 135-139 (2003).
Cario E. Toll-like receptors and gastrointestinal diseases: from bench to bedside? Curr. Opin. Gastroenterol. 18: 696-704 (2002).
Cario E, Golenbock DT, Visintin A, Runzi M, Gerken G, Podolsky DK. Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance. J. Immunol. 176: 4258-4266 (2006). *
Carl VS, Brown-Steinke K, Nicklin MJ, Smith MF Jr. Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages. J. Biol. Chem. 277: 17448-17456 (2002). *
Carlin JM, Borden EC, Sondel PM, Byrne GI. Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J. Leukoc. Biol. 45: 29-34 (1989). *
Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R. Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat. Res. 551: 199-211 (2004).
Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B-cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 104: 3021-3027 (2004). *
Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH. Negative regulation of Toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 317: 675-678 (2007). *
Carroll MC, Prodeus AP. Linkages of innate and adaptive immunity. Curr. Opin. Immunol. 10: 36-40 (1998).
Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 4: 277-287 (2007). *
Cartwright N, Murch O, McMaster SK, Paul-Clark MJ, van Heel DA, Ryffel B, Quesniaux VF, Evans TW, Thiemermann C, Mitchell JA. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. Am. J. Respir. Crit. Care Med. 175: 595-603 (2007). *
Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC, Pallone F, Macdonald TT, Monteleone G. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 136: 2270-2279 (2009). *
Cascales L, Mas-Moruno C, Tamborero S, Acena JL, Sanz-Cervera JF, Fustero S, Cruz LJ, Mora P, Albericio F, Perez-Paya E. Tiratricol neutralizes bacterial endotoxins and reduces lipopolysaccharide-induced TNF-alpha production in the cell. Chem. Biol. Drug Des. 72: 320-328 (2008).
Castelli R, Ferrari B, Cortelezzi A, Guariglia A. Thromboembolic complications in malignant haematological disorders. Curr. Vasc. Pharmacol. Jan 1 [Epub ahead of print] (2009).
Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278: 10443-10449 (2003). *
Cates EA, Connor EE, Mosser DM, Bannerman DD. Functional characterization of bovine TIRAP and MyD88 in mediating bacterial lipopolysaccharide-induced endothelial NF-kappaB activation and apoptosis. Comp. Immunol. Microbiol. Infect. Dis. Aug 27 [Epub ahead of print] (2008). *
Cauwels A, Bultinck J, Brouckaert P. Dual role of endogenous nitric oxide in tumor necrosis factor shock: induced NO tempers oxidative stress. Cell. Mol. Life Sci. 62: 1632-1640 (2005). *
Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10: 233 (2006). *
Cawood AL, Carroll MP, Wootton SA, Calder PC. Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr. Opin. Clin. Nutr. Metab. Care 8: 153-159 (2005).
Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 106: 2735-2740 (2009). *
Chai SK, Altman GM, Yazdanbakhsh M, Tsuji J, Godat L, Takaro TK. Production of interleukin 10 and transforming growth factor beta in concomitant allergy and autoimmunity. Ann. Allergy Asthma Immunol. 94: 279-285 (2005).
Chaluvadi MR, Nyagode BA, Kinloch RD, Morgan ET. TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease. Biochem. Pharmacol. 77: 464-471 (2009). *
Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, Ogura Y, Kawasaki A, Fukase K, Kusumoto S, Valvano MA, Foster SJ, Mak TW, Nunez G, Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4: 702-707 (2003). *
Chan KL, Ho JC, Chan KW, Tam PK. A study of gut immunity to enteral endotoxin in rats of different ages: a possible cause for necrotizing enterocolitis. J. Pediatr. Surg. 37: 1435-1440 (2002).
Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest. Ophthalmol. Vis. Sci. 48: 1711-1717 (2007). *
Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br. J. Ophthalmol. 90: 103-108 (2006).
Chang JM, Lee YR, Hung LM, Liu SY, Kuo MT, Wen WC, Chen P. An extract of Antrodia camphorata mycelia attenuates the progression of nephritis in systemic lupus erythematosus-prone NZB/W F1 mice. Evid. Based Complement. Alternat. Med. Sep 2 [Epub ahead of print] (2008).
Chang JX, Chen S, Ma LP, Jiang LY, Chen JW, Chang RM, Wen LQ, Wu W, Jiang ZP, Huang ZT. Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock. World J. Gastroenterol. 11: 5485-5491 (2005). *
Chang L, Zhang Z, Li W, Dai J, Guan Y, Wang X. Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kappaB pathway. Biochem. Biophys. Res. Commun. 357: 772-778 (2007). *
Chang WW, Su IJ, Lai MD, Chang WT, Huang W, Lei HY. Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression. World J. Gastroenterol. 11: 6631-6637 (2005). *
Chao CC, Janoff EN, Hu SX, Thomas K, Gallagher M, Tsang M, Peterson PK. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 3: 292-298 (1991).
Chaouche-Drider N, Kaparakis M, Karrar A, Fernandez MI, Carneiro LA, Viala J, Boneca IG, Moran AP, Philpott DJ, Ferrero RL. A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cells. PLoS ONE 4: e5396 (2009). *
Chase MA, Wheeler DS, Lierl KM, Hughes VS, Wong HR, Page K. Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism. J. Immunol. 179: 6318-6324 (2007). *
Chaudhary A, Fresquez TM, Naranjo MJ. Tyrosine kinase Syk associates with Toll-like receptor 4 and regulates signaling in human monocytic cells. Immunol. Cell Biol. 85: 249-256 (2007). *
Chaudhry MZ, Wang JH, Blankson S, Redmond HP. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg. Infect. (Larchmt.) 9: 183-194 (2008).
Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, Bondada S. Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J. Leukoc. Biol. 79: 1314-1327 (2006). *
Chen A, Zheng S. Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. Br. J. Pharmacol. 153: 557-567 (2008). *
Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, Morgan ET, Ntambi JM, Idle JR, Gonzalez FJ. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell. Metab. 7: 135-147 (2008). *
Chen D, Nie M, Fan MW, Bian Z. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis. Pharmacology 82: 264-269 (2008).
Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, Ulloa L, Yang H, Fan S, Goyert SM, Wang P, Tracey KJ, Sama AE, Wang H. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J. Leukoc. Biol. 76: 994-1001 (2004). *
Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J. Immunol. 179: 6097-6106 (2007). *
Chen J, Li C, Guan Y, Kong Q, Li C, Guo X, Chen Q, Jing X, Lv Z, An Y. Protection of mice from lethal Escherichia coli infection by chimeric human bactericidal/permeability-increasing protein and immunoglobulin G1 Fc gene delivery. Antimicrob. Agents Chemother. 51: 724-731 (2007). *
Chen J, Rao JN, Zou T, Liu L, Marasa BS, Xiao L, Zeng X, Turner DJ, Wang JY. Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G568-G576 (2007). *
Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 7: 1271-1285 (2007).
Chen LP, Cai M, Zhang QH, Li ZL, Qian YY, Bai HW, Wei X, Shi BY, Dong JH. Activation of interleukin-6/STAT3 in rat cholangiocyte proliferation induced by lipopolysaccharide. Dig. Dis. Sci. 54: 547-554 (2009). *
Chen LW, Huang HL, Lee IT, Hsu CM, Lu PJ. Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors. Crit. Care Med. 34: 1758-1768 (2006).
Chen Q, Yan CQ, Liu FJ, Tong J, Miao SL, Chen JP. Overexpression of the PDCD2-like gene results in Inhibited TNF-alpha production in activated Daudi cells. Hum. Immunol. 69: 259-265 (2008).
Chen S, Wong MH, Schulte DJ, Arditi M, Michelsen KS. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells. J. Endotoxin Res. 13: 281-296 (2007). *
Chen X, Noguchi K, Tanikawa K. Uptake of Escherichia coli lipopolysaccharide and expression of tumor necrosis factor-alpha-mRNA by isolated rat intrahepatic bile duct epithelial cells. Zhonghua Bing Li Xue Za Zhi 26: 78-81 (1997).
Chen Y, Chen Y, Liu WL, Zhou TH, Cai JT, Du Q, Wang LJ, Wu JG, Si JM. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats. J. Gastroenterol. Hepatol. Feb 4 [Epub ahead of print] (2009). *
Chen Y, Jiang G, Yang HR, Gu X, Wang L, Hsieh CC, Chou HS, Fung JJ, Qian S, Lu L. Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J. Hepatol. [In Press] (2009).
Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res. 65: 11771-11778 (2005). *
Chen YH, Wang JP, Wang H, Sun MF, Wei LZ, Wei W, Xu DX. Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology 211: 242-252 (2005). *
Chen Z, Takahashi M, Naruse T, Nakajima T, Chen YW, Inoue Y, Ishikawa I, Iwai T, Kimura A. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Hum. Genet. 122: 367-372 (2007). *
Cheng HM, Hsiang CY, Chen GW, Wu SL, Chen JC, Huang CY, Bau DT, Ho TY. Inhibition of lipopolysaccharide-induced interleukin-1beta and tumor necrosis factor-alpha production by menthone through nuclear factor-kappaB signaling pathway in HaCat cells. Chin. J. Physiol. 51: 160-166 (2008).
Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm. Bowel Dis. 12: 1152-1161 (2006). *
Cherayil BJ. How not to get bugged by bugs: mechanisms of cellular tolerance to microorganisms. Curr. Opin. Gastroenterol. 19: 572-577 (2003).
Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154: 5492-5499 (1995).
Cherrington NJ, Slitt AL, Li N, Klaassen CD. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab. Dispos. 32: 734-741 (2004). *
Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103: 2274-2279 (2006). *
Chia WT, Chen YW, Cheng LY, Lee HS, Chang DM, Sytwu HK. MMP-9 mRNA as a therapeutic marker in acute and chronic stages of arthritis induced by type II collagen antibody. J. Formos. Med. Assoc. 107: 245-252 (2008).
Chikanza IC, Kozaci D, Chernajovsky Y. The molecular and cellular basis of corticosteroid resistance. J. Endocrinol. 179: 301-310 (2003). *
Child NJ, Yang IA, Pulletz MC, de Courcy-Golder K, Andrews AL, Pappachan VJ, Holloway JW. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans. 31: 652-653 (2003). *
Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashimoto M, Yagita H, Nawata H, Yoshimura A. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFN-gamma and IL-4 are involved. Gastroenterology 130: 373-388 (2006). *
Chino A, Sakurai H, Choo MK, Koizumi K, Shimada Y, Terasawa K, Saiki I. Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages. Int. Immunopharmacol. 5: 871-882 (2005).
Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin. Liver Dis. 21: 27-41 (2001).
Chiu CC, Huang YT, Chuang HL, Chen HH, Chung TC. Co-exposure of lipopolysaccharide and Pseudomonas aeruginosa exotoxin A-induced multiple organ injury in rats. Immunopharmacol. Immunotoxicol. 31: 75-82 (2009).
Cho HH, Bae YC, Jung JS. Role of Toll-like receptors on human adipose-derived stromal cells. Stem Cells 24: 2744-2752 (2006). *
Cho JH. The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease. Inflamm. Bowel Dis. 7: 271-275 (2001). *
Cho JH. Update on the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 3: 458-463 (2001).
Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY, Lee SY, Park MK, Min JK, Park SH, Lee SH, Kim HY. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol. Lett. 108: 121-128 (2007).
Cho NH, Seong SY. Apolipoproteins inhibit the innate immunity activated by necrotic cells or bacterial endotoxin. Immunology Dec 17 [Epub ahead of print] (2008). *
Cho YC, Kim HJ, Kim YJ, Lee KY, Choi HJ, Lee IS, Kang BY. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. Int. Immunopharmacol. 8: 567-573 (2008).
Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis. Vet. Microbiol. 125: 80-90 (2007).
Choda Y, Morimoto Y, Miyaso H, Shinoura S, Saito S, Yagi T, Iwagaki H, Tanaka N. Failure of the gut barrier system enhances liver injury in rats: protection of hepatocytes by gut-derived hepatocyte growth factor. Eur. J. Gastroenterol. Hepatol. 16: 1017-1025 (2004).
Choi EJ, Ko HH, Lee MW, Bang H, Lee CS. Inhibition of activated responses in dendritic cells exposed to lipopolysaccharide and lipoteichoic acid by diarylheptanoid oregonin. Int. Immunopharmacol. 8: 748-755 (2008).
Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, Ballantyne CM, Constant SL, Aird WC, Papayannopoulou T, Gahmberg CG, Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322: 1101-1104 (2008). *
Choi J, Ha KH, Byun MS, Min SY, Park MJ, Park HS, Oh HJ, Ju JH, Kim HY, Jue DM. Treatment with N-tosyl-L-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation. Eur. J. Pharmacol. 595: 108-113 (2008).
Choi S, Choi HH, Lee SH, Ko SH, You HJ, Ye SK, Chung MH. Anti-inflammatory effects of 8-hydroxy-2'-deoxyguanosine on lipopolysaccharide-induced inflammation via Rac suppression in Balb/c mice. Free Radic. Biol. Med. 43: 1594-1603 (2007).
Chon H, Choi B, Lee E, Lee S, Jeong G. Immunomodulatory effects of specific bacterial components of Lactobacillus plantarum KFCC11389P on the murine macrophage cell line RAW 264.7. J. Appl. Microbiol. Apr 15 [Epub ahead of print] (2009). *
Chorny A, Gonzalez-Rey E, Delgado M. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation. Ann. N. Y. Acad. Sci. 1088: 187-194 (2006). *
Chowdhury P, Sacks SH, Sheerin NS. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin. Exp. Immunol. 145: 346-356 (2006). *
Chung J, Koyama T, Ohsawa M, Shibamiya A, Hoshi A, Hirosawa S. 1,25(OH)(2)D(3) blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-kappaB. Lab. Invest. 87: 540-547 (2007). *
Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK. Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147: 5340-5351 (2006). *
Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J. Biol. Chem. 275: 32681-32687 (2000). *
Ci X, Li H, Song Y, An N, Yu Q, Zeng F, Deng X. Ceftiofur regulates LPS-induced production of cytokines and improves LPS-induced survival rate in mice. Inflammation 31: 422-427 (2008). *
Cianchi G, De Gaudio AR, Zecchi Orlandini S, Martini M, Evangelista S. Endotoxin-mediated intestinal damage: protective effect of capsaicin in the rat. Scand. J. Gastroenterol. 33: 736-742 (1998). *
Cifelli CJ, Ross AC. All-trans-retinoic acid distribution and metabolism in vitamin A-marginal rats. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G195-G202 (2006). *
Cihakova D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 102: 175-194 (2004).
Cleland LG, Caughey GE, James MJ, Proudman SM. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. J. Rheumatol. 33: 1973-1979 (2006).
Collin M, Murch O, Thiemermann C. Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia. Crit. Care Med. 34: 1131-1138 (2006).
Combarros O, Infante J, Rodriguez E, Llorca J, Pena N, Fernandez-Viadero C, Berciano J. CD14 receptor polymorphism and Alzheimer's disease risk. Neurosci. Lett. 380: 193-196 (2005). *
Comeau JL, Lin TJ, Macken MB, Li B, Ku CL, von Bernuth H, Casanova JL, Issekutz AC. Staphylococcal pericarditis, and liver and paratracheal abscesses as presentations in two new cases of interleukin-1 receptor associated kinase 4 deficiency. Pediatr. Infect. Dis. J. 27: 170-174 (2008).
Cong Y, Oliver AO, Elson CO. Effects of cholera toxin on macrophage production of co-stimulatory cytokines. Eur. J. Immunol. 31: 64-71 (2001). *
Connor EE, Cates EA, Williams JL, Bannerman DD. Cloning and radiation hybrid mapping of bovine Toll-like receptor-4 (TLR-4) signaling molecules. Vet. Immunol. Immunopathol. 112: 302-308 (2006). *
Connor TJ, Starr N, O'Sullivan JB, Harkin A. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? Neurosci. Lett. 441: 29-34 (2008).
Constante M, Jiang W, Wang D, Raymond VA, Bilodeau M, Santos MM. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G229-G237 (2006). *
Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD. Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J. Virol. 80: 9151-9158 (2006). *
Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D; Inflammation and the Host Response to Injury Investigators. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12: 60-67 (2005). *
Corpechot C, Poupon R. Promoter polymorphism of the CD14 endotoxin receptor gene and primary biliary cirrhosis. Hepatology 35: 242-243 (2002). *
Corrales JJ, Almeida M, Burgo R, Mories MT, Miralles JM, Orfao A. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J. Endocrinol. 189: 595-604 (2006). *
Correa F, Docagne F, Mestre L, Loria F, Hernangomez M, Borrell J, Guaza C. Cannabinoid system and neuroinflammation: implications for multiple sclerosis. Neuroimmunomodulation 14: 182-187 (2007).
Corsini E, Racchi M, Sinforiani E, Lucchi L, Viviani B, Rovati GE, Govoni S, Galli CL, Marinovich M. Age-related decline in RACK-1 expression in human leukocytes is correlated to plasma levels of dehydroepiandrosterone. J. Leukoc. Biol. 77: 247-256 (2005). *
Costalonga M, Zell T. Lipopolysaccharide enhances in vivo interleukin-2 production and proliferation by naive antigen-specific CD4 T cells via a Toll-like receptor 4-dependent mechanism. Immunology 122: 124-130 (2007). *
Cowdery JS, Boerth NJ, Norian LA, Myung PS, Koretzky GA. Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J. Immunol. 162: 6770-6775 (1999). *
Crabb DW. Pathogenesis of alcoholic liver disease: newer mechanisms of injury. Keio. J. Med. 48: 184-188 (1999).
Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 23: 142-148 (2007).
Crawford JH, Yang S, Zhou M, Simms HH, Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit. Care Med. 32: 502-508 (2004).
Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Khanolkar M, Evans M, Harte AL, Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292: E740-E747 (2007). *
Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF, LPS, or hypoxia produce growth factors by an NFkB but not JNK dependent mechanism. Am. J. Physiol. Cell Physiol. 294: C675-C682 (2008). *
Crispe IN, Giannandrea M, Klein I, John B, Sampson B, Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol. Rev. 213: 101-118 (2006). *
Crocenzi FA, Mottino AD, Roma MG. Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention. Curr. Med. Chem. 11: 501-524 (2004).
Cruz M, Maldonado-Bernal C, Mondragon-Gonzalez R, Sanchez-Barrera R, Wacher NH, Carvajal-Sandoval G, Kumate J. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. J. Endocrinol. Invest. 31: 694-699 (2008).
Cuchacovich M, Merino G, Yamamoto JH, Villarroel F, Saavedra T, Jofre S, Gatica H, Velasquez V, Pizzo SV, Gonzalez-Gronow M. Behcet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation. Clin. Exp. Rheumatol. 23: S27-S34 (2005).
Cuenca J, Cuchacovich M, Perez C, Ferreira L, Aguirre A, Schiattino I, Soto L, Cruzat A, Salazar-Onfray F, Aguillon JC. The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology (Oxford) 42: 308-313 (2003). *
Cuenca J, Martin-Sanz P, Alvarez-Barrientos AM, Bosca L, Goren N. Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. Am. J. Pathol. 169: 1567-1576 (2006). *
Cui W, Wang Y, Ma L, Wen Y, Liu P. The impact of tumor necrosis factor alpha on expression of intestinal epithelial tight junction protein occludin in fulminant hepatic failure mice model. Zhonghua Nei Ke Za Zhi 46: 478-481 (2007).
Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF, Deacon RM, Rawlins JN, Perry VH. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 65: 304-312 (2009).
Currie CG, McCallum K, Poxton IR. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease. J. Med. Microbiol. 50: 345-354 (2001). *
Cuschieri J, Billgren J, Maier RV. Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14. J. Leukoc. Biol. 80: 407-414 (2006). *
Cuschieri J, Bulger E, Biligren J, Garcia I, Maier RV. Vitamin E inhibits endotoxin-mediated transport of phosphatases to lipid rafts. Shock 27: 19-24 (2007). *
Cuschieri J, Bulger E, Billgrin J, Garcia I, Maier RV. Acid sphingomyelinase is required for lipid raft TLR4 complex formation. Surg. Infect. (Larchmt.) 8: 91-106 (2007).
Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, Demichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res. 67: 1842-1852 (2007). *
Czeslick E, Struppert A, Simm A, Sablotzki A. E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes. Inflamm. Res. 55: 511-515 (2006). *
Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T. Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J. Immunol. 34: 2874 (2004). *
Dackor R, Caron K. Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock. Peptides 28: 2164-2170 (2007). *
Dagvadorj J, Naiki Y, Tumurkhuu G, Hassan F, Islam S, Koide N, Mori I, Yoshida T, Yokochi T. Interleukin-10 inhibits tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW 264.7 cells through reduced MyD88 expression. Innate Immun. 14: 109-115 (2008). *
Dai Q, Pruett SB. Ethanol suppresses LPS-induced Toll-like receptor 4 clustering, reorganization of the actin cytoskeleton, and associated TNF-alpha production. Alcohol Clin. Exp. Res. 30: 1436-1444 (2006).
Damen GM, Hol J, de Ruiter L, Bouquet J, Sinaasappel M, van der Woude J, Laman JD, Hop WC, Buller HA, Escher JC, Nieuwenhuis EE. Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 42: 142-149 (2006). *
Damsgaard CT, Lauritzen L, Calder PC, Kjaer TR, Frokiaer H. Reduced ex vivo interleukin-6 production by dietary fish oil is not modified by linoleic acid intake in healthy men. J. Nutr. Jun 3 [Epub ahead of print] (2009).
Dang HT, Lee HJ, Yoo ES, Hong J, Bao B, Choi JS, Jung JH. New jasmonate analogues as potential anti-inflammatory agents. Bioorg. Med. Chem. 16: 10228-10235 (2008). *
Dann SM, Eckmann L. Innate immune defenses in the intestinal tract. Curr. Opin. Gastroenterol. 23: 115-120 (2007).
Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect. Immun. 72: 5041-5051 (2004). *
Das R, Chen X, Komorowski R, Hessner MJ, Drobyski WR. Interleukin 23 secretion by donor antigen presenting cells is critical for organ-specific pathology in graft versus host disease. Blood 113: 2352-2362 (2009). *
Das S, Haddadi A, Veniamin S, Samuel J. Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34(+) progenitor-derived dendritic cells. J. Biomed. Mater. Res. A. 85: 983-992 (2008). *
Dasgupta S, Bandopadhyay M, Pahan K. Generation of functional blocking monoclonal antibodies against mouse interleukin-12 p40 homodimer and monomer. Hybridoma (Larchmt.) 27: 141-151 (2008).
Dasu MR, Devaraj S, Du Clos TW, Jialal I. Biological effects of C-reactive protein are not due to endotoxin contamination: evidence from Toll like receptor 4 knock-down human aortic endothelial cells. J. Lipid Res. 48: 509-512 (2007). *
Dasu MR, Park S, Devaraj S, Jialal I. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology Apr 23 [Epub ahead of print] (2009). *
Datta PK, Lianos EA. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. Kidney Int. 56: 486-493 (1999). *
Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 86: 9-22 (2006). *
Davey MP, Martin TM, Planck SR, Lee J, Zamora D, Rosenbaum JT. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvasc. Res. 71: 103-107 (2006). *
Davis MC, Zautra AJ, Younger J, Motivala SJ, Attrep J, Irwin MR. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav. Immun. 22: 24-32 (2008). *
Davtyan TK, Hakobyan GS, Avetisyan SA, Harutyunyan VA. Engaging anti-inflammatory mechanisms and triggering inflammatory effector apoptosis during Familial Mediterranean Fever attack. Inflamm. Res. 57: 65-74 (2008). *
Dawczynski C, Schubert R, Hein G, Muller A, Eidner T, Vogelsang H, Basu S, Jahreis G. Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Br. J. Nutr. 101: 1517-1526 (2009). *
Dawiskiba J, Kornafel P, Kwiatkowska D, Zimecki M. Alterations of tumor necrosis factor-alpha and interleukin 6 production and activity of the reticuloendothelial system in experimental obstructive jaundice in rats. HPB (Oxford) 4: 11-19 (2002). *
Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26: 1021-1028 (2006). *
Day CP. Alcoholic steatohepatitis (ASH). Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper�s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 85-86. October 17 - 19 (2003). *
Day CP. Alcoholic liver disease. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 77 (2005). *
De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 14: 1829-1836 (1994).
De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am. J. Clin. Nutr. 71: 213S-223S (2000). *
de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 6: 167-170 (2005). *
de Jong BA, Westendorp RG, Bakker AM, Huizinga TW. Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production. Genes Immun. 3: 25-29 (2002). *
de Kozak Y, Omri B, Smith JR, Naud MC, Thillaye-Goldenberg B, Crisanti P. Protein kinase Czeta (PKCzeta) regulates ocular inflammation and apoptosis in endotoxin-induced uveitis (EIU): signaling molecules involved in EIU resolution by PKCzeta inhibitor and interleukin-13. Am. J. Pathol. 170: 1241-1257 (2007). *
de la Fontaine L, Schwarz M, Plischke H, Kleindienst N, Gruber R. Lack of association of the CD14/C-159T polymorphism with susceptibility and serological activity parameters of rheumatoid arthritis. Scand. J. Rheumatol. 35: 20-22 (2006). *
De Libero G, Moran AP, Gober HJ, Rossy E, Shamshiev A, Chelnokova O, Mazorra Z, Vendetti S, Sacchi A, Prendergast MM, Sansano S, Tonevitsky A, Landmann R, Mori L. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22: 763-772 (2005). *
de Oliveira AC, Candelario-Jalil E, Bhatia HS, Lieb K, Hull M, Fiebich BL. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia 56: 844-855 (2008).
De Soyza A, Silipo A, Lanzetta R, Govan JR, Molinaro A. Review: chemical and biological features of Burkholderia cepacia complex lipopolysaccharides. Innate Immun. 14: 127-144 (2008). *
de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27: 537-541 (1995).
De Vries-Bouwstra JK, Goekoop-Ruiterman YP, Wesoly J, Hulsmans HJ, de Craen AJ, Breedveld FC, Dijkmans BA, Allaart CF, Huizinga TW. Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage. Ann. Rheum. Dis. 66: 1033-1037 (2007). *
Defaux A, Zurich MG, Braissant O, Honegger P, Monnet-Tschudi F. Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. J. Neuroinflammation 6: 15 (2009). *
Deghmane AE, Veckerle C, Giorgini D, Hong E, Ruckly C, Taha MK. Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis. PLoS Pathog. 5: e1000405 (2009). *
Deininger S, Traub S, Aichele D, Rupp T, Baris T, Moller HM, Hartung T, von Aulock S. Presentation of lipoteichoic acid potentiates its inflammatory activity. Immunobiology 213: 519-529 (2008).
Deitch EA. Role of bacterial translocation in necrotizing enterocolitis. Acta Paediatr. Suppl. 396: 33-36 (1994).
Deitch EA. Bacterial translocation: the influence of dietary variables. Gut 35: S23-S27 (1994). *
Dejager L, Libert C. Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice. Cytokine 42: 55-61 (2008).
del Fresno C, Garcia-Rio F, Gomez-Pina V, Soares-Schanoski A, Fernandez-Ruiz I, Jurado T, Kajiji T, Shu C, Marin E, Gutierrez del Arroyo A, Prados C, Arnalich F, Fuentes-Prior P, Biswas SK, Lopez-Collazo E. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J. Immunol. 182: 6494-6507 (2009).
del Fresno C, Gomez-Pina V, Lores V, Soares-Schanoski A, Fernandez-Ruiz I, Rojo B, Alvarez-Sala R, Caballero-Garrido E, Garcia F, Veliz T, Arnalich F, Fuentes-Prior P, Garc�a-R�o F, Lopez-Collazo E. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PLoS ONE 3: e2667 (2008). *
Del Turco S, Basta G, Lazzerini G, Evangelista M, Rainaldi G, Tanganelli P, Camera M, Tremoli E, De Caterina R. Parallel decrease of tissue factor surface exposure and increase of tissue factor microparticle release by the n-3 fatty acid docosahexaenoate in endothelial cells. Thromb. Haemost. 98: 210-219 (2007).
Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274: 32048-32054 (1999). *
Delgado M, Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis. Ann. N. Y. Acad. Sci. 1070: 233-238 (2006). *
Demengeot J, Zelenay S, Moraes-Fontes MF, Caramalho I, Coutinho A. Regulatory T cells in microbial infection. Springer Semin. Immunopathol. 28: 41-50 (2006). *
Demento SL, Eisenbarth SC, Foellmer HG, Platt C, Caplan MJ, Mark Saltzman W, Mellman I, Ledizet M, Fikrig E, Flavell RA, Fahmy TM. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27: 3013-3021 (2009).
Deng GM. Tumor necrosis factor receptor pre-ligand assembly domain is an important therapeutic target in inflammatory arthritis. BioDrugs 21: 23-29 (2007).
Deng J, Ma-Krupa W, Gewirtz AT, Younge BR, Goronzy JJ, Weyand CM. Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ. Res. 104: 488-495 (2009).
Deng X, Stachlewitz RF, Liguori MJ, Blomme EA, Waring JF, Luyendyk JP, Maddox JF, Ganey PE, Roth RA. Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation. J. Pharmacol. Exp. Ther. 319: 1191-1199 (2006). *
Denkers EY, Butcher BA, Del Rio L, Kim L. Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection. Immunol. Rev. 201: 191-205 (2004). *
Denson LA, Auld KL, Schiek DS, McClure MH, Mangelsdorf DJ, Karpen SJ. Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J. Biol. Chem. 275: 8835-8843 (2000). *
Dentener MA, Creutzberg EC, Pennings HJ, Rijkers GT, Mercken E, Wouters EF. Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration 76: 275-282 (2008).
Dentener MA, Francot GJ, Buurman WA. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes. J. Infect. Dis. 173: 252-255 (1996).
Dentener MA, Francot GJ, Smit FT, Froon AH, Pennings HJ, Wouters EF, Buurman WA. Presence of bactericidal/permeability-increasing protein in disease: detection by ELISA. J. Infect. Dis. 171: 739-743 (1995).
Dentener MA, Smit FT, Francot GJ, Buurman WA. Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein. J. Infect. Dis. 170: 1483-1489 (1994).
Dentovskaya SV, Bakhteeva IV, Titareva GM, Shaikhutdinova RZ, Kondakova AN, Bystrova OV, Lindner B, Knirel YA, Anisimov AP. Structural diversity and endotoxic activity of the lipopolysaccharide of Yersinia pestis. Biochemistry (Mosc.) 73: 192-199 (2008).
Desai A, Konda VR, Darland G, Austin M, Prabhu KS, Bland JS, Carroll BJ, Tripp ML. META060 inhibits multiple kinases in the NF-kB pathway and suppresses LPS-mediated inflammation in vitro and ex vivo. Inflamm. Res. 58: 229-234 (2009). *
Desiderio S, Yoo JY. A genome-wide analysis of the acute-phase response and its regulation by Stat3beta. Ann. N. Y. Acad. Sci. 987: 280-284 (2003). *
Devaux Y, Grosjean S, Seguin C, David C, Dousset B, Zannad F, Meistelman C, De Talance N, Mertes PM, Ungureanu-Longrois D. Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo. Am. J. Physiol. Endocrinol. Metab. 279: E1045-E1053 (2000). *
Devaux Y, Seguin C, Grosjean S, de Talance N, Schwartz M, Burlet A, Zannad F, Meistelman C, Mertes PM, Ungureanu-Longrois D. Retinoic acid and lipopolysaccharide act synergistically to increase prostanoid concentrations in rats in vivo. J. Nutr. 131: 2628-2635 (2001). *
Devine DA. Antimicrobial peptides in defence of the oral and respiratory tracts. Mol. Immunol. 40: 431-443 (2003). *
Dheen ST, Jun Y, Yan Z, Tay SS, Ling EA. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 50: 21-31 (2005).
Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM, Paulli M, Cifone MG, Corazza GR. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55: 469-477 (2006). *
Diaz-Ropero MP, Martin R, Sierra S, Lara-Villoslada F, Rodriguez JM, Xaus J, Olivares M. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J. Appl. Microbiol. 102: 337-343 (2007). *
Diaz-Viciedo R, Hortelano S, Giron N, Masso JM, Rodriguez B, Villar A, de Las Heras B. Modulation of inflammatory responses by diterpene acids from Helianthus annuus L. Biochem. Biophys. Res. Commun. 369: 761-766 (2008). *
Dick EP, Prince LR, Prestwich EC, Renshaw SA, Whyte MK, Sabroe I. Pathways regulating lipopolysaccharide-induced neutrophil survival revealed by lentiviral transduction of primary human neutrophils. Immunology 127: 249-255 (2009).
Dickinson MA, Harnett EL, Venditti CC, Smith GN. Transient lipopolysaccharide-induced cytokine responses in the maternal serum and amniotic fluid of the guinea pig. Am. J. Obstet. Gynecol. 200: 534.e1-e6 (2009).
Diczfalusy U, Olofsson KE, Carlsson AM, Gong M, Golenbock DT, Rooyackers O, Flaring U, Bjorkbacka H. Marked up-regulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. Jun 5 [Epub ahead of print] (2009). *
Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, Kaslin E, Sirard JC, Angelov G, Tschopp J, Burns K. Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol. Cell. Biol. 26: 735-742 (2006). *
Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105: 1323-1332 (1993).
Dijkstra IM, de Haas AH, Brouwer N, Boddeke HW, Biber K. Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo. Glia 54: 861-872 (2006).
Dikopoulos N, Schmid RM, Bachem M, Buttenschoen K, Adler G, Chiang JY, Weidenbach H. Bile synthesis in rat models of inflammatory bowel diseases. Eur. J. Clin. Invest. 37: 222-230 (2007). *
Dikopoulos N, Weidenbach H, Adler G, Schmid RM. Lipopolysaccharide represses cholesterol 7-alpha hydroxylase and induces binding activity to the bile acid response element II. Eur. J. Clin. Invest. 33: 58-64 (2003). *
Diks SH, Kok K, O'Toole T, Hommes DW, Van Dijken P, Joore J, Peppelenbosch MP. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 279: 49206-49213 (2004). *
Diks SH, van Deventer SJ, Peppelenbosch MP. Lipopolysaccharide recognition, internalisation, signalling and other cellular effects. J. Endotoxin Res. 7: 335-348 (2001). *
DiMagno MJ, Lee SH, Hao Y, Zhou Sy, McKenna BJ, Owyang C. A proinflammatory, anti-apoptotic phenotype underlies the susceptibility to acute pancreatitis in UNC cftr (-/-) mice. Gastroenterology 129: 665-681 (2005). *
Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409 (1995). *
Ding G, Cheng L, Qin Q, Frontin S, Yang Q. PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J. Mol. Cell. Cardiol. 40: 821-828 (2006). *
Ding LA, Li JS, Li YS, Zhu NT, Liu FN, Tan L. Intestinal barrier damage caused by trauma and lipopolysaccharide. World J. Gastroenterol. 10: 2373-2378 (2004). *
Dings RP, Haseman JR, Mayo KH. Probing structure-activity relationships in bactericidal peptide betapep-25. Biochem. J. 414: 143-150 (2008). *
Dionne S, Laberge S, Deslandres C, Seidman EG. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease. Clin. Exp. Immunol. 133: 108-114 (2003). *
Distante S, Elmberg M, Foss Haug KB, Ovstebo R, Berg JP, Kierulf P, Hultcrantz R, Bell H. Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis. Scand. J. Gastroenterol. 38: 871-877 (2003). *
Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114: 57-66 (2004). *
Diya Zhang , Lili Chen , Shenglai Li , Zhiyuan Gu , Jie Yan. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun. 14: 99-107 (2008). *
Dobbs BR, Rogers GW, Xing HY, Fraser R. Endotoxin-induced defenestration of the hepatic sinusoidal endothelium: a factor in the pathogenesis of cirrhosis? Liver 14: 230-233 (1994).
Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27: 277-285 (2001). *
Dohnal AM, Luger R, Paul P, Fuchs D, Felzmann T. CD40 ligation restores type 1 polarizing capacity in TLR4 activated dendritic cells that have ceased interleukin-12 expression. J. Cell. Mol. Med. Nov 8 [Epub ahead of print] (2008). *
Dolganiuc A, Bakis G, Kodys K, Mandrekar P, Szabo G. Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts. Alcohol Clin. Exp. Res. 30: 76-85 (2006). *
Dombrecht EJ, Aerts NE, Schuerwegh AJ, Hagendorens MM, Ebo DG, Van Offel JF, Bridts CH, Stevens WJ, De Clerck LS. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 24: 31-37 (2006).
Dong L, Li H, Wang S, Li Y. Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. J. Asthma 46: 229-233 (2009).
Dong L, Wang S, Chen M, Li H, Bi W. The activation of macrophage and upregulation of CD40 costimulatory molecule in lipopolysaccharide-induced acute lung injury. J. Biomed. Biotechnol. 2008: 852571 (2008). *
Dong Y, Hou W, Wei J, Weiner C. Chronic hypoxemia absent bacterial infection is one cause of the fetal inflammatory response syndrome (FIRS). Reprod. Sci. 16: 650-656 (2009).
Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J. Leukoc. Biol. 79: 797-802 (2006). *
Donner MG, Warskulat U, Saha N, Haussinger D. Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol. Chem. 385: 331-339 (2004).
Dos Santos Mendes S, Candi A, Vansteenbrugge M, Pignon MR, Bult H, Boudjeltia KZ, Munaut C, Raes M. Microarray analyses of the effects of NFkappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells. Synergistic effects of rapamycin on LPS induced MMP9-overexpression. Cell Signal. 21: 1109-1122 (2009). *
Doshi M, Watanabe S, Niimoto T, Kawashima H, Ishikura Y, Kiso Y, Hamazaki T. Effect of dietary enrichment with n-3 polyunsaturated fatty acids (PUFA) or n-9 PUFA on arachidonate metabolism in vivo and experimentally induced inflammation in mice. Biol. Pharm. Bull. 27: 319-323 (2004). *
Dotsch J, Puls J, Klimek T, Rascher W. Reduction of neuronal and inducible nitric oxide synthase gene expression in patients with cystic fibrosis. Eur. Arch. Otorhinolaryngol. 259: 222-226 (2002).
Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Top. HIV Med. 15: 114-117 (2007). *
Douwes J, Le Gros G, Gibson P, Pearce N. Can bacterial endotoxin exposure reverse atopy and atopic disease? J. Allergy Clin. Immunol. 114: 1051-1054 (2004). *
Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin LL. Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J. Immunol. 180: 3520-3534 (2008). *
Doyle SL, O'Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 72: 1102-1113 (2006). *
Dschietzig T, Bartsch C, Baumann G, Stangl K. RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway. Regul. Pept. 154: 77-84 (2009).
Du T, Zhou ZG, You S, Huang G, Lin J, Yang L, Li X, Zhou WD, Chao C. Modulation of monocyte hyperresponsiveness to TLR ligands by 1,25-dihydroxy-vitamin D3 from LADA and T2DM. Diabetes Res. Clin. Pract. 83: 208-214 (2009).
Du T, Zhou ZG, You S, Lin J, Yang L, Zhou WD, Huang G, Chao C. Regulation by 1,25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin. Chim. Acta 402: 133-138 (2009). *
Duan RS, Jin T, Yang X, Mix E, Adem A, Zhu J. Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells. Glia 55: 772-776 (2007).
Duan ZX, Zhu PF, Dong H, Gu W, Yang C, Liu Q, Wang ZG, Jiang JX. Functional significance of the TLR4/11367 polymorphism identified in Chinese Han population. Shock 28: 160-164 (2007).
Duenas AI, Orduna A, Sanchez Crespo M, Garcia-Rodriguez C. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int. Immunol. 16: 1467-1475 (2004). *
Duerr RH. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132: 2045-2049 (2007). *
Dunn AC, Walmsley RS, Dedrick RL, Wakefield AJ, Lockwood CM. Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain. J. Infect. 39: 81-87 (1999).
Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 6: 52-68 (2006).
Dunn-Siegrist I, Leger O, Daubeuf B, Poitevin Y, Depis F, Herren S, Kosco-Vilbois M, Dean Y, Pugin J, Elson G. Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J. Biol. Chem. 282: 34817-34827 (2007). *
Dunne A, O'Neill L. New insights into the post-translational modification of Toll-like receptor signaling molecules. J. Endotoxin Res. 11: 325-332 (2005). *
Dunzendorfer S, Lee HK, Soldau K, Tobias PS. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J. Immunol. 173: 1166-1170 (2004). *
Duvigneau JC, Piskernik C, Haindl S, Kloesch B, Hartl RT, Huttemann M, Lee I, Ebel T, Moldzio R, Gemeiner M, Redl H, Kozlov AV. A novel endotoxin-induced pathway: upregulation of heme oxygenase 1, accumulation of free iron, and free iron-mediated mitochondrial dysfunction. Lab. Invest. 88: 70-77 (2008). *
Dziarski R, Gupta D. Peptidoglycan recognition in innate immunity. J. Endotoxin Res. 11: 304-310 (2005). *
Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J. Immunol. 166: 1938-1944 (2001). *
Eastin CE, McClain CJ, Lee EY, Bagby GJ, Chawla RK. Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. Alcohol Clin. Exp. Res. 21: 1037-1041 (1997). *
Eberl M, Roberts GW, Meuter S, Williams JD, Topley N, Moser B. A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog. 5: e1000308 (2009). *
Eckert M, Wittmann I, Rollinghoff M, Gessner A, Schnare M. Endotoxin-induced expression of murine bactericidal permeability/increasing protein is mediated exclusively by Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta-dependent pathways. J. Immunol. 176: 522-528 (2006). *
Eckhardt A, Harorli T, Limtanyakul J, Hiller KA, Bosl C, Bolay C, Reichl FX, Schmalz G, Schweikl H. Inhibition of cytokine and surface antigen expression in LPS-stimulated murine macrophages by triethylene glycol dimethacrylate. Biomaterials 30: 1665-1674 (2009). *
Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections. Curr. Opin. Gastroenterol. 22: 95-101 (2006).
Edelman DA, Jiang Y, Tyburski J, Wilson RF, Steffes C. Toll-like receptor-4 message is up-regulated in lipopolysaccharide-exposed rat lung pericytes. J. Surg. Res. 134: 22-27 (2006). *
Edelman DA, Jiang Y, Tyburski JG, Wilson RF, Steffes CP. Lipopolysaccharide activation of pericyte's Toll-like receptor-4 regulates co-culture permeability. Am. J. Surg. 193: 730-735 (2007). *
Edelman DA, Jiang Y, Tyburski JG, Wilson RF, Steffes CP. Cytokine production in lipopolysaccharide-exposed rat lung pericytes. J. Trauma 62: 89-93 (2007).
Edfeldt K, Bennet AM, Eriksson P, Frostegard J, Wiman B, Hamsten A, Hansson GK, Faire Ud U, Yan ZQ. Association of hypo-responsive Toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25: 1447-1453 (2004). *
Edwards RA, Smock AZ. Defective arachidonate release and PGE2 production in Gialpha2-deficient intestinal and colonic subepithelial myofibroblasts. Inflamm. Bowel Dis. 12: 153-165 (2006). *
Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM, Robine S, Karin M, Kagnoff MF. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 101: 2452-2457 (2004). *
Egawa K, Yoshida M, Sakaino R, Kasai N. Hepatic drug-metabolizing enzyme system and endotoxin tolerance: structural requirement of LPS in induction of an early tolerance. Microbiol. Immunol. 28: 1181-1190 (1984).
El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol. Lett. 111: 36-44 (2007).
El Temple S, Pham K, Glendenning P, Phillips M, Waterer GW. Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: correlation with elevated expression of TLR4. Cell. Immunol. 251: 69-71 (2008). *
El-Beshbishy HA. Aqueous garlic extract attenuates hepatitis and oxidative stress induced by galactosamine/lipoploysaccharide in rats. Phytother. Res. 22: 1372-1379 (2008).
El-Remessy AB, Tang Y, Zhu G, Matragoon S, Khalifa Y, Liu EK, Liu JY, Hanson E, Mian S, Fatteh N, Liou GI. Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. Mol. Vis. 14: 2190-2203 (2008). *
El-Taukhy MA, Salama SM, Abou-Shousha SA, Ismail SS, Saleh M. Effects of chronic ethanol and vitamin C administration on production of tumor necrosis factor-alpha and interleukin-6 in rats. Egypt. J. Immunol. 13: 1-10 (2006).
Eley HL, Russell ST, Tisdale MJ. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am. J. Physiol. Endocrinol. Metab. 295: E1409-E1416 (2008). *
Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, Groothuis GM. LPS-induced down-regulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1008-G1016 (2004). *
Elias E. Hepatology highlights. Hepatology 39: 1467-1468 (2004). *
Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B. Effects of resveratrol in inflammatory arthritis. Inflammation 30: 1-6 (2007). *
Elner SG, Petty HR, Elner VM, Yoshida A, Bian ZM, Yang D, Kindezelskii AL. TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression. Trans. Am. Ophthalmol. Soc. 103: 126-137 (2005). *
Elsakka NE, Webster NR, Galley HF. Polymorphism in the manganese superoxide dismutase gene. Free Radic. Res. 41: 770-778 (2007). *
Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J. Leukoc. Biol. 64: 14-18 (1998). *
Elsbach P. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin. Ciba Found. Symp. 186: 176-187 (1994).
Elsbach P. Recent advances in therapy of sepsis: focus on recombinant bactericidal/permeability-increasing protein (BPI). BioDrugs. 9: 435-442 (1998).
Elsbach P, Weiss J. Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections. Infect. Agents Dis. 4: 102-109 (1995).
Elsbach P, Weiss J. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Curr. Opin. Immunol. 5: 103-107 (1993).
Elsbach P, Weiss J. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187: 417-429 (1993).
Elsbach P, Weiss J. Role of the bactericidal/permeability-increasing protein in host defence. Curr. Opin. Immunol. 10: 45-49 (1998).
Elsbach P, Weiss J, Doerfler M, Shu C, Kohn F, Ammons WS, Kung AH, Meszaros KK, Parent JB. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo. Prog. Clin. Biol. Res. 388: 41-51 (1994).
Elson CO, Kagnoff MF, Fiocchi C, Befus AD, Targan S. Intestinal immunity and inflammation: recent progress. Gastroenterology 91: 746-768 (1986).
Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to gram-negative and gram-positive bacteria. Blood 109: 1574-1583 (2007). *
Elvevoll EO, Barstad H, Breimo ES, Brox J, Eilertsen KE, Lund T, Olsen JO, Osterud B. Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. Lipids 41: 1109-1114 (2006).
Emingil G, Berdeli A, Baylas H, Saygan BH, Gurkan A, Kose T, Atilla G. Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis. J. Periodontol. 78: 1968-1977 (2007).
Enders GA, Ballhaus S, Brendel W. The influence of Peyer's patches on the organ-specific distribution of IgA plasma cells. Immunology 63: 411-414 (1988). *
Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320: 265-271 (1989).
Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TM. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun. 5: 426-430 (2004). *
Equils O, Naiki Y, Shapiro AM, Michelsen K, Lu D, Adams J, Jordan S. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin. Exp. Immunol. 143: 58-64 (2006). *
Equils O, Shapiro A, Madak Z, Liu C, Lu D. Human immunodeficiency virus type 1 protease inhibitors block Toll-like receptor 2 (TLR2)- and TLR4-induced NF-kappaB activation. Antimicrob. Agents Chemother. 48: 3905-3911 (2004). *
Ergin A, Bussow K, Sieper J, Thiel A, Duchmann R, Adam T. Homologous high-throughput expression and purification of highly conserved E. coli proteins. Microb. Cell Fact. 6: 18 (2007). *
Ermolaeva MA, Michallet MC, Papadopoulou N, Utermohlen O, Kranidioti K, Kollias G, Tschopp J, Pasparakis M. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat. Immunol. 9: 1037-1046 (2008). *
Erridge C, Moncayo-Nieto OL, Morgan R, Young M, Poxton IR. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. J. Med. Microbiol. 56: 165-171 (2007). *
Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2. J. Med. Microbiol. 53: 735-740 (2004). *
Erridge C, Spickett CM, Webb DJ. Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2. Cardiovasc. Res. 73: 181-189 (2007). *
Erridge C, Stewart J, Poxton IR. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197: 1787-1791 (2003). *
Esen N, Kielian T. Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs). J. Neuroinflammation 4: 10 (2007). *
Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas 61: 122-131 (2008).
Esters N, Pierik M, van Steen K, Vermeire S, Claessens G, Joossens S, Vlietinck R, Rutgeerts P. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am. J. Gastroenterol. 99: 299-305 (2004). *
Evans HG, Gullick NJ, Kelly S, Pitzalis C, Lord GM, Kirkham BW, Taams LS. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc. Natl. Acad. Sci. U.S.A. 106: 6232-6237 (2009). *
Everett B, Cameron B, Li H, Vollmer-Conna U, Davenport T, Hickie I, Wakefield D, Vernon S, Reeves WC, Lloyd AR. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever. Genes Immun. 8: 699-702 (2007). *
Ewaschuk J, Endersby R, Thiel D, Diaz H, Backer J, Ma M, Churchill T, Madsen K. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46: 841-850 (2007). *
Ewer AK, Al-Salti W, Coney AM, Marshall JM, Ramani P, Booth IW. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 53: 207-213 (2004). *
Fageras Bottcher M, Hmani-Aifa M, Lindstrom A, Jenmalm MC, Mai XM, Nilsson L, Zdolsek HA, Bjorksten B, Soderkvist P, Vaarala O. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J. Allergy Clin. Immunol. 114: 561-567 (2004). *
Fagone P, Gunter C, Sage CR, Gunn KE, Brewer JW, Jackowski S. CTP:phosphocholine cytidylyltransferase alpha is required for B-cell proliferation and class switch recombination. J. Biol. Chem. 284: 6847-6854 (2009). *
Fahy RJ, Wewers MD. Pulmonary defense and the human cathelicidin hCAP-18/LL-37. Immunol. Res. 31: 75-89 (2005). *
Fainaru O, Shseyov D, Hantisteanu S, Groner Y. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc. Natl. Acad. Sci. U.S.A. 102: 10598-10603 (2005). *
Faisal A, Saurin A, Gregory B, Foxwell B, Parker PJ. The scaffold MyD88 acts to couple protein kinase Cepsilon to Toll-like receptors. J. Biol. Chem. 283: 18591-18600 (2008). *
Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212 (2003). *
Fan H, Zingarelli B, Harris V, Tempel GE, Halushka PV, Cook JA. Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: potential anti-inflammatory signaling pathways. Mol. Med. 14: 422-428 (2008). *
Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, Vodovotz Y, Yang H, Tracey KJ, Billiar TR, Wilson MA. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J. Immunol. 178: 6573-6580 (2007). *
Fan Y, Wu SD, Sun L, Fu BB, Su Y. Possible relationship between intestinal barrier function and formation of pigment gallstones in hamsters. Hepatobiliary Pancreat. Dis. Int. 7: 529-532 (2008). *
Fang C, Yoon S, Tindberg N, Jarvelainen HA, Lindros KO, Ingelman-Sundberg M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem. Pharmacol. 67: 1389-1397 (2004). *
Fang CW, Yao YM, Zhai HX, Yu Y, Wu Y, Lu LR, Sheng ZY, Y Sheng C. Tissue lipopolysaccharide-binding protein expression in rats after thermal injury: potential role of TNF-alpha. Burns 30: 225-231 (2004).
Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR, Sheng ZY. Effect of recombinant bactericidal/permeability-increasing protein on endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression in rats after thermal injury. Crit. Care Med. 29: 1452-1459 (2001).
Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int. 28: 1026-1033 (2008). *
Farkas L, Stoelcker B, Jentsch N, Heitzer S, Pfeifer M, Schulz C. Muramyldipeptide modulates CXCL-8 release of BEAS-2B cells via NOD2. Scand. J. Immunol. 68: 315-322 (2008). *
Farrar WE Jr, Corwin LM, Kent TH. Mitochondrial fatty acid oxidation and susceptibility to endotoxin in acute liver injury. J. Bacteriol. 90: 1365-1372 (1965). *
Fedele G, Celestino I, Spensieri F, Frasca L, Nasso M, Watanabe M, Remoli ME, Coccia EM, Altieri F, Ausiello CM. Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response. Microbes Infect. 9: 855-863 (2007). *
Fedele G, Nasso M, Spensieri F, Palazzo R, Frasca L, Watanabe M, Ausiello CM. Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J. Immunol. 181: 208-216 (2008).
Fedyk ER, Phipps RP. Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc. Natl. Acad. Sci. U.S.A. 93: 10978-10983 (1996). *
Feillet H, Bach JF. Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? Curr. Opin. Gastroenterol. 20: 560-564 (2004).
Feingold K, Kim MS, Shigenaga J, Moser A, Grunfeld C. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am. J. Physiol. Endocrinol. Metab. 286: E201-E207 (2004). *
Feleszko W, Jaworska J, Hamelmann E. Toll-like receptors-novel targets in allergic airway disease (probiotics, friends and relatives). Eur. J. Pharmacol. 533: 308-318 (2006). *
Ferguson JW, Dover AR, Chia S, Cruden NL, Hayes PC, Newby DE. Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites. Gut 55: 542-546 (2006). *
Fernandez ED, Flohe S, Siemers F, Nau M, Ackermann M, Ruwe M, Schade FU. Endotoxin tolerance protects against local hepatic ischemia/reperfusion injury in the rat. J. Endotoxin Res. 6: 321-328 (2000). *
Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A. Anti-inflammatory role for intracellular dimeric immunoglobulin A by neutralization of lipopolysaccharide in epithelial cells. Immunity 18: 739-749 (2003). *
Fernandez-Irigoyen J, Santamaria M, Sanchez-Quiles V, Latasa MU, Santamar�a E, Munoz J, Sanchez Del Pino MM, Valero ML, Prieto J, Avila MA, Corrales FJ. Redox regulation of methylthioadenosine phosphorylase in liver cells: molecular mechanism and functional implications. Biochem. J. 411: 457-465 (2008). *
Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, Netea MG. Functional consequences of Toll-like receptor 4 polymorphisms. Mol. Med. 14: 346-352 (2008). *
Finnerty K, Choi JE, Lau A, Davis-Gorman G, Diven C, Seaver N, Linak WP, Witten M, McDonagh PF. Instillation of coarse ash particulate matter and lipopolysaccharide produces a systemic inflammatory response in mice. J. Toxicol. Environ. Health A. 70: 1957-1966 (2007). *
Fiocchi C, Battisto JR, Farmer RG. Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides. Dig. Dis. Sci. 26: 728-736 (1981).
Firpo MA, Rollins MD, Szabo A, Gull JD, Jackson JD, Shao Y, Glasgow RE, Mulvihill SJ. A conscious mouse model of gastric ileus using clinically relevant endpoints. BMC Gastroenterol. 5: 18 (2005). *
Fischer H, Ellstrom P, Ekstrom K, Gustafsson L, Gustafsson M, Svanborg C. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell. Microbiol. 9: 1239-1251 (2007). *
Fischer R, Reinehr R, Lu TP, Schonicke A, Warskulat U, Dienes HP, Haussinger D. Intercellular communication via gap junctions in activated rat hepatic stellate cells. Gastroenterology 128: 433-448 (2005). *
Fiset PO, Tulic MK, Skrablin PS, Grover SM, Letuve S, Mazer BD, Hamid Q. Signal transducer and activator of transcription 6 down-regulates Toll-like receptor-4 expression of a monocytic cell line. Clin. Exp. Allergy 36: 158-165 (2006). *
Fisher CJ Jr, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study. Crit. Care Med. 22: 553-558 (1994).
Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83 (2001). *
Fitzpatrick LR, Small J, Hoerr RA, Bostwick EF, Maines L, Koltun WA. In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis. Br. J. Nutr. 100: 530-541 (2008). *
Fletcher MA, McKenna TM, Quance JL, Wainwright NR, Williams TJ. Lipopolysaccharide detoxification by endotoxin neutralizing protein. J. Surg. Res. 55: 147-154 (1993).
Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ferrara JL, Ward PA. Adverse functions of IL-17A in experimental sepsis. FASEB J. 22: 2198-2205 (2008). *
Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, Gao H, Van Rooijen N, Huber-Lang MS, Neubig RR, Ward PA. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449: 721-725 (2007). *
Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br. J. Dermatol. 152: 202-216 (2005). *
Flynn MG, McFarlin BK. Toll-like receptor 4: link to the anti-inflammatory effects of exercise? Exerc. Sport Sci. Rev. 34: 176-181 (2006).
Focareta A, Paton JC, Morona R, Cook J, Paton AW. A recombinant probiotic for treatment and prevention of cholera. Gastroenterology 130: 1688-1695 (2006). *
Folwaczny M, Glas J, Torok HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin. Exp. Immunol. 135: 330-335 (2004). *
Fontaine C, Rigamonti E, Nohara A, Gervois P, Teissier E, Fruchart JC, Staels B, Chinetti-Gbaguidi G. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ. Res. 101: 40-49 (2007). *
Fontana S, Moratto D, Mangal S, De Francesco M, Vermi W, Ferrari S, Facchetti F, Kutukculer N, Fiorini C, Duse M, Das PK, Notarangelo LD, Plebani A, Badolato R. Functional defects of dendritic cells in patients with CD40 deficiency. Blood 102: 4099-4106 (2003). *
Forchielli ML, Walker WA. The role of gut-associated lymphoid tissues and mucosal defence. Br. J. Nutr. 93 Suppl. 1: S41-S48 (2005). *
Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43: 163-172 (2009).
Foss NT, Foss-Freitas MC, Ferreira MA, Cardili RN, Barbosa CM, Foss MC. Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients. Diabetes Metab. 33: 439-443 (2007).
Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control. Ann. N. Y. Acad. Sci. 1079: 177-180 (2006). *
Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978 (2007). *
Fox ES, Thomas P, Broitman SA. Clearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology 96: 456-461 (1989).
Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, Jagirdar R, Inohara N, Vandenabeele P, Bertin J, Coyle A, Grant EP, Nunez G. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in Salmonella-infected macrophages. Nat. Immunol. 7: 576-582 (2006). *
Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-992 (2004). *
Frank J, Witte K, Schrodl W, Schutt C. Chronic alcoholism causes deleterious conditioning of innate immunity. Alcohol. Alcohol. 39: 386-392 (2004). *
Franke A, Lante W, Kurig E, Zoeller LG, Kollig E, Markewitz A. Postoperative PMBC-derived IL-6 and TNF-alpha-release is uninfluenced by IL-12-mediated restoration of IFN-gamma synthesis. Scand. Cardiovasc. J. 43: 136-144 (2009).
Fraser DA, Bohlson SS, Jasinskiene N, Rawal N, Palmarini G, Ruiz S, Rochford R, Tenner AJ. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J. Leukoc. Biol. 80: 107-116 (2006). *
Fraunberger P, Grone E, Grone HJ, Walli AK. Simvastatin reduces endotoxin-induced NF-kappaB activation and mortality in guinea pigs despite lowering circulating LDL cholesterol. Shock Nov 11 [Epub ahead of print] (2008).
Freedman SD, Weinstein D, Blanco PG, Martinez-Clark P, Urman S, Zaman M, Morrow JD, Alvarez JG. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid. J. Appl. Physiol. 92: 2169-2176 (2002). *
Frey T, De Maio A. Increased expression of CD14 in macrophages after inhibition of the cholesterol biosynthetic pathway by lovastatin. Mol. Med. 13: 592-604 (2007). *
Fries W, Renda MC, Lo Presti MA, Raso A, Orlando A, Oliva L, Giofre MR, Maggio A, Mattaliano A, Macaluso A, Cottone M. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am. J. Gastroenterol. 100: 2730-2736 (2005). *
Fritz JH, Girardin SE. How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J. Endotoxin Res. 11: 390-394 (2005). *
Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, Caroff M, Cavaillon JM, Philpott DJ, Adib-Conquy M. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 35: 2459-2470 (2005). *
Frost RA, Lang CH. Regulation of muscle growth by pathogen associated molecules. J. Anim. Sci. 86: E84-E93 (2008).
Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in mouse skeletal muscle and C2C12 myoblasts via Toll-like receptor-4 and c-Jun NH2-terminal kinase pathways. Am. J. Physiol. Cell Physiol. 287: C1605-C1615 (2004). *
Fujigaki H, Saito K, Fujigaki S, Takemura M, Sudo K, Ishiguro H, Seishima M. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear � J. Biochem. 139: 655-662 (2006). *
Fujimoto T, Yamazaki S, Eto-Kimura A, Takeshige K, Muta T. The amino-terminal region of Toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J. Biol. Chem. 279: 47431-47437 (2004). *
Fujita S, Arii S, Monden K, Adachi Y, Funaki N, Higashitsuji H, Furutani M, Mise M, Ishiguro S, Kitao T, et al. Participation of hepatic macrophages and plasma factors in endotoxin-induced liver injury. J. Surg. Res. 59: 263-270 (1995). *
Fujita S, Arii S, Monden K, Ishiguro S, Nakamura T, Mizumoto M, Imamura M. The preventive effects of OK432 on endotoxin-induced liver injury: liver protection by the modulation of hepatic macrophage function. Surg. Today 26: 29-35 (1996).
Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, Xu R, Inoue H, Arditi M, Dannenberg AJ, Abreu MT. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877 (2006). *
Fukuda Y, Tao Y, Tomita T, Hori K, Fukunaga K, Noguchi T, Hayashi T, Shimoyama T, Tahahashi R. A traditional Japanese medicine mitigates TNBS-induced colitis in rats. Scand. J. Gastroenterol. 41: 1183-1189 (2006). *
Fukui H. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcohol Clin. Exp. Res. 29: 172S-179S (2005).
Fukushima K, Sasaki I, Takahashi K, Naito H, Ogawa H, Sato S, Matsuno S. Lipopolysaccharide exhibits synergistic enhancement of butyrate-induced and retinoic acid-mediated alkaline phosphatase activity on small intestinal epithelial cell line, IEC-6. Digestion 59: 683-688 (1998).
Fukushima T, Matsuzawa SI, Kress CL, Bruey JM, Krajewska M, Lefebvre S, Zapata JM, Ronai Z, Reed JC. Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc. Natl. Acad. Sci. U.S.A. 104: 6371-6376 (2007). *
Fung E, Tang SM, Canner JP, Morishige K, Arboleda-Velasquez JF, Cardoso AA, Carlesso N, Aster JC, Aikawa M. Delta-like 4 induces Notch signaling in macrophages: implications for inflammation. Circulation 115: 2948-2956 (2007). *
Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, Israel A, Courtois G, D'Urso M, Ursini MV. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Hum. Mol. Genet. 13: 1763-1773 (2004). *
Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schurmeyer TH, Ehlert U. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 30: 188-198 (2005).
Gabler NK, Spencer JD, Webel DM, Spurlock ME. n-3 PUFA attenuate lipopolysaccharide-induced down-regulation of Toll-like receptor 4 expression in porcine adipose tissue but does not alter the expression of other immune modulators. J. Nutr. Biochem. 19: 8-15 (2008). *
Galbois A, Thabut D, Tazi KA, Rudler M, Mohammadi MS, Bonnefont-Rousselot D, Bennani H, Bezeaud A, Tellier Z, Guichard C, Coant N, Ogier-Denis E, Moreau R, Lebrec D. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology 49: 175-184 (2009).
Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A. Autoinflammatory syndromes. Clin. Exp. Rheumatol. 24: S79-S85 (2006).
Gallet M, Vayssade M, Morra M, Verhoef R, Perrone S, Cascardo G, Vigneron P, Schols HA, Nagel MD. Inhibition of LPS-induced proinflammatory responses of J774.2 macrophages by immobilized enzymatically tailored pectins. Acta Biomater. Mar 31 [Epub ahead of print] (2009).
Gangloff M, Gay NJ. MD-2: the Toll 'gatekeeper' in endotoxin signalling. Trends Biochem. Sci. 29: 294-300 (2004). *
Gangloff M, Weber AN, Gay NJ. Conserved mechanisms of signal transduction by Toll and Toll-like receptors. J. Endotoxin Res. 11: 294-298 (2005). *
Gao D, Wang R, Li B, Yang Y, Zhai Z, Chen DY. WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappaB activation pathway. Cell. Mol. Life Sci. Jun 12 [Epub ahead of print] (2009).
Gao L, Tsai YJ, Grigoryev DN, Barnes KC. Host defense genes in asthma and sepsis and the role of the environment. Curr. Opin. Allergy Clin. Immunol. 7: 459-467 (2007).
Gao Q, Meijer MJ, Schluter UG, van Hogezand RA, van der Zon JM, van den Berg M, van Duijn W, Lamers CB, Verspaget HW. Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. Inflamm. Bowel Dis. 13: 693-702 (2007). *
Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ. Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation 31: 121-132 (2008). *
Garantziotis S, Palmer SM, Snyder LD, Ganous T, Chen BJ, Wang T, Cook DN, Schwartz DA. Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide. Transplantation 84: 1012-1019 (2007).
Garcia-Herrera J, Marca MC, Brot-Laroche E, Guillen N, Acin S, Navarro MA, Osada J, Rodriguez-Yoldi MJ. Protein kinases, TNF-alpha and proteasome contribute in the inhibition of fructose intestinal transport by sepsis in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G155-G164 (2008). *
Garcia-Lazaro JF, Thieringer F, Luth S, Czochra P, Meyer E, Renteria IB, Galle PR, Lohse AW, Herkel J, Kanzler S. Hepatic over-expression of TGF-beta1 promotes LPS-induced inflammatory cytokine secretion by liver cells and endotoxemic shock. Immunol. Lett. 101: 217-222 (2005).
Gardiner KR, Anderson NH, McCaigue MD, Erwin PJ, Halliday MI, Rowlands BJ. Adsorbents as antiendotoxin agents in experimental colitis. Gut 34: 51-55 (1993). *
Gardiner KR, Anderson NH, Rowlands BJ, Barbul A. Colitis and colonic mucosal barrier dysfunction. Gut 37: 530-535 (1995). *
Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36: 897-901 (1995). *
Gartung C, Matern S. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis. Yale J. Biol. Med. 70: 355-363 (1997).
Gatot JS, Gioia R, Chau TL, Patrascu F, Warnier M, Close P, Chapelle JP, Muraille E, Brown K, Siebenlist U, Piette J, Dejardin E, Chariot A. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J. Biol. Chem. 282: 31131-31146 (2007). *
Gatti G, Rivero V, Motrich RD, Maccioni M. Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation. J. Leukoc. Biol. 79: 989-998 (2006). *
Gattoni A, Marotta F, Vangieri B, Pisani G, Cristiano F. Hepatorenal syndrome. Clin. Ter. 155: 375-389 (2004).
Gavilanes X, Huaux F, Meyer M, Lebecque P, Marbaix E, Lison D, Scholte B, Wallemacq P, Leal T. Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice. J. Cyst. Fibros. 8: 203-210 (2009).
Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76: 141-165 (2007). *
Gazouli M, Atsaves V, Mantzaris G, Economou M, Nasioulas G, Evangelou K, Archimandritis AJ, Anagnou NP. Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease. Inflamm. Bowel Dis. 14: 1323-1330 (2008). *
Geddes K, Philpott DJ. A new role for intestinal alkaline phosphatase in gut barrier maintenance. Gastroenterology 135: 8-12 (2008). *
Gee JM, Kalil A, Thullbery M, Becker KJ. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 39: 1575-1582 (2008).
Gee K, Lim W, Ma W, Nandan D, Diaz-Mitoma F, Kozlowski M, Kumar A. Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression. J. Immunol. 169: 5660-5672 (2002). *
Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, Lorenzen J, Matern S, Gartung C. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38: 345-354 (2003). *
Geier A, Kim SK, Gerloff T, Dietrich CG, Lammert F, Karpen SJ, Stieger B, Meier PJ, Matern S, Gartung C. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. J. Hepatol. 37: 198-205 (2002). *
Gentili C, Tutolo G, Pianezzi A, Cancedda R, Descalzi Cancedda F. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression. Matrix Biol. 24: 35-44 (2005).
Geraldes P, Yamagata M, Rook SL, Sassa Y, Ma RC, Clermont A, Gao B, Aiello LP, Feener EP, King GL. Glypican 4, a membrane binding protein for bactericidal/permeability-increasing protein signaling pathways in retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 48: 5750-5755 (2007). *
Gerbitz A, Schultz M, Wilke A, Linde HJ, Scholmerich J, Andreesen R, Holler E. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 103: 4365-4367 (2004). *
Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, Liu GY, Sitthimonchai S, Frank N. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res. 523-524: 163-172 (2003).
Gerhold K, Avagyan A, Seib C, Frei R, Steinle J, Ahrens B, Dittrich AM, Blumchen K, Lauener R, Hamelmann E. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J. Allergy Clin. Immunol. 118: 666-673 (2006). *
Gerits N, Shiryaev A, Kostenko S, Klenow H, Shiryaeva O, Johannessen M, Moens U. The transcriptional regulation and cell-specific expression of the MAPK-activated protein kinase MK5. Cell. Mol. Biol. Lett. May 30 [Epub ahead of print] (2009). *
Gewurz H, Mergenhagen SE, Nowotny A, Phillips JK. Interactions of the complement system with native and chemically modified endotoxins. J. Bacteriol. 95: 397-405 (1968). *
Geyeregger R, Zeyda M, Bauer W, Kriehuber E, Saemann MD, Zlabinger GJ, Maurer D, Stulnig TM. Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin bundling protein fascin. Blood 109: 4288-4295 (2007). *
Gharavi N, El-Kadi AO. Role of nitric oxide in downregulation of cytochrome P450 1a1 and NADPH: quinone oxidoreductase 1 by tumor necrosis factor-alpha and lipopolysaccharide. J. Pharm. Sci. 96: 2795-2807 (2007). *
Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target. Mol. Biotechnol. 31: 239-244 (2005).
Ghia JE, Blennerhassett P, El-Sharkawy RT, Collins SM. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G711-G718 (2007). *
Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131: 1122-1130 (2006). *
Ghisletti S, Meda C, Maggi A, Vegeto E. 17beta-Estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol. Cell. Biol. 25: 2957-2968 (2005). *
Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Integration of nuclear receptors and cell signaling pathways on bile acid physiology. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 44. June 18-19 (2004). *
Ghose R, Mulder J, von Furstenberg RJ, Thevananther S, Kuipers F, Karpen SJ. Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver. J. Hepatol. 46: 115-123 (2007). *
Ghose R, White D, Guo T, Vallejo J, Karpen SJ. Regulation of hepatic drug metabolizing enzyme genes by Toll-like receptor 4 signaling is independent of TIR-domain containing adaptor protein (TIRAP). Drug Metab. Dispos. 36: 95-101 (2008). *
Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl. Recept. 2: 4 (2004). *
Giamarellos-Bourboulis EJ. Immunomodulatory therapies for sepsis: unexpected effects with macrolides. Int. J. Antimicrob. Agents 32 Suppl. 1: S39-S43 (2008). *
Gidlof AC, Zhang W, Gidlof A, Sirsjo A. Synthetic retinoids improve survival in rodent model of endotoxic shock. Eur. J. Surg. 166: 165-169 (2000).
Gijsbers K, Van Assche G, Joossens S, Struyf S, Proost P, Rutgeerts P, Geboes K, Van Damme J. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur. J. Immunol. 34: 1992-2000 (2004). *
Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Kennedy K, Hai T, Bolouri H, Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441: 173-178 (2006). *
Gingras S, Parganas E, de Pauw A, Ihle JN, Murray PJ. Re-examination of the role of SOCS1 in the regulation of Toll-like receptor signaling. J. Biol. Chem. 279: 54702-54707 (2004). *
Gioannini TL, Weiss JP. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol. Res. 39: 249-260 (2007).
Girardin SE, Tournebize R, Mavris M, Page AL, Li X, Stark GR, Bertin J, DiStefano PS, Yaniv M, Sansonetti PJ, Philpott DJ. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2: 736-742 (2001). *
Girkontaite I, Sakk V, Wagner M, Borggrefe T, Tedford K, Chun J, Fischer KD. The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization. J. Exp. Med. 200: 1491-1501 (2004). *
Giroir BP, Quint PA, Barton P, Kirsch EA, Kitchen L, Goldstein B, Nelson BJ, Wedel NJ, Carroll SF, Scannon PJ. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 350: 1439-1443 (1997). *
Glas J, Torok HP, Tonenchi L, Hamann S, Malachova O, Euba A, Folwaczny C, Folwaczny M. A645G (Lys216Glu) polymorphism of the bactericidal/permeability-increasing protein gene in periodontal disease. Int. J. Immunogenet. 33: 255-260 (2006). *
Glatzle J, Beckert S, Kasparek MS, Mueller MH, Mayer P, Meile T, Konigsrainer A, Steurer W. Olive oil is more potent than fish oil to reduce septic pulmonary dysfunctions in rats. Langenbecks Arch. Surg. 392: 323-329 (2007). *
Glatzle J, Kasparek MS, Mueller MH, Binder F, Meile T, Kreis ME, Konigsrainer A, Steurer W. Enteral immunonutrition during sepsis prevents pulmonary dysfunction in a rat model. J. Gastrointest. Surg. 11: 719-724 (2007). *
Glauser MP. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 52 Suppl. 2: 9-17 (1996).
Gluck T, Kiefmann B, Grohmann M, Falk W, Straub RH, Scholmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J. Rheumatol. 32: 1473-1480 (2005).
Goh F, Irvine KM, Lovelace E, Donnelly S, Jones MK, Brion K, Hume DA, Kotze AC, Dalton JP, Ingham A, Sweet MJ. Selective induction of the Notch ligand Jagged-1 in macrophages by soluble egg antigen from Schistosoma mansoni involves ERK signalling. Immunology 127: 326-337 (2009). *
Goldberg RF, Austen WG Jr, Zhang X, Munene G, Mostafa G, Biswas S, McCormack M, Eberlin KR, Nguyen JT, Tatlidede HS, Warren HS, Narisawa S, Millan JL, Hodin RA. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc. Natl. Acad. Sci. U.S.A. 105: 3551-3556 (2008). *
Golden JM, Lacasse CJ, Simova DV, Murphy TR, Kurt RA. Differential mediator production by dendritic cells upon Toll-like receptor stimulation does not impact T cell cytokine expression. Immunol. Lett. 118: 30-35 (2008).
Goldsmith M, Avni D, Ernst O, Glucksam Y, Levy-Rimler G, Meijler MM, Zor T. Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways. Mol. Immunol. 46: 1979-1987 (2009). *
Goldsmith M, Avni D, Levy-Rimler G, Mashiach R, Ernst O, Levi M, Webb B, Meijler MM, Gray NS, Rosen H, Zor T. A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophages. Immunology 127: 103-115 (2009). *
Golec M. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Ann. Agric. Environ. Med. 14: 1-4 (2007). *
Gong Q, Xu JF, Yin H, Liu SF, Duan LH, Bian ZL. Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice. Scand. J. Immunol. 69: 29-35 (2009). *
Gonzalez-Rey E, Chorny A, Robledo G, Delgado M. Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J. Exp. Med. 203: 563-571 (2006). *
Gonzalez-Rey E, Gonzalez MA, Rico L, Buscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58: 929-939 (2009).
Goodall JC, Ellis L, Yeo GS, Gaston JS. Does HLA-B27 influence the monocyte inflammatory response to lipopolysaccharide? Rheumatology (Oxford) 46: 232-237 (2007). *
Goodridge HS, McGuiness S, Houston KM, Egan CA, Al-Riyami L, Alcocer MJ, Harnett MM, Harnett W. Phosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells. Parasite Immunol. 29: 127-137 (2007). *
Goos M, Lange P, Hanisch UK, Prinz M, Scheffel J, Bergmann R, Ebert S, Nau R. Fibronectin is elevated in the cerebrospinal fluid of patients suffering from bacterial meningitis and enhances inflammation caused by bacterial products in primary mouse microglial cell cultures. J. Neurochem. 102: 2049-2060 (2007).
Gorczynski R, Boudakov I, Khatri I. Peptides of CD200 modulate LPS-induced TNF-alpha induction and mortality in vivo. J. Surg. Res. 145: 87-96 (2008).
Gorg B, Bidmon HJ, Keitel V, Foster N, Goerlich R, Schliess F, Haussinger D. Inflammatory cytokines induce protein tyrosine nitration in rat astrocytes. Arch. Biochem. Biophys. 449: 104-114 (2006). *
Gorg B, Wettstein M, Metzger S, Schliess F, Haussinger D. Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology 41: 1065-1073 (2005). *
Gorlach A, Bonello S. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem. J. 412: e17-e19 (2008). *
Gottlieb AB, Strober B, Krueger JG, Rohane P, Zeldis JB, Hu CC, Kipnis C. An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast. Curr. Med. Res. Opin. 24: 1529-1538 (2008).
Gowri Priya C, Rathinam S, Muthukkaruppan V. Evidences for endotoxin as a causative factor for leptospiral uveitis in humans. Invest. Ophthalmol. Vis. Sci. 49: 5419-5424 (2008).
Goyarts E, Matsui M, Mammone T, Bender AM, Wagner JA, Maes D, Granstein RD. Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp. Dermatol. 17: 188-196 (2008).
Granado M, Martin AI, Lopez-Menduina M, Lopez-Calderon A, Villanua MA. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am. J. Physiol. Endocrinol. Metab. 294: E131-E141 (2008). *
Granfeldt A, Ebdrup L, Tonnesen E, Wogensen L. Renal cytokine profile in an endotoxemic porcine model. Acta Anaesthesiol. Scand. 52: 614-620 (2008).
Granzotto M, Fabbro E, Maschio M, Martelossi S, Quaglia S, Tommasini A, Presani G, Ventura A. Heterozygous nucleotide-binding oligomerization domain-2 mutations affect monocyte maturation in Crohn's disease. World J. Gastroenterol. 13: 6191-6196 (2007). *
Gray P, Dunne A, Brikos C, Jefferies CA, Doyle SL, O'Neill LA. MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J. Biol. Chem. 281: 10489-10495 (2006). *
Gray PW, Corcorran AE, Eddy RL Jr, Byers MG, Shows TB. The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20. Genomics 15: 188-190 (1993).
Grebowska A, Rechcinski T, Bak-Romaniszyn L, Czkwianianc E, Moran A, Druszczynska M, Kowalewicz-Kulbat M, Owczarek A, Dziuba M, Krzeminska-Pakula M, Planeta-Malecka I, Rudnicka W, Chmiela M. Potential role of LPS in the outcome of Helicobacter pylori related diseases. Pol. J. Microbiol. 55: 25-30 (2006).
Green N, Hu Y, Janz K, Li HQ, Kaila N, Guler S, Thomason J, Joseph-McCarthy D, Tam SY, Hotchandani R, Wu J, Huang A, Wang Q, Leung L, Pelker J, Marusic S, Hsu S, Telliez JB, Hall JP, Cuozzo JW, Lin LL. Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles. J. Med. Chem. 50: 4728-4745 (2007). *
Gregson JN, Steel A, Bower M, Gazzard BG, Gotch FM, Goodier MR. Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals. AIDS 23: 29-34 (2009).
Greve JW, Gouma DJ, Buurman WA. Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology 10: 454-458 (1989).
Griffin S, Carroll TP, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG. Effect of pro-inflammatory stimuli on mucin expression and inhibition by secretory leucoprotease inhibitor. Cell. Microbiol. 9: 670-679 (2007). *
Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease. Hepatogastroenterology 52: 808-811 (2005).
Griga T, Wilkens C, Schmiegel W, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Klein W. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. Eur. J. Med. Res. 10: 183-186 (2005).
Grimble RF, Howell WM, O'Reilly G, Turner SJ, Markovic O, Hirrell S, East JM, Calder PC. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am. J. Clin. Nutr. 76: 454-459 (2002). *
Grimm MC, Elsbury SK, Pavli P, Doe WF. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J. Leukoc. Biol. 59: 804-812 (1996). *
Grimm MC, Elsbury SK, Pavli P, Doe WF. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 38: 90-98 (1996). *
Grimm MC, Pavli P, Van de Pol E, Doe WF. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin. Exp. Immunol. 100: 291-297 (1995). *
Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastroenterol. Hepatol. 10: 387-395 (1995).
Grinko I, Geerts A, Wisse E. Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. J. Hepatol. 23: 449-458 (1995). *
Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Forster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils; protective and deleterious effects. Immunity 22: 93-104 (2005). *
Groschel S, Piggott KD, Vaglio A, Ma-Krupa W, Singh K, Goronzy JJ, Weyand CM. TLR-mediated induction of negative regulatory ligands on dendritic cells. J. Mol. Med. 86: 443-455 (2008). *
Gross V, Villiger PM, Zhang B, Lotz M. Retinoic acid inhibits interleukin-1-induced cytokine synthesis in human monocytes. J. Leukoc. Biol. 54: 125-132 (1993). *
Grulke S, Franck T, Gangl M, Peters F, Salciccia A, Deby-Dupont G, Serteyn D. Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease. Can. J. Vet. Res. 72: 37-42 (2008).
Grunewald J, Tsao ML, Perera R, Dong L, Niessen F, Wen BG, Kubitz DM, Smider VV, Ruf W, Nasoff M, Lerner RA, Schultz PG. Immunochemical termination of self-tolerance. Proc. Natl. Acad. Sci. U.S.A. 105: 11276-11280 (2008). *
Gu BB, Miao JF, Zhu YM, Deng YE, Zou SX. Protective effect of retinoid against endotoxin-induced mastitis in rats. Inflamm. Res. 58: 81-88 (2009). *
Gu Y, Yang J, Ouyang X, Liu W, Li H, Yang J, Bromberg J, Chen SH, Mayer L, Unkeless JC, Xiong H. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. 38: 1807-1813 (2008). *
Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur. J. Gastroenterol. Hepatol. 17: 27-31 (2005).
Gubern C, Lopez-Bermejo A, Biarnes J, Vendrell J, Ricart W, Fernandez-Real JM. Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55: 216-224 (2006). *
Gujral JS, Liu J, Farhood A, Jaeschke H. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 40: 998-1007 (2004). *
Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, Kantengwa S, Rubbia-Brandt L, Mensi N, Angelillo-Scherrer A, Martinez-Soria E, Tacchini-Cottier F, Garcia I. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41: 773-781 (2004). *
Gumy C, Chandsawangbhuwana C, Dzyakanchuk AA, Kratschmar DV, Baker ME, Odermatt A. Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production. PLoS ONE 3: e3545 (2008). *
Gundacker NC, Haudek VJ, Wimmer H, Slany A, Griss J, Bochkov V, Zielinski C, Wagner O, St�ckl J, Gerner C. Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. J. Proteome Res. 8: 2799-2811 (2009). *
Gundersen RY, Ruud TE, Jorgensen PF, Scholz T, Reinholt FP, Wang JE, Lyngstadaas SP, Aasen AO. Systemic administration of enamel matrix derivative to lipopolysaccharide-challenged pigs: effects on the inflammatory response. Surg. Infect. (Larchmt.) 9: 161-169 (2008).
Gunn J, Ernst R. The structure and function of Francisella LPS. Ann. N. Y. Acad. Sci. 1105: 202-218 (2007).
Guo J, Loke J, Zheng F, Hong F, Yea S, Fugita M, Tarocchi M, Abar OT, Huang H, Sninsky JJ, Friedman SL. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 49: 960-968 (2009). *
Guo JP, Verdrengh M, Tarkowski A, Lange S, Jennische E, Lorentzen JC, Harris RA. The rat antigen-presenting lectin-like receptor complex influences innate immunity and development of infectious diseases. Genes Immun. 10: 227-236 (2009).
Guo Q, Zhu J, Xia B. Polymorphism of CD14 gene but not the mutation of TLR4 gene is associated with colorectal cancer in Chinese patients. J. Gastroenterol. Hepatol. 21: 92-97 (2006). *
Guo QS, Xia B, Jiang Y, Morre SA, Cheng L, Li J, Crusius JB, Pena AS. Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients. Postgrad. Med. J. 81: 526-529 (2005). *
Guo QS, Xia B, Jiang Y, Qu Y, Li J. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J. Gastroenterol. 10: 1069-1071 (2004). *
Gupta S, Aggarwal S, See D, Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J. Psychiatr. Res. 31: 149-156 (1997).
Gupta S, Aggarwal S, Starr A. Increased production of interleukin-6 by adherent and non-adherent mononuclear cells during 'natural fatigue' but not following 'experimental fatigue' in patients with chronic fatigue syndrome. Int. J. Mol. Med. 3: 209-213 (1999).
Gupta SK, Agarwal R, Srivastava S, Agarwal P, Agrawal SS, Saxena R, Galpalli N. The anti-inflammatory effects of Curcuma longa and Berberis aristata in endotoxin-induced uveitis in rabbits. Invest. Ophthalmol. Vis. Sci. 49: 4036-4040 (2008). *
Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, Franchimont D, Louis H, Deviere J, Le Moine O. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43: 989-1000 (2006). *
Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 277: 41701-41705 (2002). *
Guzylack-Piriou L, Piersma S, McCullough K, Summerfield A. Role of natural interferon-producing cells and T lymphocytes in porcine monocyte-derived dendritic cell maturation. Immunology 118: 78-87 (2006). *
Ha SA, Tsuji M, Suzuki K, Meek B, Yasuda N, Kaisho T, Fagarasan S. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203: 2541-2550 (2006). *
Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T, Izumo S, Kelley J, Gao X, Browder W, Williams DL, Kao RL, Li C. Lipopolysaccharide-induced myocardial protection against ischemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc. Res. 78: 546-553 (2008). *
Haas CS, Amin MA, Ruth JH, Allen BL, Ahmed S, Pakozdi A, Woods JM, Shahrara S, Koch AE. In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum. 56: 2535-2548 (2007). *
Haase H, Ober-Blobaum JL, Engelhardt G, Hebel S, Heit A, Heine H, Rink L. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J. Immunol. 181: 6491-6502 (2008).
Haase H, Rink L. Signal transduction in monocytes: the role of zinc ions. Biometals 20: 579-585 (2007). *
Habu Y, Seki S, Takayama E, Ohkawa T, Koike Y, Ami K, Majima T, Hiraide H. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis. J. Immunol. 166: 5439-5447 (2001). *
Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 357: re13 (2006). *
H�ggblom JO, Jokilammi-Siltanen AB, Peuravuori H, Nevalainen TJ. Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein. Mediators Inflamm. 5: 47-50 (1996). *
Hagiwara S, Iwasaka H, Hidaka S, Hasegawa A, Koga H, Noguchi T. Antagonist of the Type-1 ANG II receptor prevents against LPS-induced septic shock in rats. Intensive Care Med. Jun 16 [Epub ahead of print] (2009).
Hagiwara S, Iwasaka H, Hidaka S, Hasegawa A, Noguchi T. Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB. Inflamm. Res. 58: 198-203 (2009). *
Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T. Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit. Care 12: R43 (2008). *
Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T. Changes in cell culture temperature alter release of inflammatory mediators in murine macrophagic RAW264.7 cells. Inflamm. Res. 56: 297-303 (2007). *
Hagiwara S, Iwasaka H, Shingu C, Noguchi T. Effect of enteral vs. parenteral nutrition on inflammation and cardiac function in a rat model of endotoxin-induced sepsis. Shock 30: 280-284 (2008).
Haider DG, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L, Kapiotis S, Wolzt M. C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin. Exp. Immunol. 146: 533-539 (2006). *
Hailemariam TK, Huan C, Liu J, Li Z, Roman C, Kalbfeisch M, Bui HH, Peake DA, Kuo MS, Cao G, Wadgaonkar R, Jiang XC. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation. Arterioscler. Thromb. Vasc. Biol. 28: 1519-1526 (2008).
Hajishengallis G, Tapping RI, Harokopakis E, Nishiyama S, Ratti P, Schifferle RE, Lyle EA, Triantafilou M, Triantafilou K, Yoshimura F. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell. Microbiol. 8: 1557-1570 (2006). *
Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3: 354-359 (2002). *
Haller D, Holt L, Parlesak A, Zanga J, Bauerlein A, Sartor RB, Jobin C. Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology 112: 310-320 (2004). *
Halme L, Turunen U, Paavola-Sakki P, Helio T, Lappalainen M, Farkkila M, Kontula K, Repo H. CARD15 frameshift mutation in patients with CROHN disease is associated with immune dysregulation. Scand. J. Gastroenterol. 39: 1243-1249 (2004). *
Hamann L, Alexander C, Stamme C, Zahringer U, Schumann RR. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect. Immun. 73: 193-200 (2005). *
Hamann L, Kumpf O, Muller M, Visintin A, Eckert J, Schlag PM, Schumann RR. A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. Genes Immun. 5: 283-288 (2004). *
Hamano R, Takahashi HK, Iwagaki H, Yoshino T, Nishibori M, Tanaka N. Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the Toll-like receptor 4 expression in human monocytes. Shock 26: 358-364 (2006). *
Hamdi H, Bigorgne A, Naveau S, Balian A, Bouchet-Delbos L, Cassard-Doulcier AM, Maillot MC, Durand-Gasselin I, Prevot S, Delaveaucoupet J, Emilie D, Perlemuter G. Glucocorticoid-induced leucine zipper: a key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis. Hepatology 46: 1986-1992 (2007). *
Hammer KD, Hillwig ML, Neighbors JD, Sim YJ, Kohut ML, Wiemer DF, Wurtele ES, Birt DF. Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction. Phytochemistry 69: 2354-2362 (2008). *
Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357: 1925-1928 (2001). *
Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352: 342-344 (1991). *
Hampton RY, Raetz CR. Macrophage catabolism of lipid A is regulated by endotoxin stimulation. J. Biol. Chem. 266: 19499-19509 (1991). *
Han SB, Lee JK. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. Arch. Pharm. Res. 32: 613-624 (2009).
Han SJ, Ko HM, Choi JH, Seo KH, Lee HS, Choi EK, Choi IW, Lee HK, Im SY. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J. Biol. Chem. 277: 44715-44721 (2002). *
Han TH, Jin P, Ren J, Slezak S, Marincola FM, Stroncek DF. Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma. J. Immunother. 32: 399-407 (2009).
Hanck C, Manigold T, Bocker U, Kurimoto M, Kolbel CB, Singer MV, Rossol S. Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis. Gut 49: 106-111 (2001). *
Hang J, Zhou W, Zhang H, Sun B, Dai H, Su L, Christiani DC. TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population. J. Endotoxin Res. 10: 238-240 (2004). *
Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis or post-infectious arthritis? Best Pract. Res. Clin. Rheumatol. 20: 419-433 (2006).
Hanson JC, Bostick MK, Campe CB, Kodali P, Lee G, Yan J, Maher JJ. Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity. J. Hepatol. 44: 359-367 (2006). *
Hao HN, Peduzzi-Nelson JD, Vandevord PJ, Barami K, Desilva SP, Pelinkovic D, Morawa LG. Lipopolysaccharide-induced inflammatory cytokine production by Schwann's cells dependent upon TLR4 expression. J. Neuroimmunol. Jun 12 [Epub ahead of print] (2009).
Harada K, Isse K, Kamihira T, Shimoda S, Nakanuma Y. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology 41: 1329-1338 (2005). *
Harada K, Isse K, Nakanuma Y. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J. Clin. Pathol. 59: 184-190 (2006). *
Harada K, Isse K, Sato Y, Ozaki S, Nakanuma Y. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int. 26: 935-942 (2006). *
Harada K, Nakanuma Y. Biliary innate immunity and cholangiopathy. Hepatol. Res. 37 Suppl. 3: S430-S437 (2007). *
Harada K, Ohba K, Ozaki S, Isse K, Hirayama T, Wada A, Nakanuma Y. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40: 925-932 (2004). *
Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, Nakanuma Y. Lipopolysaccharide activates nuclear factor-kappaB through Toll-like receptors and related molecules in cultured biliary epithelial cells. Lab. Invest. 83: 1657-1667 (2003). *
Harada K, Sato Y, Isse K, Ikeda H, Nakanuma Y. Induction of innate immune response and absence of subsequent tolerance to dsRNA in biliary epithelial cells relate to the pathogenesis of biliary atresia. Liver Int. 28: 614-621 (2008). *
Harada N, Kusuyama A, Morishima M, Okada K, Takahashi A, Nakaya Y. Bezafibrate improves bacterial lipopolysaccharide-induced dyslipidemia and anorexia in rats. Metabolism 56: 517-522 (2007). *
Haraguchi G, Kosuge H, Maejima Y, Suzuki JI, Imai T, Yoshida M, Isobe M. Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis. Intensive Care Med. 34: 1304-1312 (2008). *
Harari OA, Alcaide P, Ahl D, Luscinskas FW, Liao JK. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway. Circ. Res. 98: 1134-1140 (2006). *
Harder J, Glaser R, Schroder JM. Human antimicrobial proteins effectors of innate immunity. J. Endotoxin Res. 13: 317-338 (2007). *
Harrington L, Srikanth CV, Antony R, Rhee SJ, Mellor AL, Shi HN, Cherayil BJ. Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis. Infect. Immun. 76: 3045-3053 (2008). *
Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol. 99: 331-337 (1995). *
Hartel C, Rupp J, Hoegemann A, Bohler A, Spiegler J, von Otte S, Roder K, Schultz C, Gopel W. 159C>T CD14 genotype: functional effects on innate immune responses in term neonates. Hum. Immunol. 69: 338-343 (2008).
Hartmann G, Cheung AK, Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther. 303: 273-281 (2002). *
Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int. Immunopharmacol. 1: 189-199 (2001).
Hartung T, Wendel A. Endotoxin-inducible cytotoxicity in liver cell cultures - I. Biochem. Pharmacol. 42: 1129-1135 (1991).
Haruta I, Hashimoto E, Shibata N, Kato Y, Kobayashi M, Shiratori K. Lipoteichoic acid may affect the pathogenesis of PBC-like bile duct damage and might be involved in systemic multifocal epithelial inflammations in chronic colitis-harboring TCRalpha-/-xAIM-/- mice. Autoimmunity 40: 372-379 (2007). *
Haruta Y, Koarada S, Tada Y, Mitamura M, Ohta A, Fukuoka M, Hayashi S, Nagasawa K. High expression of Toll-like receptor 4 on CD14+ monocytes in acute infectious diseases. Scand. J. Infect. Dis. 39: 577-583 (2007).
Hasegawa T, Sakurai K, Kambayashi Y, Saniabadi AR, Nagamoto H, Tsukada K, Takahashi A, Kuwano H, Nakano M. Effects of OPC-6535 on lipopolysaccharide-induced acute liver injury in the rat: involvement of superoxide and tumor necrosis factor-alpha from hepatic macrophages. Surgery 134: 818-826 (2003). *
Hashizume T, Togawa A, Nochi T, Igarashi O, Kweon MN, Kiyono H, Yamamoto M. Peyer's patches are required for intestinal IgA responses to Salmonella. Infect. Immun. 76: 927-934 (2008). *
Hasko G, Deitch EA, Nemeth ZH, Kuhel DG, Szabo C. Inhibitors of ATP-binding cassette transporters suppress interleukin-12 p40 production and major histocompatibility complex II up-regulation in macrophages. J. Pharmacol. Exp. Ther. 301: 103-110 (2002). *
Hasko G, Szabo C, Nemeth ZH, Deitch EA. Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression. Immunology 103: 473-478 (2001). *
Hassan F, Islam S, Tumurkhuu G, Naiki Y, Koide N, Mori I, Yoshida T, Yokochi T. Intracellular expression of Toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide. BMC Cancer 6: 281 (2006). *
Hassan F, Morikawa A, Islam S, Tumurkhuu G, Dagvadorj J, Koide N, Naiki Y, Mori I, Yoshida T, Yokochi T. Lipopolysaccharide augments the in vivo lethal action of doxorubicin against mice via hepatic damage. Clin. Exp. Immunol. 151: 334-340 (2008). *
Hattar K, Grandel U, Moeller A, Fink L, Iglhaut J, Hartung T, Morath S, Seeger W, Grimminger F, Sibelius U. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 � Crit. Care Med. 34: 835-841 (2006).
Hattar K, van Burck S, Bickenbach A, Grandel U, Maus U, Lohmeyer J, Csernok E, Hartung T, Seeger W, Grimminger F, Sibelius U. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation. J. Leukoc. Biol. 78: 992-1000 (2005). *
Hattori Y, Murakami Y, Hattori S, Kuroda H, Kasai K, Shimoda S. Ursodeoxycholic acid inhibits the induction of nitric oxide synthase. Eur. J. Pharmacol. 300: 147-150 (1996).
Haugen F, Drevon CA. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 148: 5478-5486 (2007). *
Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T, Scholmerich J, Herfarth H, Ray K, Falk W, Rogler G. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122: 1987-2000 (2002). *
Haussinger D, Gorg B, Reinehr R, Schliess F. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy. Metab. Brain Dis. 20: 285-294 (2005).
Haversen L, Danielsson KN, Fogelstrand L, Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 202: 382-393 (2009).
Hawn TR, Ozinsky A, Williams LM, Rodrigues S, Clark A, Pham U, Hill HR, Ochs H, Aderem A, Liles WC. Hyper-IgE syndrome is not associated with defects in several candidate Toll-like receptor pathway genes. Hum. Immunol. 66: 842-847 (2005).
Hayashi M, Tomita M. Mechanistic analysis for drug permeation through intestinal membrane. Drug. Metab. Pharmacokinet. 22: 67-77 (2007). *
Hayashi T, Kishiwada M, Fujii K, Yuasa H, Nishioka J, Ido M, Gabazza EC, Suzuki K. Lipopolysaccharide-induced decreased protein S expression in liver cells is mediated by MEK/ERK signaling and NFkappaB activation: involvement of membrane-bound CD14 and Toll-like receptor-4. J. Thromb. Haemost. 4: 1763-1773 (2006). *
Haynes TE, Li P, Li X, Shimotori K, Sato H, Flynn NE, Wang J, Knabe DA, Wu G. L-Glutamine or L-alanyl-L-glutamine prevents oxidant- or endotoxin-induced death of neonatal enterocytes. Amino Acids 37: 131-142 (2009). *
He W, Liu Q, Wang L, Chen W, Li N, Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol. Immunol. 44: 2850-2859 (2007). *
Healy LJ, Collins HL, Thompson SJ. Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis. Open Rheumatol. J. 2: 71-80 (2008). *
Hebeis BJ, Vigorito E, Turner M. The p110delta subunit of phosphoinositide 3-kinase is required for the lipopolysaccharide response of mouse B cells. Biochem. Soc. Trans. 32: 789-791 (2004). *
Heemskerk S, Masereeuw R, Moesker O, Bouw MP, van der Hoeven JG, Peters WH, Russel FG, Pickkers P; On behalf of the APSEP Study Group.. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit. Care Med. 37: 417-423, e1 (2009).
Heemskerk S, van Koppen A, van den Broek L, Poelen GJ, Wouterse AC, Dijkman HB, Russel FG, Masereeuw R. Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia. Pflugers Arch. 454: 321-334 (2007). *
Heesen M, Bloemeke B, Bachmann-Mennenga B, Kunz D. The CD14-260 C --> T promoter polymorphism co-segregates with the tumor necrosis factor-alpha (TNF-alpha)-308 G --> A polymorphism and is associated with the interleukin-1 beta (IL-1 beta) synthesis capacity of human leukocytes. Eur. Cytokine Netw. 13: 230-233 (2002).
Heesen M, Bloemeke B, Heussen N, Kunz D. Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines. Crit. Care Med. 30: 664-669 (2002).
Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M. The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Intensive Care Med. 28: 1161-1163 (2002). *
Heesen M, Schippers EF, Bloemeke B, Kunz D, van Dissel JT. Cytokine response to endotoxin in individuals heterozygous for the Delta32 mutation of chemokine receptor CCR5. Cytokine 21: 195-199 (2003).
Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 202: 1703-1713 (2005). *
Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, Liesenfeld O, Schumann RR, Gobel UB, Bereswill S. Exacerbation of murine ileitis by Toll-like receptor 4 meditated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56: 941-948 (2007). *
Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int. Arch. Allergy Immunol. 130: 180-192 (2003).
Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, Lapp WS. T cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103: 3457-3464 (2004). *
Heinrichsdorff J, Luedde T, Perdiguero E, Nebreda AR, Pasparakis M. p38alpha MAPK inhibits JNK activation and collaborates with IkappaB kinase 2 to prevent endotoxin-induced liver failure. EMBO Rep. 9: 1048-1054 (2008). *
Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276: 32008-32015 (2001). *
Hellman P, Eriksson H. Early activation markers of human peripheral dendritic cells. Hum. Immunol. 68: 324-333 (2007).
Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S. Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk. Lymphoma 46: 869-872 (2005).
Hellweg CE, Arenz A, Bogner S, Schmitz C, Baumstark-Khan C. Activation of nuclear factor kappaB by different agents: influence of culture conditions in a cell-based assay. Ann. N. Y. Acad. Sci. 1091: 191-204 (2006). *
Henderson B, Poole S, Wilson M. Microbial/host interactions in health and disease: who controls the cytokine network? Immunopharmacology 35: 1-21 (1996).
Hendriks BS, Hua F, Chabot JR. Analysis of mechanistic pathway models in drug discovery: p38 pathway. Biotechnol. Prog. 24: 96-109 (2008).
Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 23: 309-317 (2009).
Hernesniemi J, Lehtimaki T, Rontu R, Islam MS, Eklund C, Mikkelsson J, Ilveskoski E, Kajander O, Goebeler S, Viiri LE, Hurme M, Karhinen PJ. Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions. Scand. J. Clin. Lab. Invest. 66: 667-676 (2006). *
Herrema H, Derks TG, van Dijk TH, Bloks VW, Gerding A, Havinga R, Tietge UJ, Muller M, Smit GP, Kuipers F, Reijngoud DJ. Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice. Hepatology 47: 1894-1904 (2008). *
Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin. Chim. Acta 323: 59-72 (2002). *
Hevia H, Varela-Rey M, Corrales FJ, Berasain C, Martinez-Chantar ML, Latasa MU, Lu SC, Mato JM, Garcia-Trevijano ER, Avila MA. 5-Methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology 39: 1088-1098 (2004). *
Heyen JR, Ye S, Finck BN, Johnson RW. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77: 138-147 (2000).
Hildenbrand B, Lorenzen D, Sauer B, Hertkorn C, Freudenberg MA, Peters JH, Nesselhut T, Unger C, Azemar M. IFN-gamma enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions. Anticancer Res. 28: 1467-1476 (2008).
Hill MR, Clarke S, Rodgers K, Thornhill B, Peters JM, Gonzalez FJ, Gimble JM. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. Infect. Immun. 67: 3488-3493 (1999). *
Hilmy KM. Synthesis of new pyrrolo[2, 3-b]pyridines as a potent inhibitor of tumour necrosis factor alpha. Arch. Pharm. (Weinheim.) 337: 15-19 (2004). *
Hirai S, Kim YI, Goto T, Kang MS, Yoshimura M, Obata A, Yu R, Kawada T. Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci. 81: 1272-1279 (2007). *
Hirata N, Yanagawa Y, Ebihara T, Seya T, Uematsu S, Akira S, Hayashi F, Iwabuchi K, Onoe K. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. Mol. Immunol. 45: 2734-2742 (2008). *
Hirata N, Yanagawa Y, Iwabuchi K, Onoe K. Selective regulation of interleukin-10 production via Janus kinase pathway in murine conventional dendritic cells. Cell. Immunol. 258: 9-17 (2009). *
Hirotani Y, Ikeda K, Kato R, Myotoku M, Umeda T, Ijiri Y, Tanaka K. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. Yakugaku Zasshi 128: 1363-1368 (2008).
Hisajima T, Kojima Y, Yamaguchi A, Goris RC, Funakoshi K. Morphological analysis of the relation between immunoglobulin A production in the small intestine and the enteric nervous system. Neurosci. Lett. 381: 242-246 (2005). *
Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, Caughey RC, Brown R, Millikin PD, Darras FS. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 57: 2360-2374 (2000). *
Ho CH, Hsu SP, Yang CC, Lee YH, Chien CT. Sialic acid reduces acute endotoxemia-induced liver dysfunction in the rat. Shock Dec 22 [Epub ahead of print] (2008).
Ho CH, Hsu SP, Yang CC, Lee YH, Chien CT. Sialic acid reduces acute endotoxemia-induced liver dysfunction in the rat. Shock Dec 4 [Epub ahead of print] (2008).
Ho HH, Antoniv TT, Ji JD, Ivashkiv LB. Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1. J. Immunol. 181: 5089-5097 (2008).
Hoareau L, Buyse M, Festy F, Ravanan P, Gonthier MP, Matias I, Petrosino S, Tallet F, d'Hellencourt CL, Cesari M, Di Marzo V, Roche R. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity (Silver Spring) 17: 431-438 (2009). *
Hochholzer P, Lipford GB, Wagner H, Pfeffer K, Heeg K. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect. Immun. 68: 3502-3508 (2000). *
Hocke AC, Ermert M, Althoff A, Brell B, N'guessan PD, Suttorp N, Ermert L. Regulation of interleukin IL-4, IL-13, IL-10, and their downstream components in lipopolysaccharide-exposed rat lungs. Comparison of the constitutive expression between rats and humans. Cytokine 33: 199-211 (2006).
Hodgkinson CP, Laxton RC, Patel K, Ye S. Advanced glycation end-product of low density lipoprotein activates the Toll-like 4 receptor pathway: implications for diabetic atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28: 2275-2281 (2008).
Hodgson JC. Endotoxin and mammalian host responses during experimental disease. J. Comp. Pathol. 135: 157-175 (2006). *
Hoebe K, Jiang Z, Tabeta K, Du X, Georgel P, Crozat K, Beutler B. Genetic analysis of innate immunity. Adv. Immunol. 91: 175-226 (2006).
Hoek JB, Pastorino JG. Cellular signaling mechanisms in alcohol-induced liver damage. Semin. Liver Dis. 24: 257-272 (2004).
Hoentjen F, Sartor RB, Ozaki M, Jobin C. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105: 689-696 (2005). *
Hoffmann R, Grewe M, Estler HC, Schulze-Specking A, Decker K. Regulation of tumor necrosis factor-alpha-mRNA synthesis and distribution of tumor necrosis factor-alpha-mRNA synthesizing cells in rat liver during experimental endotoxemia. J. Hepatol. 20: 122-128 (1994).
Hoglen NC, Chen LS, Fisher CD, Hirakawa BP, Groessl T, Contreras PC. Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor. J. Pharmacol. Exp. Ther. 309: 634-640 (2004). *
Hohler T, Grossmann S, Stradmann-Bellinghausen B, Kaluza W, Reuss E, de Vlam K, Veys E, Marker-Hermann E. Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis. Ann. Rheum. Dis. 61: 213-218 (2002). *
Hojo M, Sano N, Takikawa H. Effects of lipopolysaccharide on the biliary excretion of bile acids and organic anions in rats. J. Gastroenterol. Hepatol. 18: 815-821 (2003). *
Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KE, Lissowska J, Zatonski W, Schoenberg JB, Blot WJ, Mowat NA, Fraumeni JF Jr, El-Omar EM. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132: 905-912 (2007). *
Holland SM, Deleo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608-1619 (2007). *
Hollenbach M, Hintersdorf A, Huse K, Sack U, Bigl M, Groth M, Santel T, Buchold M, Lindner I, Otto A, Sicker D, Schellenberger W, Almendinger J, Pustowoit B, Birkemeyer C, Platzer M, Oerlecke I, Hemdan N, Birkenmeier G. Ethyl pyruvate and ethyl lactate down-regulate the production of pro-inflammatory cytokines and modulate expression of immune receptors. Biochem. Pharmacol. 76: 631-644 (2008). *
Holler E. NOD2/CARD15 polymorphisms: more indirect than direct effects in allogeneic SCT? Haematologica 91: 1301B (2006).
Hollmann TJ, Mueller-Ortiz SL, Braun MC, Wetsel RA. Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a. Mol. Immunol. 45: 1907-1915 (2008). *
Holloway JW, Yang IA, Ye S. Variation in the Toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet. Genomics 15: 15-21 (2005).
Holmqvist B, Olsson CF, Svensson ML, Svanborg C, Forsell J, Alm P. Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4. J. Mol. Histol. 36: 499-516 (2005). *
Holtta V, Klemetti P, Sipponen T, Westerholm-Ormio M, Kociubinski G, Salo H, Rasanen L, Kolho KL, Farkkila M, Savilahti E, Vaarala O. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm. Bowel Dis. 14: 1175-1184 (2008). *
Honda Y, Yamagiwa S, Matsuda Y, Takamura M, Ichida T, Aoyagi Y. Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis. J. Hepatol. 47: 404-411 (2007). *
Hong I, Lee MH, Na TY, Zouboulis CC, Lee MO. LXRalpha enhances lipid synthesis in SZ95 sebocytes. J. Invest. Dermatol. 128: 1266-1272 (2008). *
Hong M, Ryan KR, Arkwright PD, Gennery AR, Costigan C, Dominguez M, Denning DW, McConnell V, Cant AJ, Abinun M, Spickett GP, Swan DC, Gillespie CS, Young DA, Lilic D. Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. Clin. Exp. Immunol. 156: 40-51 (2009). *
Hong S, Brass A, Seman M, Haag F, Koch-Nolte F, Dubyak GR. Lipopolysaccharide, IFN-gamma, and IFN-beta induce expression of the thiol-sensitive ART2.1 ecto-ADP-ribosyltransferase in murine macrophages. J. Immunol. 179: 6215-6227 (2007). *
Hong TJ, Ban JE, Choi KH, Son YH, Kim SM, Eo SK, Park HJ, Rhim BY, Kim K. TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells. Vascul. Pharmacol. 50: 34-39 (2009).
Hoogerwerf JJ, de Vos AF, Bresser P, van der Zee JS, Pater JM, de Boer A, Tanck M, Lundell DL, Her-Jenh C, Draing C, von Aulock S, van der Poll T. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am. J. Respir. Crit. Care Med. 178: 34-41 (2008). *
Hoon Lee J, Joe EH, Jou I. PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia. Neuroreport 16: 829-833 (2005).
Hopf U, Stemerowicz R, Knigge O, Khadar R, Konig V, Lobeck H, Neuhaus P. Primary sclerosing cholangitis (PSC) - humoral immune phenomena, pathogenetic aspects and therapeutic possibilities. Z. Gastroenterol. 31 Suppl. 2: 106-110 (1993).
Hopkins PA, Fraser JD, Pridmore AC, Russell HH, Read RC, Sriskandan S. Superantigen recognition by HLA class II on monocytes up-regulates Toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood 105: 3655-3662 (2005). *
Hori Y, Ohyanagi H. Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice. Surg. Today 27: 140-144 (1997).
Horiuchi K, Kimura T, Miyamoto T, Takaishi H, Okada Y, Toyama Y, Blobel CP. Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol. 179: 2686-2689 (2007). *
Hornef MW, Bogdan C. The role of epithelial Toll-like receptor expression in host defense and microbial tolerance. J. Endotoxin Res. 11: 124-128 (2005). *
Horwitz AH, Williams RE, Nowakowski G. Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein. Infect. Immun. 63: 522-527 (1995). *
Houdijk AP, Oosterling SJ, Siroen MP, de Jong S, Richir M, Rijssenbeek AL, Teerlink T, van Leeuwen PA. Hypertaurinemia in bile duct-ligated rats after surgery: the effect of gut endotoxin restriction on organ fluxes and oxidative status. JPEN J. Parenter. Enteral Nutr. 30: 186-193 (2006).
Hoy SM, Keating GM. Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia. Drugs 69: 1077-1105 (2009).
Hozumi H, Adachi Y, Murakami T, Miura NN, Ohno N. Increment of plasma soluble CD14 level in carrageenan-primed endotoxin shock model mice. Biol. Pharm. Bull. 29: 1015-1021 (2006). *
Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G. The critical role of Toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48: 1224-1231 (2008).
Hritz I, Velayudham A, Dolganiuc A, Kodys K, Mandrekar P, Kurt-Jones E, Szabo G. Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion. Hepatology 48: 1342-1347 (2008).
Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji JD, Tateya T, Kang YJ, Han J, Gessler M, Kageyama R, Ivashkiv LB. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 29: 691-703 (2008). *
Hua J, Qiu DK, Li JQ, Li EL, Chen XY, Peng YS. Expression of Toll-like receptor 4 in rat liver during the course of carbon tetrachloride-induced liver injury. J. Gastroenterol. Hepatol. 22: 862-869 (2007). *
Hua T, Xiping Z, Chengjun W, Li C, Rongchao Y, Jing Y, Bingyan Y, Qian Y, Yan P, Meili M, Feibo Z. Effects of baicalin and octreotide on the serum TNF-alpha level and apoptosis in multiple organs of rats with severe acute pancreatitis. Inflammation 32: 191-201 (2009). *
Huang H, Park PH, McMullen MR, Nagy LE. Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J. Gastroenterol. Hepatol. 23 Suppl. 1: S50-S53 (2008). *
Huang JR, Wu CC, Hou RC, Jeng KC. Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14. Immunol. Invest. 37: 263-277 (2008).
Huang LF, Yao YM, Meng HD, Zhao XD, Dong N, Yu Y, Sheng ZY. The effect of high mobility group box-1 protein on immune function of human T lymphocytes in vitro. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 20: 7-13 (2008).
Huang Q, Ma Y, Adebayo A, Pope RM. Increased macrophage activation mediated through Toll-like receptors in rheumatoid arthritis. Arthritis Rheum. 56: 2192-2201 (2007). *
Huang TH, Tran VH, Roufogalis BD, Li Y. Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells. Toxicol. Appl. Pharmacol. 218: 30-36 (2007). *
Huang WC, Lin YS, Wang CY, Tsai CC, Tseng HC, Chen CL, Lu PJ, Chen PS, Qian L, Hong JS, Lin CF. Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology Oct 29 [Epub ahead of print] (2009).
Huang XX, Wang XP, Ma JJ, Jing DD, Wang PW, Wu K. Effects of enteral nutrition supplemented with glutamine and arginine on gut barrier in patients with severe acute pancreatitis: a prospective randomized controlled trial. Zhonghua Yi Xue Za Zhi 88: 2407-2409 (2008).
Huang YH, Chou MH, Du YY, Huang CC, Wu CL, Chen CL, Chuang JH. Expression of Toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab. Invest. 87: 66-74 (2007). *
Hubacek JA, Pitha J, Skodova Z, Adamkov� V, Podrapska I, Schmitz G, Poledne R. Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction. Clin. Chem. Lab. Med. 40: 1097-1100 (2002).
Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Ritter M, Rothe G, Schmitz G. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit. Care Med. 29: 557-561 (2001).
Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Rothe G, Schmitz G. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun. 1: 405-407 (2000). *
Hubbard NE, Lim D, Mukutmoni M, Cai A, Erickson KL. Expression and regulation of murine macrophage angiopoietin-2. Cell. Immunol. 234: 102-109 (2005). *
Huber M, Kalis C, Keck S, Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Beutler B, Galanos C, Freudenberg MA. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur. J. Immunol. 36: 701-711 (2006). *
Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. U.S.A. 103: 678-683 (2006). *
Hugot JP, Cho JH. Update on genetics of inflammatory bowel disease. Curr. Opin. Gastroenterol. 18: 410-415 (2002).
Hunter RL, Choi DY, Ross SA, Bing G. Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats. Neurosci. Lett. 432: 198-201 (2008).
Husebye H, Halaas O, Stenmark H, Tunheim G, Sandanger O, Bogen B, Brech A, Latz E, Espevik T. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 25: 683-692 (2006). *
Hussain A, Flint N, Livsey S, Wong R, Spiers P, Bukhari S. Bickerstaff's brainstem encephalitis related to Campylobacter jejuni gastroenteritis. J. Clin. Pathol. 60: 1161-1162 (2007).
Hussain Mian A, Saito H, Alles N, Shimokawa H, Aoki K, Ohya K. Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo. J. Bone Miner. Metab. 26: 469-477 (2008).
Hussain S. Role of surfactant protein A in the innate host defense and autoimmunity. Autoimmunity 37: 125-130 (2004).
Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am. J. Pathol. 167: 47-58 (2005). *
Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum. Immunol. 67: 53-62 (2006).
Hwang HJ, Lee HJ, Kim CJ, Shim I, Hahm DH. Inhibitory effect of amygdalin on lipopolysaccharide-inducible TNF-alpha and IL-1beta mRNA expression and carrageenan-induced rat arthritis. J. Microbiol. Biotechnol. 18: 1641-1647 (2008). *
Hyun JG, Barrett TA. Oral tolerance therapy in inflammatory bowel disease. Am. J. Gastroenterol. 101: 569-571 (2006). *
Ichikawa H, Nakamura Y, Kashiwada Y, Aggarwal BB. Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr. Pharm. Des. 13: 3400-3416 (2007).
Ichikawa H, Okamoto S, Kamada N, Nagamoto H, Kitazume MT, Kobayashi T, Chinen H, Hisamatsu T, Hibi T. Tetomilast suppressed production of proinflammatory cytokines from human monocytes and ameliorated chronic colitis in IL-10-deficient mice. Inflamm. Bowel Dis. 14: 1483-1490 (2008).
Ide T, Sata M, Nakano H, Suzuki H, Tanikawa K. Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis. Hepatogastroenterology 44: 1569-1573 (1997).
Ide T, Sata M, Suzuki H, Uchimura Y, Murashima S, Shirachi M, Tanikawa K. An experimental animal model of primary biliary cirrhosis induced by lipopolysaccharide and pyruvate dehydrogenase. Kurume. Med. J. 43: 185-188 (1996).
Ierano T, Silipo A, Cescutti P, Leone MR, Rizzo R, Lanzetta R, Parrilli M, Molinaro A. Structural study and conformational behavior of the two different lipopolysaccharide O-antigens produced by the cystic fibrosis pathogen Burkholderia multivorans. Chemistry Jun 16 [Epub ahead of print] (2009).
Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y. A novel cyclohexene derivative, TAK-242, selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol. 69: 1288-1295 (2006). *
Iida A, Inagaki K, Miyazaki A, Yonemori F, Ito E, Igarashi K. Bach1 deficiency ameliorates hepatic injury in a mouse model. Tohoku J. Exp. Med. 217: 223-229 (2009). *
Ikarashi Y, Kawai K, Watanabe H, Matsumoto Y, Omata S, Fujiwara M. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference. Immunology 79: 95-102 (1993). *
Illig T, Bongardt F, Schopfer A, Holle R, Muller S, Rathmann W, Koenig W, Meisinger C, Wichmann HE, Kolb H; KORA Study Group. The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52: 2861-2864 (2003). *
Illoh K, Campbell C, Illoh O, Diehl J, Cherry J, Elkhaloun A, Chen Y, Hallenbeck J. Mucosal tolerance to E-selectin and response to systemic inflammation. J. Cereb. Blood Flow Metab. 26: 1538-1550 (2006).
Imahara SD, Jelacic S, Junker CE, O'keefe GE. The influence of gender on human innate immunity. Surgery 138: 275-282 (2005).
Imahara SD, Jelacic S, Junker CE, O'keefe GE. The TLR4 +896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes. Genes Immun. 6: 37-43 (2005). *
Imler JL, Ferrandon D, Royet J, Reichhart JM, Hetru C, Hoffmann JA. Toll-dependent and Toll-independent immune responses in Drosophila. J. Endotoxin Res. 10: 241-246 (2004). *
Inatsu A, Kinoshita M, Nakashima H, Shimizu J, Saitoh D, Tamai S, Seki S. Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity. Hepatology 49: 2044-2054 (2009).
Ince MN, Elliott DE, Setiawan T, Blum A, Metwali A, Wang Y, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after lipopolysaccharide stimulation. J. Immunol. 176: 726-729 (2006). *
Indoh T, Yokota SI, Okabayashi T, Yokosawa N, Fujii N. Suppression of NF-kappaB and AP-1 activation in monocytic cells persistently infected with measles virus. Virology 361: 294-303 (2006). *
Inohara N, Ogura Y, Chen FF, Muto A, Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276: 2551-2554 (2001). *
Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278: 5509-5512 (2003). *
Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr. Opin. Microbiol. 5: 76-80 (2002). *
Inoue K, Takano H, Yanagisawa R, Sakurai M, Shimada A, Morita T, Sato M, Yoshino S, Yoshikawa T. Role of interleukin-6 in Toll-like receptor 4 and 2 expressions induced by lipopolysaccharide in the lung. Immunopharmacol. Immunotoxicol. 29: 63-68 (2007).
Inoue KI, Takano H, Sato H, Yanagisawa R, Yoshikawa T. Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice. Immunopharmacol. Immunotoxicol. Mar 4 [Epub ahead of print] (2009).
Inoue W, Somay G, Poole S, Luheshi GN. Immune-to-brain signaling and central prostaglandin E2 synthesis in fasted rats with altered lipopolysaccharide-induced fever. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295: R133-R143 (2008). *
Invernizzi P, Salzman AL, Szabo C, Ueta I, O'Connor M, Setchell KD. Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo. Am. J. Physiol. 273: G131-G138 (1997).
Iovine NM, Elsbach P, Weiss J. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc. Natl. Acad. Sci. U.S.A. 94: 10973-10978 (1997). *
Irwin MR, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav. Immun. Jun 8 [Epub ahead of print] (2009).
Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW, McKim SE, Parsons C, Rippe RA, Wheeler MD. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1318-G1328 (2006). *
Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J. Gastroenterol. 34: 66-74 (1999).
Ishikawa M, Uemura M, Matsuyama T, Matsumoto M, Ishizashi H, Kato S, Morioka C, Fujimoto M, Kojima H, Yoshiji H, Tsujimoto T, Takimura C, Fujimura Y, Fukui H. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia. Alcohol Clin. Exp. Res. Dec 16 [Epub ahead of print] (2008).
Ishimoto H, Mukae H, Sakamoto N, Amenomori M, Kitazaki T, Imamura Y, Fujita H, Ishii H, Nakayama S, Yanagihara K, Kohno S. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. J. Antimicrob. Chemother. 63: 109-114 (2009).
Ishiyama K, Ohdan H, Tokita D, Shishida M, Tanaka Y, Irei T, Asahara T. Induction of endotoxin tolerance inhibits alloimmune responses. Transpl. Immunol. 16: 158-165 (2006).
Isse K, Harada K, Nakanuma Y. IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules. Liver Int. 27: 672-680 (2007). *
Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 41: 506-516 (2005). *
Ito K, Ozasa H, Noda Y, Arii S, Horikawa S. Effects of free radical scavenger on acute liver injury induced by d-galactosamine and lipopolysaccharide in rats. Hepatol. Res. 38: 194-201 (2008). *
Ito S, Ito Y, Katagiri H, Suzuki T, Hoka S, Yokomizo T, Shimizu T, Majima M. Leukotriene B4/leukotriene B4 receptor pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxin. Shock 30: 87-91 (2008).
Ito S, Yukawa T, Uetake S, Yamauchi M. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Alcohol Clin. Exp. Res. 31: S83-S87 (2007). *
Iwaki D, Mitsuzawa H, Murakami S, Sano H, Konishi M, Akino T, Kuroki Y. The extracellular Toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J. Biol. Chem. 277: 24315-24320 (2002). *
Iwanaga Y, Davey MP, Martin TM, Planck SR, DePriest ML, Baugh MM, Suing CM, Rosenbaum JT. Cloning, sequencing and expression analysis of the mouse NOD2/CARD15 gene. Inflamm. Res. 52: 272-276 (2003). *
Iwata M, Harada K, Hiramatsu K, Tsuneyama K, Kaneko S, Kobayashi K, Nakanuma Y. Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis. Liver 20: 129-135 (2000).
Jackola DR, Basu S, Liebeler CL, Willaert R, Luah SS, Oetting W, King RA, Blumenthal MN. CD14 promoter polymorphisms in atopic families: implications for modulated allergen-specific immunoglobulin E and G1 responses. Int. Arch. Allergy Immunol. 139: 217-224 (2006).
Jacob A, Hensley LK, Safratowich BD, Quigg RJ, Alexander JJ. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab. Invest. 87: 1186-1194 (2007). *
Jacob JB, Kong YC, Meroueh C, Snower DP, David CS, Ho YS, Wei WZ. Control of her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells. Cancer Res. 67: 7020-7027 (2007). *
Jaekal J, Abraham E, Azam T, Netea MG, Dinarello CA, Lim JS, Yang Y, Yoon DY, Kim SH. Individual LPS responsiveness depends on the variation of Toll-like receptor (TLR) expression level. J. Microbiol. Biotechnol. 17: 1862-1867 (2007). *
Jaen O, Rulle S, Bessis N, Zago A, Boissier MC, Falgarone G. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo. Immunology 126: 35-44 (2009). *
Jaeschke H. Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am. J. Physiol. 273: G602-G611 (1997).
Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2: 223-228 (2001). *
Jalan R, Bernuau J. Induction of cerebral hyperemia by ammonia plus endotoxin: does hyperammonemia unlock the blood-brain barrier? J. Hepatol. 47: 168-171 (2007). *
Janardhan KS, McIsaac M, Fowlie J, Shrivastav A, Caldwell S, Sharma RK, Singh B. Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. Histol. Histopathol. 21: 687-696 (2006).
Jang HS, Chung HS, Ko E, Shin JS, Shin MK, Hong MC, Kim Y, Min BI, Bae H. Microarray analysis of gene expression profiles in response to treatment with bee venom in lipopolysaccharide activated RAW 264.7 cells. J. Ethnopharmacol. 121: 213-220 (2009).
Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16: 637-646 (2003). *
Janssens S, Burns K, Tschopp J, Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr. Biol. 12: 467-471 (2002). *
Janssens S, Burns K, Vercammen E, Tschopp J, Beyaert R. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression. FEBS Lett. 548: 103-107 (2003). *
Jaresova I, Rozkova D, Spisek R, Janda A, Brazova J, Sediva A. Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. Microbes Infect. 9: 1359-1367 (2007). *
Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33: 1148-1153 (2001). *
Jaso-Friedmann L, Leary JH 3rd, Praveen K, Waldron M, Hoenig M. The effects of obesity and fatty acids on the feline immune system. Vet. Immunol. Immunopathol. 122: 146-152 (2008).
Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J. Appl. Physiol. 102: 429-433 (2007). *
Jennewein C, Kuhn AM, Schmidt MV, Meilladec-Jullig V, von Knethen A, Gonzalez FJ, Brune B. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J. Immunol. 181: 5646-5652 (2008).
Jensen BA, Leeman RJ, Schlezinger JJ, Sherr DH. Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study. Environ. Health 2: 16 (2003). *
Jeon YJ, Han SH, Lee YW, Lee M, Yang KH, Kim HM. Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. Immunopharmacology 48: 173-183 (2000).
Jerala R. Structural biology of the LPS recognition. Int. J. Med. Microbiol. 297: 353-363 (2007).
Jerala R, Porro M. Endotoxin neutralizing peptides. Curr. Top. Med. Chem. 4: 1173-1184 (2004).
Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, Croner RS. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J. Hepatol. 42: 870-879 (2005). *
Jetten AM. Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr. Drug Targets Inflamm. Allergy 3: 395-412 (2004).
Jeyarajah DR, Kielar ML, Frantz N, Lindberg G, Lu CY. Infection by gram-negative organisms via the biliary route results in greater mortality than portal venous infection. Clin. Diagn. Lab. Immunol. 10: 664-669 (2003). *
Jia LQ, Wang QM, Liu C, Tian L, Fu MD. Study on the protective effect of HDL subclasses against lipopolysaccharide. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23: 616-619 (2007).
Jia Y, Turek JJ. Inducible nitric oxide synthase links NF-kappaB to PGE2 in polyunsaturated fatty acid altered fibroblast in-vitro wound healing. Lipids Health Dis. 4: 14 (2005). *
Jia Y, Turek JJ. Altered NF-kappaB gene expression and collagen formation induced by polyunsaturated fatty acids. J. Nutr. Biochem. 16: 500-506 (2005). *
Jiang J, Zhu P, Wang Z, He Y, Liu D, Tian K, Diao Y. Protective effect of bactericidal/permeability-increasing protein in mice with E. coli sepsis. Chin. J. Traumatol. 1: 21-24 (1998).
Jiang W, Bell CW, Pisetsky DS. The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J. Immunol. 178: 6495-6503 (2007). *
Jiang W, Pisetsky DS. The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J. Immunol. 177: 3337-3343 (2006). *
Jiang W, Sun R, Wei H, Tian Z. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of Toll-like receptor 4 expression on macrophages. Proc. Natl. Acad. Sci. U.S.A. 102: 17077-17082 (2005). *
Jiang WL, Chen XG, Zhu HB, Tian JW. Effect of cornuside on experimental sepsis. Planta Med. Mar 4 [Epub ahead of print] (2009).
Jin W, Wang H, Ji Y, Hu Q, Yan W, Chen G, Yin H. Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury. Cytokine 44: 135-140 (2008).
Jing Y, Shishkov A, Ponnappa BC. Inhibition of tumor necrosis factor alpha secretion in rat Kupffer cells by siRNA: in vivo efficacy of siRNA-liposomes. Biochim. Biophys. Acta 1780: 34-40 (2008). *
Jirillo E, Caccavo D, Magrone T, Piccigallo E, Amati L, Lembo A, Kalis C, Gumenscheimer M. The role of the liver in the response to LPS: experimental and clinical findings. J. Endotoxin Res. 8: 319-327 (2002). *
Johannessen LN, Lovik M, Steinshamn S, Nilsen AM. Monocyte exposure to Saccharomyces cerevisiae cell wall mannan and decreased TNF-alpha production in mild asthma: a role for mannan-binding lectin? Scand. J. Immunol. 68: 511-515 (2008). *
Johansen P, Senti G, Martinez Gomez JM, Storni T, von Beust BR, Wuthrich B, Bot A, Kundig TM. Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy. Clin. Exp. Allergy 35: 1591-1598 (2005). *
John G, Yildirim AO, Rubin BK, Gruenert DC, Henke MO. Toll-like receptor (TLR)-4 mediated innate immunity is reduced in cystic fibrosis airway cells. Am. J. Respir. Cell. Mol. Biol. Jun 5 [Epub ahead of print] (2009).
Johnson BJ, Le TT, Dobbin CA, Banovic T, Howard CB, Leon Flores FD, Vanags D, Naylor DJ, Hill GR, Suhrbier A. Heat shock protein 10 Inhibits lipopolysaccharide-induced inflammatory mediator production. J. Biol. Chem. 280: 4037-4047 (2005). *
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann. Neurol. 50: 434-442 (2001).
Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc. Natl. Acad. Sci. U.S.A. 104: 16239-16244 (2007). *
Joo SS, Kang HC, Won TJ, Lee DI. Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1beta and nitric oxide in rat microglia. Arch. Pharm. Res. 26: 1067-1073 (2003).
Jose P, Avdiushko MG, Akira S, Kaplan AM, Cohen DA. Inhibition of interleukin-10 signaling in lung dendritic cells by Toll-like receptor 4 ligands. Exp. Lung Res. 35: 1-28 (2009).
Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9: 213-219 (2003). *
Joyee AG, Yang X. Role of Toll-like receptors in immune responses to chlamydial infections. Curr. Pharm. Des. 14: 593-600 (2008).
Jozefowicz E, Brisson H, Rozenberg S, Mebazaa A, Gele P, Callebert J, Lebuffe G, Vallet B, Bordet R, Tavernier B. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats. Crit. Care Med. 35: 856-863 (2007).
Juarranz Y, Gutierrez-Canas I, Arranz A, Martinez C, Abad C, Leceta J, Pablos JL, Gomariz RP. VIP decreases TLR4 expression induced by LPS and TNF-alpha treatment in human synovial fibroblasts. Ann. N. Y. Acad. Sci. 1070: 359-364 (2006). *
Jung YO, Cho ML, Kang CM, Jhun JY, Park JS, Oh HJ, Min JK, Park SH, Kim HY. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunol. Lett. 109: 21-27 (2007).
Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK. Synergism of Toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Immunol. Lett. 123: 138-143 (2009).
Jung YW, Schoeb TR, Weaver CT, Chaplin DD. Antigen and lipopolysaccharide play synergistic roles in the effector phase of airway inflammation in mice. Am. J. Pathol. 168: 1425-1434 (2006). *
Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J. Neuroinflammation 5: 52 (2008).
J�rgensen VL, Ibsen M, Andresen L, Schulzke JD, Perner A. Effects of endotoxaemia on markers of permeability, metabolism and inflammation in the large bowel of healthy subjects. Acta Anaesthesiol. Scand. 51: 1085-1092 (2007).
Kabaroff LC, Rodriguez A, Quinton M, Boermans H, Karrow NA. Assessment of the ovine acute phase response and hepatic gene expression in response to Escherichia coli endotoxin. Vet. Immunol. Immunopathol. 113: 113-124 (2006).
Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19: 39-45 (2007).
Kagami S, Kanari H, Suto A, Fujiwara M, Ikeda K, Hirose K, Watanabe N, Iwamoto I, Nakajima H. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells. Int. Arch. Allergy Immunol. 146 Suppl. 1: 61-66 (2008).
Kaiser HB. Risk factors in allergy/asthma. Allergy Asthma Proc. 25: 7-10 (2004).
Kaisho T, Akira S. Critical roles of Toll-like receptors in host defense. Crit. Rev. Immunol. 20: 393-405 (2000).
Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ida N. Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol. Jpn. 28: 18-24 (1993).
Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97: 3466-3469 (2001). *
Kalitsky-Szirtes J, Shayeganpour A, Brocks DR, Piquette-Miller M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab. Dispos. 32: 20-27 (2004). *
Kalliomaki M, Isolauri E. Pandemic of atopic diseases - a lack of microbial exposure in early infancy? Curr. Drug Targets Infect. Disord. 2: 193-199 (2002).
Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J. Invest. Dermatol. 114: 1180-1183 (2000). *
Kamon H, Kawabe T, Kitamura H, Lee J, Kamimura D, Kaisho T, Akira S, Iwamatsu A, Koga H, Murakami M, Hirano T. TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation. EMBO J. 25: 4108-4119 (2006). *
Kamoun WS, Karaa A, Kresge N, Merkel SM, Korneszczuk K, Clemens MG. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1. Hepatology 43: 182-190 (2006). *
Kampmann E, Johann S, van Neerven S, Beyer C, Mey J. Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes. J. Neurochem. 106: 320-332 (2008).
Kanaya S, Nemoto E, Ogawa T, Shimauchi H. Porphyromonas gingivalis fimbriae induce unique dendritic cell subsets via Toll-like receptor 2. J. Periodontal Res. Oct 7 [Epub ahead of print] (2008).
Kanayama S, Yamada Y, Onogi A, Shigetomi H, Ueda S, Tsuji Y, Haruta S, Kawaguchi R, Yoshida S, Sakata M, Sado T, Kitanaka T, Oi H, Yagyu T, Kobayashi H. Bikunin suppresses expression of pro-inflammatory cytokines induced by lipopolysaccharide in neutrophils. J. Endotoxin Res. 13: 369-376 (2007). *
Kaneko M, Akiyama Y, Takimoto H, Kumazawa Y. Mechanism of up-regulation of immunoglobulin A production in the intestine of mice unresponsive to lipopolysaccharide. Immunology 116: 64-70 (2005). *
Kang BS, Han JY, Kang SK, Kim DI, Kim JK, Kim CH. Effect of the traditional Korean immunomodulating formulation, Gamguntang (GGT), on experimental thyroiditis model. Immunopharmacol. Immunotoxicol. 28: 51-66 (2006).
Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur. J. Pharmacol. 384: 191-195 (1999). *
Kang BY, Chung SW, Im SY, Choe YK, Kim TS. Sulfasalazine prevents T-helper 1 immune response by suppressing interleukin-12 production in macrophages. Immunology 98: 98-103 (1999). *
Kang BY, Chung SW, Im SY, Hwang SY, Kim TS. Chloromethyl ketones inhibit interleukin-12 production in mouse macrophages stimulated with lipopolysaccharide. Immunol. Lett. 70: 135-138 (1999).
Kang BY, Chung SW, Kim SH, Kang SN, Choe YK, Kim TS. Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Th1 cytokine profile in CD4(+) T cells. Br. J. Pharmacol. 130: 581-586 (2000). *
Kang BY, Chung SW, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB. Immunol. Lett. 77: 159-163 (2001).
Kang BY, Kim SH, Cho D, Kim TS. Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid. Arch. Pharm. Res. 28: 274-279 (2005).
Kang YJ, Chen J, Otsuka M, Mols J, Ren S, Wang Y, Han J. Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation. J. Immunol. 180: 5075-5082 (2008). *
Kang YJ, Kim SO, Shimada S, Otsuka M, Seit-Nebi A, Kwon BS, Watts TH, Han J. Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat. Immunol. 8: 601-609 (2007). *
Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Nunez G. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26: 433-443 (2007). *
Kaplan R, Gan X, Menke JG, Wright SD, Cai TQ. Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway. J. Lipid Res. 43: 952-959 (2002). *
Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165: 1045-1053 (2004). *
Karahashi H, Michelsen KS, Arditi M. Lipopolysaccharide-induced apoptosis in transformed bovine brain endothelial cells and human dermal microvessel endothelial cells: the role of JNK. J. Immunol. 182: 7280-7286 (2009).
Karavitis J, Murdoch EL, Gomez CR, Ramirez L, Kovacs EJ. Acute ethanol exposure attenuates pattern recognition receptor activated macrophage functions. J. Interferon Cytokine Res. 28: 413-422 (2008).
Karban A, Waterman M, Panhuysen CI, Pollak RD, Nesher S, Datta L, Weiss B, Suissa A, Shamir R, Brant SR, Eliakim R. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic jews with Crohn's disease. Am. J. Gastroenterol. 99: 1134-1140 (2004). *
Kariko K, Weissman D, Welsh FA. Inhibition of Toll-like receptor and cytokine signaling - a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24: 1288-1304 (2004).
Karrar A, Broome U, Sodergren T, Jaksch M, Bergquist A, Bjornstedt M, Sumitran-Holgersson S. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 132: 1504-1514 (2007). *
Kaser A, Ludwiczek O, Waldenberger P, Jaschke W, Vogel W, Tilg H. Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver 22: 380-387 (2002). *
Katagiri H, Ito Y, Ishii K, Hayashi I, Suematsu M, Yamashina S, Murata T, Narumiya S, Kakita A, Majima M. Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology 39: 139-150 (2004). *
Katagiri H, Ito Y, Ito S, Murata T, Narumiya S, Watanabe M, Majima M. Tumor necrosis factor-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver. Shock Feb 21 [Epub ahead of print] (2008).
Katagiri H, Ito Y, Ito S, Murata T, Yukihiko S, Narumiya S, Watanabe M, Majima M. TNF-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver. Shock 30: 463-467 (2008).
Katayama M, Xu D, Specian RD, Deitch EA. Role of bacterial adherence and the mucus barrier on bacterial translocation: effects of protein malnutrition and endotoxin in rats. Ann. Surg. 225: 317-326 (1997). *
Kato I, Canzian F, Plummer M, Franceschi S, van Doorn LJ, Vivas J, Lopez G, Lu Y, Gioia-Patricola L, Severson RK, Schwartz AG, Munoz N. Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig. Dis. Sci. 52: 254-261 (2007). *
Katschinski T, Galanos C, Coumbos A, Freudenberg MA. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60: 1994-2001 (1992). *
Katsuki H, Kurimoto E, Takemori S, Kurauchi Y, Hisatsune A, Isohama Y, Izumi Y, Kume T, Shudo K, Akaike A. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling. J. Neurochem. May 14 [Epub ahead of print] (2009).
Katsuno G, Takahashi HK, Iwagaki H, Sugita S, Mori S, Saito S, Yoshino T, Nishibori M, Tanaka N. The effect of ciprofloxacin on CD14 and Toll-like receptor-4 expression on human monocytes. Shock 25: 247-253 (2006). *
Kaufmann T, Jost PJ, Pellegrini M, Puthalakath H, Gugasyan R, Gerondakis S, Cretney E, Smyth MJ, Silke J, Hakem R, Bouillet P, Mak TW, Dixit VM, Strasser A. Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 30: 56-66 (2009). *
Kavanagh T, Lonergan PE, Lynch MA. Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. Prostaglandins Leukot. Essent. Fatty Acids 70: 391-397 (2004). *
Kavin H. Celiac disease complicated by chronic nongranulomatous ulcerative enterocolitis, nodular lymphoid hyperplasia, and disseminated intravascular coagulation. Dig. Dis. Sci. 26: 73-80 (1981).
Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105: 376-381 (2005). *
Kawaguchi T, Sakisaka S, Harada M, Hanada S, Taniguchi E, Koga H, Sasatomi K, Tanikawa K, Sata M. Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets. Hepatol. Res. 20: 144-154 (2001).
Kawaguchi T, Sakisaka S, Mitsuyama K, Harada M, Koga H, Taniguchi E, Sasatomi K, Kimura R, Ueno T, Sawada N, Mori M, Sata M. Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis. Hepatology 31: 1285-1295 (2000). *
Kawahara K, Hashiguchi T, Masuda K, Saniabadi AR, Kikuchi K, Tancharoen S, Ito T, Miura N, Morimoto Y, Biswas KK, Nawa Y, Meng X, Oyama Y, Takenouchi K, Shrestha B, Sameshima H, Shimizu T, Adachi T, Adachi M, Maruyama I. Mechanism of HMGB1 release inhibition from RAW264.7 cells by oleanolic acid in Prunus mume Sieb. et Zucc. Int. J. Mol. Med. 23: 615-620 (2009).
Kawahara M, Human LG, Winningham JS, Domingue GJ. Antibodies to Escherichia coli 06 porins cross-react with urinary pathogens. Immunobiology 192: 65-76 (1994).
Kawakami A, Nakashima K, Tamai M, Nakamura H, Iwanaga N, Fujikawa K, Aramaki T, Arima K, Iwamoto N, Ichinose K, Kamachi M, Ida H, Origuchi T, Eguchi K. Toll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line. J. Rheumatol. 34: 1019-1026 (2007).
Kawanishi H, Mirabella S. Regulation of mucosal IgA production in vitro by autoreactive immunoregulatory T cells from murine Peyer's patches. Cell. Immunol. 114: 324-335 (1988). *
Kawanishi N, Tanaka Y, Kato Y, Shiva D, Yano H. Lipopolysaccharide-induced monocyte chemotactic protein-1 is enhanced by suppression of nitric oxide production, which depends on poor CD14 expression on the surface of skeletal muscle. Cell. Biochem. Funct. 26: 486-492 (2008). *
Kawaratani H, Tsujimoto T, Kitazawa T, Kitade M, Yoshiji H, Uemura M, Fukui H. Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet. World J. Gastroenterol. 14: 6655-6661 (2008). *
Kawasaki M, Yagasaki K, Miura Y, Funabiki R. Comparison of the changes in lipid metabolism between hepatoma-bearing and lipopolysaccharide-treated rats. Biosci. Biotechnol. Biochem. 68: 72-78 (2004). *
Kazawa T, Kawasaki T, Sakamoto A, Imamura M, Ohashi R, Jiang S, Tanaka T, Iwanari H, Hamakubo T, Sakai J, Kodama T, Naito M. Expression of liver X receptor alpha and lipid metabolism in granulocyte-macrophage colony-stimulating factor-induced human monocyte-derived macrophage. Pathol. Int. 59: 152-160 (2009). *
Kazimierczak K, Kopec W, Klinger M. Toll-like receptors (TLR) in the pathogenesis of kidney diseases. Pol. Merkur. Lekarski. 23: 382-385 (2007).
Ke S, Rabson AB, Germino JF, Gallo MA, Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J. Biol. Chem. 276: 39638-39644 (2001). *
Keefer L, Stepanski EJ, Ranjbaran Z, Benson LM, Keshavarzian A. An initial report of sleep disturbance in inactive inflammatory bowel disease. J. Clin. Sleep Med. 2: 409-416 (2006).
Kelley DS, Taylor PC, Nelson GJ, Schmidt PC, Ferretti A, Erickson KL, Yu R, Chandra RK, Mackey BE. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34: 317-324 (1999).
Kelly CJ, Cech AC, Argenteanu M, Gallagher H, Shou J, Minnard E, Daly JM. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia. Surgery 114: 140-146 (1993).
Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T, Mor G. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 66: 3859-3868 (2006). *
Kennedy MN, Mullen GE, Leifer CA, Lee C, Mazzoni A, Dileepan KN, Segal DM. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J. Biol. Chem. 279: 34698-34704 (2004). *
Kerek F, Szegli G, Cremer L, Lupu AR, Durbaca S, Calugaru A, Herold A, Radu DL. The novel arthritis-drug substance MCS-18 attenuates the antibody production in vivo. Acta Microbiol. Immunol. Hung. 55: 15-31 (2008).
Kershenobich D, Antonio Alanis J, Fe Bornstein M, Perez Herrera M, Alvarado Ramos E, Irene Suarez G. Endotoxins and liver. Rev. Gastroenterol. Mex. 43: 49-57 (1978).
Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, Fields JZ. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J. Pharmacol. Exp. Ther. 299: 442-448 (2001). *
Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats? J. Hepatol. 50: 538-547 (2009).
Keshavarzian A, Haydek JM, Jacyno M, Holmes EW, Harford F. Modulatory effects of the colonic milieu on neutrophil oxidative burst: a possible pathogenic mechanism of ulcerative colitis. J. Lab. Clin. Med. 130: 216-225 (1997).
Kessel A, Toubi E, Pavlotzky E, Mogilner J, Coran AG, Lurie M, Karry R, Sukhotnik I. Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat. Clin. Exp. Immunol. 151: 341-347 (2008). *
Kett K, Baklien K, Bakken A, Kral JG, Fausa O, Brandtzaeg P. Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology 109: 819-825 (1995).
Khachigian LM. Collagen antibody-induced arthritis. Nat. Protoc. 1: 2512-2516 (2006). *
Khalfoun B, Thibault G, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion. Transplantation 62: 1649-1657 (1996).
Khan MA, Ma C, Knodler LA, Valdez Y, Rosenberger CM, Deng W, Finlay BB, Vallance BA. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect. Immun. 74: 2522-2536 (2006). *
Khil LY, Jun HS, Kwon H, Yoo JK, Kim S, Notkins AL, Yoon JW. Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia 50: 2147-2155 (2007). *
Khorramizadeh MR, Hosseinzadeh S, Safavifar F, Saadat F, Aalizadeh N, Falak R, Jadali Z, Pezeshki M. Iteraction of CpG-oligodeoxynucleotides with Toll like receptor 9 induces apoptosis and modulates metaloproteinase-2 activity in human intestinal epithelium. Iran. J. Allergy Asthma Immunol. 6: 107-114 (2007).
Khoury M, Escriou V, Courties G, Galy A, Yao R, Largeau C, Scherman D, Jorgensen C, Apparailly F. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Arthritis Rheum. 58: 2356-2367 (2008). *
Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J. Lipid Res. 44: 1728-1736 (2003). *
Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol. Motil. 21: 439-450 (2009).
Kidd M, Hauso O, Drozdov I, Gustafsson BI, Modlin IM. Delineation of the chemomechanosensory regulation of gastrin secretion using pure rodent G cells. Gastroenterology Jan 14 [Epub ahead of print] (2009). *
Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T. Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway. J. Periodontal Res. 38: 557-563 (2003). *
Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347: 185-192 (2002). *
Kielar ML, Jeyarajah DR, Penfield JG, Lu CY. Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NFkappa d response elements of the iNOS promoter. Transplantation 69: 2131-2137 (2000).
Killeen ME, Englert JA, Stolz DB, Song M, Han Y, Delude RL, Kellum JA, Fink MP. The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J. Pharmacol. Exp. Ther. 316: 1070-1079 (2006). *
Killeen SD, Wang JH, Andrews EJ, Redmond HP. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br. J. Cancer 100: 1589-1602 (2009). *
Kim BH, Kang KS, Lee YS. Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE(2) release from mouse peritoneal macrophages and TNF-alpha release from rat peripheral blood mononuclear cells. Toxicol. Lett. 150: 191-201 (2004). *
Kim BH, Lee KH, Chung EY, Chang YS, Lee H, Lee CK, Min KR, Kim Y. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages. Eur. J. Pharmacol. 543: 158-165 (2006). *
Kim E, Kang BY, Kim TS. Inhibition of interleukin-12 production in mouse macrophages by hydroquinone, a reactive metabolite of benzene, via suppression of nuclear factor-kappaB binding activity. Immunol. Lett. 99: 24-29 (2005).
Kim GY, Kim JH, Ahn SC, Lee HJ, Moon DO, Lee CM, Park YM. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kB. Immunology 113: 203-211 (2004). *
Kim HA, Kim S, Chang SH, Hwang HJ, Choi YN. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int. Immunopharmacol. 7: 1286-1291 (2007).
Kim HH, Lee Y, Eun HC, Chung JH. Eicosapentaenoic acid inhibits TNF-alpha-induced matrix metalloproteinase-9 expression in human keratinocytes, HaCaT cells. Biochem. Biophys. Res. Commun. 368: 343-349 (2008). *
Kim HY, Kim JR, Kim HS. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages. J. Microbiol. Biotechnol. 18: 1170-1178 (2008).
Kim JG, Lee SJ, Kagnoff MF. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by Toll-like receptors. Infect. Immun. 72: 1487-1495 (2004). *
Kim JH, Na HJ, Kim CK, Kim JY, Ha KS, Lee H, Chung HT, Kwon HJ, Kwon YG, Kim YM. The non-provitamin A carotenoid, lutein, inhibits NF-kappaB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-kappaB-inducing kinase pathways: Role of H(2)O(2) in NF-kappaB activation. Free Radic. Biol. Med. 45: 885-896 (2008).
Kim JS, Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 115: 375-387 (2005). *
Kim JS, Narula AS, Jobin C. Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NFkB signalling in intestinal epithelial cells. Clin. Exp. Immunol. 141: 288-297 (2005). *
Kim JW, Kim BG, Lee KL, Jeong JB, Jung YJ, Kim JS, Jung HC, Song IS. The effects of DA-6034 on NF-kappaB activity induced by lipopolysaccharide or tumor necrosis factor alpha in a human colonic epithelial cell line. Hepatogastroenterology 55: 2059-2064 (2008).
Kim KM, Choi JY, Yoo SE, Park MY, Lee BS, Ko YH, Sung SH, Shin HM, Park JE. HMCO5, herbal extract, inhibits NF-kappaB expression in lipopolysaccharide treated macrophages and reduces atherosclerotic lesions in cholesterol fed mice. J. Ethnopharmacol. 114: 316-324 (2007). *
Kim MH, Lee HY, Roh E, Kim BH, Chung EY, Lee YR, Lee IJ, Lee H, Lee CK, Han SB, Kim Y. Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages. Biochem. Pharmacol. 76: 373-381 (2008). *
Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C. Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 278: 8988-8995 (2003). *
Kim RD, Greenberg DE, Ehrmantraut ME, Ding L, Shea Y, Chernick M, Jolley C, Raffeld M, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool R, Fitzgerald A, Darnell D, Decastro R, Porcella SF, Olivier KN, Moss J, Holland SM. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am. J. Respir. Crit. Care Med. 178: 1066-1074 (2008). *
Kim SK, Im J, Yun CH, Son JY, Son CG, Park DK, Han SH. Armillariella mellea induces maturation of human dendritic cells without induction of cytokine expression. J. Ethnopharmacol. 119: 153-159 (2008).
Kim SK, Kim YC. Attenuation of bacterial lipopolysaccharide-induced hepatotoxicity by betaine or taurine in rats. Food Chem. Toxicol. 40: 545-549 (2002). *
Kim SK, Son CG, Yun CH, Han SH. Hericium erinaceum induces maturation of dendritic cells derived from human peripheral blood monocytes. Phytother. Res. May 13 [Epub ahead of print] (2009).
Kim TW, Kwon YJ, Kim JM, Song YH, Kim SN, Kim YJ. MED16 and MED23 of Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators. Proc. Natl. Acad. Sci. U.S.A. 101: 12153-12158 (2004). *
Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, Vandenburg Y, Xiao H, Qian W, Hamilton T, Min B, Sen G, Gilmour R, Li X. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204: 1025-1036 (2007). *
Kim YJ, Chung HY. Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaenoic acid in renal epithelial cells and macrophages. J. Med. Food 10: 225-231 (2007).
Kim YS, Hwang YJ, Kim SY, Yang SM, Lee KY, Park IB. Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population. Yonsei. Med. J. 49: 58-62 (2008). *
Kim YS, Kim JS, Jung HC, Song IS. The effects of thalidomide on the stimulation of NF-kB activity and TNF-a production by lipopolysaccharide in a human colonic epithelial cell line. Mol. Cells 17: 210-216 (2004). *
Kim YW, Zhao RJ, Park SJ, Lee JR, Cho IJ, Yang CH, Kim SG, Kim SC. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br. J. Pharmacol. 154: 165-173 (2008). *
Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 46: 725-731 (2000). *
Kimmings AN, van Deventer SJ, Rauws EAJ, Huibregtse K, Gouma DJ. Systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur. J. Surg. 166: 700-705 (2000).
Kimura A, Naka T, Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc. Natl. Acad. Sci. U.S.A. 104: 12099-12104 (2007). *
Kimura H, Mukaida M, Kuwabara K, Ito T, Hashino K, Uchida K, Matsumoto K, Yoshida K. 4-Hydroxynonenal modifies IgA in rat intestine after lipopolysaccharide injection. Free Radic. Biol. Med. 41: 973-978 (2006).
Kinane DF, Shiba H, Stathopoulou PG, Zhao H, Lappin DF, Singh A, Eskan MA, Beckers S, Waigel S, Alpert B, Knudsen TB. Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399Ile are hypo-responsive to Porphyromonas gingivalis. Genes Immun. 7: 190-200 (2006). *
Kindt S, van Oudenhove L, Broekaert D, Kasran A, Ceuppens JL, Bossuyt X, Fischler B, Tack J. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol. Motil. 21: 389-398 (2009).
Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J. Biol. Chem. 280: 21720-21725 (2005). *
Kinsner A, Boveri M, Hareng L, Brown GC, Coecke S, Hartung T, Bal-Price A. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide. J. Neurochem. 99: 596-607 (2006). *
Kintz E, Goldberg JB. Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa. Future Microbiol. 3: 191-203 (2008).
Kirchhoff C, Biberthaler P, Mutschler WE, Faist E, Jochum M, Zedler S. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a prospective cohort study. Crit. Care 13: R88 (2009).
Kirino Y, Takeno M, Watanabe R, Murakami S, Kobayashi M, Ideguchi H, Ihata A, Ohno S, Ueda A, Mizuki N, Ishigatsubo Y. Association of reduced HO-1 with excessive TLR4 expression in peripheral blood mononuclear cells of Behcet's disease. Arthritis Res. Ther. 10: R16 (2008). *
Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91: 1789-1794 (1996).
Kirschning CJ, Bauer S. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses. Int. J. Med. Microbiol. 291: 251-260 (2001).
Kirschning CJ, Schumann RR. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr. Top. Microbiol. Immunol. 270: 121-144 (2002).
Kirshenbaum AS, Swindle E, Kulka M, Wu Y, Metcalfe DD. Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokine production, and protease composition. BMC Immunol. 9: 45 (2008). *
Kis K, Bodai L, Polyanka H, Eder K, Pivarcsi A, Duda E, Soos G, Bata-Csorgo Z, Kemeny L. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes. Int. Immunopharmacol. 6: 358-368 (2006).
Kisand KE, Prukk T, Kisand KV, Luus SM, Kalbe I, Uibo R. Propensity to excessive proinflammatory response in chronic Lyme borreliosis. APMIS 115: 134-141 (2007). *
Kishore SP, Bungum MK, Platt JL, Brunn GJ. Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4. FEBS Lett. 579: 699-704 (2005). *
Kitamura H, Morikawa H, Kamon H, Iguchi M, Hojyo S, Fukada T, Yamashita S, Kaisho T, Akira S, Murakami M, Hirano T. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol. 7: 971-977 (2006). *
Kitazawa T, Tsujimoto T, Kawaratani H, Fujimoto M, Fukui H. Expression of Toll-like receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure. J. Gastroenterol. Hepatol. 23: e494-e498 (2008). *
Kitazawa T, Tsujimoto T, Kawaratani H, Fukui H. Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury. J. Gastroenterol. Hepatol. Feb 13 [Epub ahead of print] (2009). *
Kitchens RL, Thompson PA, Munford RS, O'Keefe GE. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J. Lipid Res. 44: 2339-2348 (2003). *
Kiura K, Kataoka H, Nakata T, Into T, Yasuda M, Akira S, Inoue N, Shibata K. The synthetic analogue of mycoplasmal lipoprotein FSL-1 induces dendritic cell maturation through Toll-like receptor 2. FEMS Immunol. Med. Microbiol. 46: 78-84 (2006). *
Kizaki T, Izawa T, Sakurai T, Haga S, Taniguchi N, Tajiri H, Watanabe K, Day NK, Toba K, Ohno H. beta2-Adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2. Immunology 124: 348-356 (2008). *
Klein D, Einspanier R, Bolder U, Jeschke MG. Differences in the hepatic signal transcription pathway and cytokine expression between thermal injury and sepsis. Shock 20: 536-543 (2003). *
Klein W, Tromm A, Griga T, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand. J. Gastroenterol. 38: 834-836 (2003). *
Kmiec Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell. Biol. 161: III-XIII, 1-151 (2001).
Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J. Hepatol. 22: 226-229 (1995). *
Ko K, Yang H, Noureddin M, Iglesia-Ara A, Xia M, Wagner C, Luka Z, Mato JM, Lu SC. Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab. Invest. 88: 1121-1129 (2008). *
Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, Hayashi T, Ueda A, Ishigatsubo Y. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 54: 1132-1142 (2006). *
Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, Medzhitov R, Flavell RA. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199 (2002). *
Kobayashi N, Kayaba H, Takeda M, Yamaguchi K, Chiba T, Ito W, Chihara J. Activation of eosinophils by lipopolysaccharide-induced monocyte-derived cytokines. Allergol. Int. 58: 103-110 (2009). *
Koch A, Knobloch J, Dammhayn C, Raidl M, Ruppert A, Hag H, Rottlaender D, Muller K, Erdmann E. Effect of bacterial endotoxin LPS on expression of INF-gamma and IL-5 in T-lymphocytes from asthmatics. Clin. Immunol. 125: 194-204 (2007). *
Koga H, Sakisaka S, Yoshitake M, Harada M, Kumemura H, Hanada S, Taniguchi E, Kawaguchi T, Kumashiro R, Sata M. Abnormal accumulation in lipopolysaccharide in biliary epithelial cells of rats with self-filling blind loop. Int. J. Mol. Med. 9: 621-626 (2002). *
Koga K, Takaesu G, Yoshida R, Nakaya M, Kobayashi T, Kinjyo I, Yoshimura A. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 30: 372-383 (2009). *
Kohn FR, Kung AH. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Infect. Immun. 63: 333-339 (1995). *
Kohno K, Miyake M, Sano O, Tanaka-Kataoka M, Yamamoto S, Koya-Miyata S, Arai N, Fujii M, Watanabe H, Ushio S, Iwaki K, Fukuda S. Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3-one. Biol. Pharm. Bull. 31: 1938-1945 (2008). *
Koike-Kiriyama N, Adachi Y, Iwasaki M, Amou Y, Shigematsu A, Koike Y, Minamino K, Mukaide H, Shi M, Yanai S, Matsumura M, Ikehara S. High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells. Clin. Exp. Immunol. 154: 285-293 (2008).
Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic. Biol. Med. 34: 1006-1016 (2003).
Komiya A, Nagase H, Okugawa S, Ota Y, Suzukawa M, Kawakami A, Sekiya T, Matsushima K, Ohta K, Hirai K, Yamamoto K, Yamaguchi M. Expression and function of Toll-like receptors in human basophils. Int. Arch. Allergy Immunol. 140 Suppl. 1: 23-27 (2006).
Kong QL, Guan YZ, Jing XF, Li C, Guo XH, Lu Z, An YQ. BPI700-Fc gamma1(700) chimeric gene expression and its protective effect in a mice model of the lethal E. coli infection. Chin. Med. J. (Engl.) 119: 474-481 (2006).
Kong YC. Experimental autoimmune thyroiditis in the mouse. Curr. Protoc. Immunol. Chapter 15: Unit 15.7 (2007).
Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, Stockbrugger RW. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am. J. Gastroenterol. 103: 178-189 (2008). *
Koning GA, Schiffelers RM, Wauben MH, Kok RJ, Mastrobattista E, Molema G, Ten Hagen TL, Storm G. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum. 54: 1198-1208 (2006). *
Konno K, Wakabayashi Y, Akashi-Takamura S, Ishii T, Kobayashi M, Takahashi K, Kusumoto Y, Saitoh SI, Yoshizawa Y, Miyake K. A molecule that is associated with Toll-like receptor 4 and regulates its cell surface expression. Biochem. Biophys. Res. Commun. 339: 1076-1082 (2006). *
Kono H, Fujii H, Asakawa M, Maki A, Amemiya H, Hirai Y, Matsuda M, Yamamoto M. Medium-chain triglycerides enhance secretory IgA expression in rat intestine after administration of endotoxin. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G1081-G1089 (2004). *
Konrad A, Mahler M, Arni S, Flogerzi B, Klingelhofer S, Seibold F. Ameliorative effect of IDS 30, a stinging nettle leaf extract, on chronic colitis. Int. J. Colorectal Dis. 20: 9-17 (2005). *
Koo JS, Kim YD, Jetten AM, Belloni P, Nettesheim P. Overexpression of mucin genes induced by interleukin-1 beta, tumor necrosis factor-alpha, lipopolysaccharide, and neutrophil elastase is inhibited by a retinoic acid receptor alpha antagonist. Exp. Lung Res. 28: 315-332 (2002).
Koons A, Crandall M, An GC, Shapiro MB, Kramer S, West MA. Even ephemeral endotoxin exposure establishes endotoxin tolerance. J. Trauma 64: 938-942 (2008).
Kopp A, Buechler C, Neumeier M, Weigert J, Aslanidis C, Scholmerich J, Schaffler A. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity (Silver Spring) 17: 648-656 (2009). *
Korzeniowska-Kowal A, Witkowska D, Gamian A. Molecular mimicry of bacterial polysaccharides and their role in etiology of infectious and autoimmune diseases. Postepy. Hig. Med. Dosw. 55: 211-232 (2001).
Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun. 1: 185-190 (2000). *
Koss K, Satsangi J, Welsh KI, Jewell DP. Is interleukin-6 important in inflammatory bowel disease? Genes Immun. 1: 207-212 (2000). *
Kostyk AG, Dahl KM, Wynes MW, Whittaker LA, Weiss DJ, Loi R, Riches DW. Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages. Am. J. Pathol. 169: 12-20 (2006). *
Koussoulas V, Vassiliou S, Giamarellos-Bourboulis EJ, Tassias G, Kotsaki A, Barbatzas C, Tzivras M. Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease. Clin. Exp. Immunol. 156: 97-101 (2009). *
Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U.S.A. 103: 19854-19859 (2006). *
Kowalski ML, Wolska A, Grzegorczyk J, Hilt J, Jarzebska M, Drobniewski M, Synder M, Kurowski M. Increased responsiveness to Toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis. Mediators Inflamm. 2008: 132732 (2008). *
Koyama I, Matsunaga T, Harada T, Hokari S, Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 35: 455-461 (2002). *
Koyanagi T, Nakamuta M, Enjoji M, Iwamoto H, Motomura K, Sakai H, Nawata H. The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats. Int. J. Mol. Med. 7: 321-327 (2001).
Koziczak-Holbro M, Gluck A, Tschopp C, Mathison JC, Gram H. IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes. Eur. J. Immunol. 38: 788-796 (2008). *
Krack A, Sharma R, Figulla HR, Anker SD. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur. Heart J. 26: 2368-2374 (2005).
Kracker S, Radbruch A. Immunoglobulin class switching: in vitro induction and analysis. Methods Mol. Biol. 271: 149-159 (2004).
Kramer BW, Albertine KH, Moss TJ, Nitsos I, Ladenburger A, Speer CP, Newnham JP, Jobe AH. All-trans retinoic acid and intra-amniotic endotoxin-mediated effects on fetal sheep lung. Anat. Rec. (Hoboken.) 291: 1271-1277 (2008).
Krasnik L, Szponar B, Walczak M, Larsson L, Gamian A. Routine clinical laboratory tests correspond to increased serum levels of 3-hydroxy fatty acids, markers of endotoxins, in cardiosurgery patients. Arch. Immunol. Ther. Exp. (Warsz.) 54: 55-60 (2006).
Krasowska-Zoladek A, Banaszewska M, Kraszpulski M, Konat GW. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation. J. Neurosci. Res. 85: 205-212 (2007).
Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol. Rev. 220: 251-269 (2007). *
Krijt J, Cmejla R, Sykora V, Vokurka M, Vyoral D, Necas E. Different expression pattern of hepcidin genes in the liver and pancreas of C57BL/6N and DBA/2N mice. J. Hepatol. 40: 891-896 (2004). *
Krijt J, Vokurka M, Chang KT, Necas E. Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 104: 4308-4310 (2004). *
Kroeger I, Erhardt A, Abt D, Fischer M, Biburger M, Rau T, Neuhuber WL, Tiegs G. The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice. J. Hepatol. May 3 [Epub ahead of print] (2009).
Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 12: 110-119 (2000).
Kroner A, Vogel F, Kolb-Maurer A, Kruse N, Toyka KV, Hemmer B, Rieckmann P, Maurer M. Impact of the Asp299Gly polymorphism in the Toll-like receptor 4 (TLR-4) gene on disease course of multiple sclerosis. J. Neuroimmunol. 165: 161-165 (2005).
Krumbach R, Bloor S, Ryzhakov G, Randow F. Somatic cell genetics for the study of NF-kappaB signaling in innate immunity. Sci. Signal. 1: pt7 (2008). *
Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, et al. Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204: 2407-2422 (2007). *
Kubo Y, Fukuishi N, Yoshioka M, Kawasoe Y, Iriguchi S, Imajo N, Yasui Y, Matsui N, Akagi M. Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells. Inflamm. Res. 56: 70-75 (2007). *
Kubota K, Sakaki H, Imaizumi T, Nakagawa H, Kusumi A, Kobayashi W, Satoh K, Kimura H. Retinoic acid-inducible gene-I is induced in gingival fibroblasts by lipopolysaccharide or poly IC: possible roles in interleukin-1beta, -6 and -8 expression. Oral Microbiol. Immunol. 21: 399-406 (2006).
Kucuk C, Sozuer E, Gursoy S, Canoz O, Artis T, Akcan A, Akyildiz H, Muhtaroglu S. Treatment with Met-RANTES decreases bacterial translocation in experimental colitis. Am. J. Surg. 191: 77-83 (2006). *
Kudo H, Takahara T, Yata Y, Kawai K, Zhang W, Sugiyama T. Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J. Hepatol. 51: 168-175 (2009).
Kukuruzovic R, Chauhan S, Dorney S, Elliott E. Antibiotics for cholangitis and/or cholecystitis. Cochrane Database Syst. Rev. 2: CD003780 (2004). *
Kullak-Ublick GA. Regulation of bile salt transporter genes by nuclear receptors. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 43. June 18-19 (2004). *
Kullak-Ublick GA, Meier PJ. Mechanisms of cholestasis. Clin. Liver Dis. 4: 357-385 (2000).
Kullberg BJ, Ferwerda G, de Jong DJ, Drenth JP, Joosten LA, Van der Meer JW, Netea MG. Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli. Immunology 123: 600-605 (2008). *
Kumazawa Y, Kawaguchi K, Takimoto H. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr. Pharm. Des. 12: 4271-4279 (2006).
Kumpf O, Hamann L, Schlag PM, Schumann RR. Pre- and postoperative cytokine release after in vitro whole blood lipopolysaccharide stimulation and frequent Toll-like receptor 4 polymorphisms. Shock 25: 123-128 (2006). *
Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P. The Toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 68: 223-229 (2007).
Kurata S, Ariki S, Kawabata S. Recognition of pathogens and activation of immune responses in Drosophila and horseshoe crab innate immunity. Immunobiology 211: 237-249 (2006).
Kuroe K, Kitagawa K, Chiba M, Yoshida Y. Experimental colitis in rabbits. Gastroenterol. Jpn. 13: 33-42 (1978).
Kuroki Y. Recent advances in innate immune host defense - host defense lectins and endotoxin receptors. Hokkaido Igaku Zasshi 77: 3-7 (2002).
Kuroki Y, Tsuchida K, Go I, Aoyama M, Naganuma T, Takemoto Y, Nakatani T. A study of innate immunity in patients with end-stage renal disease: special reference to Toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients. Int. J. Mol. Med. 19: 783-790 (2007). *
Kusminski CM, da Silva NF, Creely SJ, Fisher FM, Harte AL, Baker AR, Kumar S, McTernan PG. The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes. J. Clin. Endocrinol. Metab. 92: 270-276 (2007). *
Kuuliala K, Orpana A, Leirisalo-Repo M, Repo H. Neutrophils of healthy subjects with a history of reactive arthritis show enhanced responsiveness, as defined by CD11b expression in adherent and non-adherent whole blood cultures. Rheumatology (Oxford) 46: 934-937 (2007). *
Kuwata H, Matsumoto M, Atarashi K, Morishita H, Hirotani T, Koga R, Takeda K. IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. Immunity 24: 41-51 (2006). *
Kuwata H, Watanabe Y, Miyoshi H, Yamamoto M, Kaisho T, Takeda K, Akira S. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102: 4123-4129 (2003). *
Kyokane T, Norimizu S, Taniai H, Yamaguchi T, Takeoka S, Tsuchida E, Naito M, Nimura Y, Ishimura Y, Suematsu M. Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology 120: 1227-1240 (2001). *
Labib R, Turkall R, Abdel-Rahman MS. Endotoxin potentiates the hepatotoxicity of cocaine in male mice. J. Toxicol. Environ. Health A. 65: 977-993 (2002).
Lacoste MG, Tamashiro H, Correa SG, de Guzman AM, Di Genaro MS. Correlation between Yersinia enterocolitica and type I collagen reactivity in patients with arthropathies. Rheumatol. Int. 27: 613-620 (2007). *
Lacroix-Lamande S, Mancassola R, Naciri M, Laurent F. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection. Infect. Immun. 70: 2090-2099. *
Laengle UW, Markstein R, Cazaubon C, Roman D. Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells. Jpn. J. Ophthalmol. 53: 159-163 (2009).
Laflamme N, Echchannaoui H, Landmann R, Rivest S. Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur. J. Immunol. 33: 1127-1138 (2003). *
Laflamme N, Soucy G, Rivest S. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 79: 648-657 (2001). *
Lafon M. Viral superantigens. Rev. Med. Interne. 21: 713-716 (2000).
Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125: 47-57 (2003). *
Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH. The role of cytokines and chemokines in the development of steatohepatitis. Semin. Liver Dis. 27: 173-193 (2007).
Lamothe B, Campos AD, Webster WK, Gopinathan A, Hur L, Darnay BG. The RING domain and first zinc-finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem. 283: 24871-24880 (2008). *
Lancioni CL, Thomas JJ, Rojas RE. Activation requirements and responses to TLR ligands in human CD4(+) T cells: comparison of two T cell isolation techniques. J. Immunol. Methods 344: 15-25 (2009). *
Lang T, Prina E, Sibthorpe D, Blackwell JM. Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. Infect. Immun. 65: 380-386 (1997). *
Lange S, Delbro DS, Jennische E, Mattsby-Baltzer I. The role of the Lps gene in experimental ulcerative colitis in mice. APMIS 104: 823-833 (1996).
Lanzavecchia A, Sallusto F. Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr. Opin. Immunol. 19: 268-274 (2007).
Lapaque N, Takeuchi O, Corrales F, Akira S, Moriyon I, Howard JC, Gorvel JP. Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides. Cell. Microbiol. 8: 401-413 (2006). *
Lappalainen MH, Roponen M, Hyvarinen A, Nevalainen A, Laine O, Pekkanen J, Hirvonen MR. Exposure to environmental bacteria may have differing effects on tumour necrosis factor-alpha and interleukin-6-producing capacity in infancy. Clin. Exp. Allergy 38: 1483-1492 (2008). *
Lappas M, Permezel M, Holdsworth SJ, Zanoni G, Porta A, Rice GE. Antiinflammatory effects of the cyclopentenone isoprostane 15-A(2)-IsoP in human gestational tissues. Free Radic. Biol. Med. 42: 1791-1796 (2007).
Lapteva N, Seethammagari MR, Hanks BA, Jiang J, Levitt JM, Slawin KM, Spencer DM. Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation. Cancer Res. 67: 10528-10537 (2007). *
Larocca L, Calafat M, Roca V, Franchi AM, Leiros CP. VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages. Int. Immunopharmacol. 7: 1343-1349 (2007).
Larsson L, Johansson P, Jansson A, Donati M, Rymo L, Berglundh T. The Sp1 transcription factor binds to the G-allele of the -1087 IL-10 gene polymorphism and enhances transcriptional activation. Genes Immun. 10: 280-284 (2009). *
Laschke MW, Menger MD, Wang Y, Lindell G, Jeppsson B, Thorlacius H. Sepsis-associated cholestasis is critically dependent on P-selectin-dependent leukocyte recruitment in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1396-G1402 (2007). *
Lau AW, Biester S, Cornall RJ, Forrester JV. Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J. Immunol. 180: 3889-3899 (2008). *
Layton DS, Bean AG, Dodge NM, Strom AD, Sandrin MS, Ierino FL. Differential cytokine expression and regulation of human anti-pig xenogeneic responses by modified porcine dendritic cells. Xenotransplantation 15: 257-267 (2008).
Lazaron V, Dunn DL. Molecular biology of endotoxin antagonism. World J. Surg. 26: 790-798 (2002). *
Lazaron V, Leslie DB, Wasiluk KR, Dunn DL. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor-mediated process. Surgery 130: 192-197 (2001).
Le Moine O, Soupison T, Sogni P, Marchant A, Moreau R, Hadengue A, Goldman M, Deviere J, Lebrec D. Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis. J. Hepatol. 23: 391-395 (1995). *
Leblanc CJ, Horohov DW, Bauer JE, Hosgood G, Mauldin GE. Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs. Am. J. Vet. Res. 69: 486-493 (2008). *
Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML, de Jong EC. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127: 331-341 (2007). *
Lech M, Garlanda C, Mantovani A, Kirschning CJ, Schlondorff D, Anders HJ. Different roles of (TIR)8/SIGIRR on Toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. Kidney Int. 72: 182-192 (2007). *
Lee C, An HJ, Kim JL, Lee H, Paik SG. Inhibitory effect of a phosphatidyl ethanolamine derivative on LPS-induced sepsis. Mol. Cells 27: 251-255 (2009). *
Lee CW, Bennouna S, Denkers EY. Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages. Infect. Immun. 74: 1916-1923 (2006). *
Lee CW, Chuang JH, Wang PW, Chang NK, Wang HC, Huang CC, Tiao MM, Lo SK. Effect of glucocorticoid pretreatment on oxidative liver injury and survival in jaundiced rats with endotoxin cholangitis. World J. Surg. 30: 2217-2226 (2006). *
Lee DJ, Biros DJ, Taylor AW. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis. Int. Immunopharmacol. May 5 [Epub ahead of print] (2009).
Lee EJ, Heo YM, Choi JH, Song HO, Ryu JS, Ahn MH. Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate. Korean J. Parasitol. 46: 145-151 (2008).
Lee HC, Vinodhkumar R, Yoon JW, Park SK, Lee CW, Kim HY. Enhanced inhibitory effect of ultra-fine granules of red ginseng on LPS-induced cytokine expression in the monocyte-derived macrophage THP-1 cells. Int. J. Mol. Sci. 9: 1379-1392 (2008). *
Lee HJ, Dang HT, Kang GJ, Yang EJ, Park SS, Yoon WJ, Jung JH, Kang HK, Yoo ES. Two enone fatty acids isolated from Gracilaria verrucosa suppress the production of inflammatory mediators by down-regulating NF-kappaB and STAT1 activity in lipopolysaccharide-stimulated RAW 264.7 cells. Arch. Pharm. Res. 32: 453-462 (2009). *
Lee HS, Chung SH, Song MY, Kim SS, Shin HD, Shim WJ, Han AR, Lee JS. Effects of bee venom on the maturation of murine dendritic cells stimulated by LPS. J. Ethnopharmacol. 120: 215-219 (2008).
Lee HS, Han SY, Bae EA, Huh CS, Ahn YT, Lee JH, Kim DH. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice. Int. Immunopharmacol. 8: 574-580 (2008).
Lee J, Hong EM, Byun HW, Choi MH, Jang HJ, Eun CS, Kae SH, Choi HS. The effect of PPARalpha and PPARgamma ligands on inflammation and ABCA1 expression in cultured gallbladder epithelial cells. Dig. Dis. Sci. 53: 1707-1715 (2008). *
Lee J, Hong EM, Koh DH, Choi MH, Jang HJ, Kae SH, Choi HS. HMG-CoA reductase inhibitors (statins) activate expression of PPARalpha/PPARgamma and ABCA1 in cultured gallbladder epithelial cells. Dig. Dis. Sci. Feb 19 [Epub ahead of print] (2009). *
Lee JH, Banerjee A, Ueno Y, Ramaiah SK. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro. Toxicol. Sci. 106: 290-299 (2008). *
Lee JH, Lee B, Lee HS, Bae EA, Lee H, Ahn YT, Lim KS, Huh CS, Kim DH. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int. J. Colorectal Dis. 24: 231-237 (2009). *
Lee JM, Hwang KT, Jun WJ, Park CS, Lee MY. Antiinflammatory effect of lactic acid bacteria: inhibition of cyclooxygenase-2 by suppressing nuclear factor-kappaB in Raw264.7 macrophage cells. J. Microbiol. Biotechnol. 18: 1683-1688 (2008). *
Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118: 163-172 (2000). *
Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44: 479-486 (2003). *
Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276: 16683-16689 (2001). *
Lee KW, Lee Y, Kim DS, Kwon HJ. Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression. Eur. J. Immunol. 36: 1254-1266 (2006). *
Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 102: 1906-1910 (2005). *
Lee PY, Tsai PS, Huang YH, Huang CJ. Inhibition of Toll-like receptor-4, nuclear factor-kappaB and mitogen-activated protein kinase by lignocaine may involve voltage-sensitive sodium channels. Clin. Exp. Pharmacol. Physiol. 35: 1052-1058 (2008). *
Lee SK, Kim HJ, Chi SG, Jang JY, Nam KD, Kim NH, Joo KR, Dong SH, Kim BH, Chang YW, Lee JI, Chang R. Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells. Korean J. Gastroenterol. 45: 328-334 (2005).
Lee SM, Yune TY, Kim SJ, Kim YC, Oh YJ, Markelonis GJ, Oh TH. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J. Neurochem. 91: 568-578 (2004).
Lee TP, Leu SJ, Huang JC, Song YC, Jhou RS, Tang SJ, Sun KH. Anti-ribosomal phosphoprotein autoantibody triggers interleukin-10 overproduction via phosphatidylinositol 3-kinase-dependent signalling pathways in lipopolysaccharide-activated macrophages. Immunology 127: 91-102 (2009). *
Lee Y, Huang H, Kim HJ, Park CK, Kim HH. The phosphatidylinositol 3-kinase-mediated production of interferon-beta is critical for the lipopolysaccharide inhibition of osteoclastogenesis. Life Sci. 83: 369-376 (2008). *
Lee YC, Kim C, Shim JS, Byun JY, Park MS, Cha CI, Kim YI, Lee JW, Yeo SG. Toll-like receptors 2 and 4 and their mutations in patients with otitis media and middle ear effusion. Clin. Exp. Otorhinolaryngol. 1: 189-195 (2008).
Leeman JR, Gilmore TD. Alternative splicing in the NF-kappaB signaling pathway. Gene 423: 97-107 (2008). *
Legssyer R, Huaux F, Lebacq J, Delos M, Marbaix E, Lebecque P, Lison D, Scholte BJ, Wallemacq P, Leal T. Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. Respir. Res. 7: 134 (2006). *
Lehmann GL, Carreras FI, Soria LR, Gradilone SA, Marinelli RA. LPS induces the TNFalpha-mediated down-regulation of rat liver aquaporin-8: role in sepsis-associated cholestasis. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G567-G575 (2008). *
Lehner M, Bailo M, Stachel D, Roesler W, Parolini O, Holter W. Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha. Leuk. Res. 31: 1729-1735 (2007).
Lehner M, Morhart P, Stilper A, Petermann D, Weller P, Stachel D, Holter W. Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors. J. Immunother. 30: 312-322 (2007).
Lehnert M, Uehara T, Bradford BU, Lind H, Zhong Z, Brenner DA, Marzi I, Lemasters JJ. Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G456-G463 (2006). *
Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, Wilensky R, Rader DJ, Lazar MA, Reilly MP. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J. Am. Coll. Cardiol. 49: 442-449 (2007).
Leicester KL, Olynyk JK, Brunt EM, Britton RS, Bacon BR. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. Liver Int. 26: 559-565 (2006). *
Leicester KL, Olynyk JK, Brunt EM, Britton RS, Bacon BR. CD14-positive hepatic monocytes/macrophages increase in hereditary hemochromatosis. Liver Int. 24: 446-451 (2004). *
Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am. J. Pathol. 154: 1711-1720 (1999). *
Lendemans S, Kreuzfelder E, Rani M, Bayeeh E, Schade FU, Flohe SB, Waydhas C, Flohe S. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system. J. Trauma 63: 740-746 (2007).
Lendemans S, Peszko A, Oberbeck R, Schmitz D, Husain B, Burkhard M, Schade FU, Flohe S. Microcirculatory alterations of hepatic and mesenteric microcirculation in endotoxin tolerance. Shock 29: 223-231 (2008).
Leng C, Gries M, Ziegler J, Lokshin A, Mascagni P, Lentzsch S, Mapara MY. Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. Exp. Hematol. 34: 776-787 (2006). *
Lennartsson A, Vidovic K, Pass MB, Cowland JB, Gullberg U. All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter. J. Leukoc Biol. 80: 196-203 (2006). *
Lenoir C, Sapin C, Broquet AH, Jouniaux AM, Bardin S, Gasnereau I, Thomas G, Seksik P, Trugnan G, Masliah J, Bachelet M. MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells. Life Sci. 82: 519-528 (2008). *
LeVan TD, Guerra S, Klimecki W, Vasquez MM, Lohman IC, Martinez FD, Halonen M, Wright AL. The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. Genes Immun. 7: 77-80 (2006). *
Levels JH, Abraham PR, van den Ende A, van Deventer SJ. Distribution and kinetics of lipoprotein-bound endotoxin. Infect. Immun. 69: 2821-2828 (2001). *
Levy E, Xanthou G, Petrakou E, Zacharioudaki V, Tsatsanis C, Fotopoulos S, Xanthou M. Distinct roles of TLR4 and CD14 in LPS-induced inflammatory responses of neonates. Pediatr. Res. Apr 22 [Epub ahead of print] (2009).
Levy O. Therapeutic potential of the bactericidal/permeability-increasing protein. Expert Opin. Investig. Drugs 11: 159-167 (2002).
Levy O, Canny G, Serhan CN, Colgan SP. Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia. Biochem. Soc. Trans. 31: 795-800 (2003). *
Levy O, Elsbach P. Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis. Curr. Infect. Dis. Rep. 3: 407-412 (2001).
Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 104: 1327-1333 (1999). *
Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins. J. Immunol. 154: 5403-5410 (1995).
Levy O, Sisson RB, Kenyon J, Eichenwald E, Macone AB, Goldmann D. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood � Infect. Immun. 68: 5120-5125 (2000). *
Levy RM, Prince JM, Yang R, Mollen KP, Liao H, Watson GA, Fink MP, Vodovotz Y, Billiar TR. Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R970-R976 (2006). *
Li CH, Wang JH, Redmond HP. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation. J. Leukoc. Biol. 79: 867-875 (2006). *
Li D, Zimmerman TL, Thevananther S, Lee HY, Kurie JM, Karpen SJ. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J. Biol. Chem. 277: 31416-31422 (2002). *
Li H, He Y, Zhang J, Sun S, Sun B. Lipopolysaccharide regulates Toll-like receptor 4 expression in human aortic smooth muscle cells. Cell Biol. Int. 31: 831-835 (2007). *
Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int. 67: 867-874 (2005). *
Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, Marcu KB. Novel NEMO/IkappaB kinase and NF-kappaB target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276: 18579-18590 (2001). *
Li J, Wang H, Mason JM, Levine J, Yu M, Ulloa L, Czura CJ, Tracey KJ, Yang H. Recombinant HMGB1 with cytokine-stimulating activity. J. Immunol. Methods 289: 211-223 (2004). *
Li L, Pan J, Yu Y. Development of sorbent therapy for multiple organ dysfunction syndrome (MODS). Biomed. Mater. 2: R12-R16 (2007).
Li N, Choudhuri S, Cherrington NJ, Klaassen CD. Down-regulation of mouse organic anion-transporting polypeptide 4 (Oatp4; Oatp1b2; Slc21a10) mRNA by lipopolysaccharide through the Toll-like receptor 4 (TLR4). Drug Metab. Dispos. 32: 1265-1271 (2004). *
Li N, Klaassen CD. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, or inducible nitric oxide synthase. Toxicol. Sci. 83: 197-203 (2005). *
Li N, Klaassen CD. Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. Mol. Pharmacol. 66: 694-701 (2004). *
Li P, Ho B, Ding JL. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity. J. Endotoxin Res. 13: 150-157 (2007). *
Li Q, Cherayil BJ. Toll-like receptor 4 mutation impairs the macrophage TNFalpha response to peptidoglycan. Biochem. Biophys. Res. Commun. 325: 91-96 (2004). *
Li QF, Zhu YS, Jiang H, Xu H, Sun Y. Heme oxygenase-1 mediates the anti-inflammatory effect of isoflurane preconditioning in LPS-stimulated macrophages. Acta Pharmacol. Sin. 30: 228-234 (2009).
Li W, Ashok M, Li J, Yang H, Sama AE, Wang H. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS ONE 2: e1153 (2007). *
Li WM, Liu W, Gao C, Zhou BG, Yang SS, Wang Z, Zhang RH, Gan RT, Kong YH, Li Y. Antigen-specific tolerance induced by IL-10 gene modified immature dendritic cells in experimental autoimmune myocarditis in rats. Chin. Med. J. (Engl.) 119: 1646-1652 (2006). *
Li X, Han de W, Zhao LF, Yin L. Effect of endotoxin on the expression of peroxisome proliferator-activated receptor alpha in the development of nonalcoholic steatohepatitis in rats. Zhonghua Gan Zang Bing Za Zhi 13: 89-91 (2005).
Li XY, Zhang C, Wang H, Ji YL, Wang SF, Zhao L, Chen X, Xu DX. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced downregulation of CYP3A in fetal liver: its repression by a low dose LPS pretreatment. Toxicol. Lett. 179: 71-77 (2008).
Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX. Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp. Mol. Pathol. 84: 1-8 (2008). *
Li Z, Diehl AM. Innate immunity in the liver. Curr. Opin. Gastroenterol. 19: 565-571 (2003).
Li Z, Oben JA, Yang S, Lin H, Stafford EA, Soloski MJ, Thomas SA, Diehl AM. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 40: 434-441 (2004). *
Li ZF, Zhang Y, Gao J, Zhang PJ, Wang JX, Liu XG. Expression and significance of Toll-like receptor 4 of splenic macrophage in patients with hypersplenism due to portal hypertension. Zhonghua Yi Xue Za Zhi 84: 1088-1091 (2004).
Li ZH, Chu N, Shan LD, Gong S, Yin QZ, Jiang XH. Inducible expression of functional Mu opioid receptors in murine dendritic cells. J. Neuroimmune Pharmacol. Feb 3 [Epub ahead of print] (2009).
Li-Masters T, Morgan ET. Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice. Drug Metab. Dispos. 29: 252-257 (2001). *
Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Li Y, Zhou H. Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin. Bioorg. Med. Chem. Lett. 18: 1525-1529 (2008). *
Liang G, Yang S, Zhou H, Shao L, Huang K, Xiao J, Huang Z, Li X. Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues. Eur. J. Med. Chem. 44: 915-919 (2009).
Liang M, Wang X, Yuan Y, Zhou Q, Tong C, Jiang W. Different effect of glutamine on macrophage tumor necrosis factor-alpha release and heat shock protein 72 expression in vitro and in vivo. Acta Biochim. Biophys. Sin. (Shanghai) 41: 171-177 (2009).
Liang MD, Bagchi A, Warren HS, Tehan MM, Trigilio JA, Beasley-Topliffe LK, Tesini BL, Lazzaroni JC, Fenton MJ, Hellman J. Bacterial peptidoglycan-associated lipoprotein: a naturally occurring Toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide. J. Infect. Dis. 191: 939-948 (2005). *
Liang XH, Cheung W, Heng CK, Wang DY. Absence of the Toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese. Ther. Clin. Risk Manag. 1: 243-246 (2005). *
Lichtman SN, Keku J, Schwab JH, Sartor RB. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100: 513-519 (1991).
Lichtman SN, Wang J, Clark RL. A microcholangiographic study of liver disease models in rats. Acad. Radiol. 2: 515-521 (1995).
Lickteig AJ, Slitt AL, Arkan MC, Karin M, Cherrington NJ. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab. Dispos. 35: 402-409 (2007). *
Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34: 9-19 (2004). *
Liebers V, Raulf-Heimsoth M, Bruning T. Health effects due to endotoxin inhalation (review). Arch. Toxicol. 82: 203-210 (2008). *
Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology 132: 913-920 (2007). *
Liedtke C, Trautwein C. The role of JNK2 in toxic liver injury. J. Hepatol. 45: 762-764 (2006). *
Liehr H. Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases. Ergeb. Inn. Med. Kinderheilkd. 48: 117-193 (1982).
Liehr H, Gr�n M, Thiel H, Brunswig D, Rasenack U. Endotoxin-induced liver necrosis and intravascular coagulation in rats enhanced by portacaval collateral circulation. Gut 16: 429-436 (1975). *
Lien E, Ingalls RR. Toll-like receptors. Crit. Care Med. 30: S1-S11 (2002).
Liew FY, Liu H, Xu D. A novel negative regulator for IL-1 receptor and Toll-like receptor 4. Immunol. Lett. 96: 27-31 (2005).
Likhoded VG, Iushchuk ND, Iakovlev MIu. Role of gram-negative bacterial endotoxins in infectious and non-infectious diseases. Arkh. Patol. 58: 8-13 (1996).
Lim CA, Yao F, Wong JJ, George J, Xu H, Chiu KP, Sung WK, Lipovich L, Vega VB, Chen J, Shahab A, Zhao XD, Hibberd M, Wei CL, Lim B, Ng HH, Ruan Y, Chin KC. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol. Cell 27: 622-635 (2007). *
Lim W, Gee K, Mishra S, Kumar A. Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells. J. Immunol. 175: 5690-5700 (2005). *
Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, Lin CJ, Tseng SC, Lin WP, Chen WT, Sheen IS. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J. Hepatol. 46: 816-826 (2007). *
Lin FY, Chen YH, Lin YW, Tsai JS, Chen JW, Wang HJ, Chen YL, Li CY, Lin SJ. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of Toll-like receptor 4 mRNA induced by endotoxin. A novel mechanism Involved in vascular inflammation. Arterioscler. Thromb. Vasc. Biol. 26: 2622-2629 (2006). *
Lin FY, Chen YH, Tasi JS, Chen JW, Yang TL, Wang HJ, Li CY, Chen YL, Lin SJ. Endotoxin induces Toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler. Thromb. Vasc. Biol. 26: 2630-2637 (2006). *
Lin J, Yao YM, Huang ZH, Yu Y, Zhu JM, Chai JK, Sheng ZY. The influence of CD14 genomic polymorphism on CD14 gene expression as well as protein release and its clinical significance in patients with extensive burns. Zhonghua Wai Ke Za Zhi 44: 907-910 (2006).
Lin M, Rippe RA, Niemela O, Brittenham G, Tsukamoto H. Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am. J. Physiol. 272: G1355-G1364 (1997).
Lin MW, Tsao LT, Chang LC, Chen YL, Huang LJ, Kuo SC, Tzeng CC, Lee MR, Wang JP. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway. Biochem. Pharmacol. 73: 1796-1806 (2007). *
Lin QP, Zhou LF, Li NN, Chen YQ, Li BC, Cai YF, Zhang SQ. Lipopolysaccharide neutralization by the antibacterial peptide CM4. Eur. J. Pharmacol. 596: 160-165 (2008).
Lin ST, Wang Y, Xue Y, Feng DC, Xu Y, Xu LY. Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway. Mol. Cell. Biochem. 315: 41-49 (2008). *
Lin TY, Tseng SH, Li SJ, Chen JC, Shieh JS, Chen Y. Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia. J. Trauma 66: 411-417 (2009).
Lin Y, Liu ZY, DI JF, Zeng YY. Premature delivery induced by LPS in syngenetically impregnated BALB/c and NOD/SCID mice. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23: 32-35 (2007).
Lin YP, Thibodeaux CH, Pena JA, Ferry GD, Versalovic J. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm. Bowel Dis. 14: 1068-1083 (2008).
Lindros KO, Jarvelainen HA. Chronic systemic endotoxin exposure: an animal model in experimental hepatic encephalopathy. Metab. Brain Dis. 20: 393-398 (2005).
Link A, Selejan S, Maack C, Lenz M, Bohm M. Phosphodiesterase 4-inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock. Crit. Care 12: R159 (2008).
Liou GI, Auchampach JA, Hillard CJ, Zhu G, Yousufzai B, Mian S, Khan S, Khalifa YM. Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Invest. Ophthalmol. Vis. Sci. 49: 5526-5531 (2008). *
Lissitsyn Y, Becker AB, Kozyrskyj AL, Hayglass KT. Level of Toll-like receptor agonist exposure differentially determines chemokine production in humans. Can. J. Physiol. Pharmacol. 85: 739-746 (2007).
Litjens NH, Rademaker M, Ravensbergen B, Thio HB, van Dissel JT, Nibbering PH. Effects of monomethylfumarate on dendritic cell differentiation. Br. J. Dermatol. 154: 211-217 (2006). *
Litjens NH, van der Plas MJ, Ravensbergen B, Numan-Ruberg SC, van Assen Y, Thio HB, van Dissel JT, van de Vosse E, Nibbering PH. Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism. J. Invest. Dermatol. 122: 923-926 (2004). *
Liu CF, Chen YL, Chang WT, Shieh CC, Yu CK, Reid KB, Wang JY. Mite allergen induces nitric oxide production in alveolar macrophage cell lines via CD14/Toll-like receptor 4, and is inhibited by surfactant protein D. Clin. Exp. Allergy 35: 1615-1624 (2005). *
Liu CH, Machado FS, Guo R, Nichols KE, Burks AW, Aliberti JC, Zhong XP. Diacylglycerol kinase zeta regulates microbial recognition and host resistance to Toxoplasma gondii. J. Exp. Med. 204: 781-792 (2007). *
Liu D, Zeng BX, Shang Y. Decreased expression of peroxisome proliferator-activated receptor-gamma in endotoxin-induced acute lung injury. Physiol. Res. 55: 291-299 (2006). *
Liu G, Park YJ, Tsuruta Y, Lorne E, Abraham E. p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury. J. Immunol. 182: 5063-5071 (2009).
Liu H, Li W, Wang X, Li J, Yu W. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas 36: 192-196 (2008).
Liu J, Cao S, Herman LM, Ma X. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J. Exp. Med. 198: 1265-1276 (2003). *
Liu J, Guan X, Ma X. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J. Exp. Med. 204: 141-152 (2007). *
Liu J, He YY, Chignell CF, Clark J, Myers P, Saavedra JE, Waalkes MP. Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice. Biochem. Pharmacol. 70: 144-151 (2005). *
Liu J, Liu Y, Zhang H, Chen G, Wang K, Xiao X. KLF4 promotes the expression, translocation, and releas eof HMGB1 in RAW264.7 macrophages in response to LPS. Shock 30: 260-266 (2008).
Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q, Chan AC, Zhou Z, Huang BX, Kim HY, Kunos G. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. U.S.A. 103: 13345-13350 (2006). *
Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta-prostaglandin J2 and pioglitazone inhibit H2O2-induced tumor necrosis factor-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. Shock Jan 19 [Epub ahead of print] (2009).
Liu LL, Gong LK, Wang H, Xiao Y, Wu XF, Zhang YH, Xue X, Qi XM, Ren J. Baicalin inhibits macrophage activation by lipopolysaccharide and protects mice from endotoxin shock. Biochem. Pharmacol. 75: 914-922 (2008). *
Liu R, Desta T, Raptis M, Darveau RP, Graves DT. P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J. Periodontol. 79: 1241-1247 (2008).
Liu S, Khemlani LS, Shapiro RA, Johnson ML, Liu K, Geller DA, Watkins SC, Goyert SM, Billiar TR. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect. Immun. 66: 5089-5098 (1998). *
Liu Y, Hao W, Letiembre M, Walter S, Kulanga M, Neumann H, Fassbender K. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 26: 12904-12913 (2006).
Liuzzi GM, Latronico T, Rossano R, Viggiani S, Fasano A, Riccio P. Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells - implications for complementary multiple sclerosis treatment. Neurochem. Res. 32: 2184-2193 (2007). *
Ljungdahl M, Lundholm M, Katouli M, Rasmussen I, Engstrand L, Haglund U. Bacterial translocation in experimental shock is dependent on the strains in the intestinal flora. Scand. J. Gastroenterol. 35: 389-397 (2000). *
Long AJ, McCarthy R, Rundell L, Goess C, Cuff CA. The efficacy of TNF blockade in asthma models depends on endotoxin levels in the allergic challenge. Proc. Am. Thorac. Soc. 6: 331-332 (2009). *
Loos T, Dekeyzer L, Struyf S, Schutyser E, Gijsbers K, Gouwy M, Fraeyman A, Put W, Ronsse I, Grillet B, Opdenakker G, Damme JV, Proost P. TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis. Lab. Invest. 86: 902-916 (2006). *
Lopez-Collazo E, Fuentes-Prior P, Arnalich F, Del Fresno C. Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state. Curr. Opin. Infect. Dis. 19: 237-244 (2006).
Loppnow H, Werdan K, Buerke M. Invited review: vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun. 14: 63-87 (2008). *
Lorenz W, Sigrist G, Shakibaei M, Mobasheri A, Trautmann C. A hypothesis for the origin and pathogenesis of rheumatoid diseases. Rheumatol. Int. 26: 641-654 (2006). *
Lorenzo-Zuniga V, Rodriguez-Ortigosa CM, Bartoli R, Martinez-Chantar ML, Martinez-Peralta L, Pardo A, Ojanguren I, Quiroga J, Planas R, Prieto J. Insulin-like growth factor-I improves intestinal barrier function in cirrhotic rats. Gut 55: 1306-1312 (2006). *
Loryman C, Mansbridge J. Inhibition of keratinocyte migration by lipopolysaccharide. Wound Repair Regen. 16: 45-51 (2008).
Lotz M, Gutle D, Walther S, Menard S, Bogdan C, Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203: 973-984 (2006). *
Lotz M, Konig T, Menard S, Gutle D, Bogdan C, Hornef MW. Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells. Immunology 122: 306-315 (2007). *
Lowe EL, Doherty TM, Karahashi H, Arditi M. Ubiquitination and de-ubiquitination: role in regulation of signaling by Toll-like receptors. J. Endotoxin Res. 12: 337-345 (2006). *
Lu B, Moser AH, Shigenaga JK, Feingold KR, Grunfeld C. Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response. J. Lipid Res. 47: 2179-2190 (2006). *
Lu CC, Sheu BS, Chen TW, Yang HB, Hung KH, Kao AW, Chuang CH, Wu JJ. Host TNF-a-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection, Am. J. Gastroenterol. 100: 1274-1282 (2005). *
Lu JW, Wang H, Yan-Li J, Zhang C, Ning H, Li XY, Zhang H, Duan ZH, Zhao L, Wei W, Xu DX. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis. J. Hepatol. 48: 442-452 (2008). *
Lu Y, Cederbaum AI. Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: role of cytochrome P450 2E1 and 2A5. Hepatology 44: 263-274 (2006). *
Lubick K, Jutila MA. LTA recognition by bovine gammadelta T cells involves CD36. J. Leukoc. Biol. 79: 1268-1270 (2006). *
Luft FC. NOD takes its Toll but stays in the CARDs in Crohn's disease. J. Mol. Med. 83: 577-578 (2005). *
Lugering N, Kucharzik T, Stein H, Winde G, Lugering A, Hasilik A, Domschke W, Stoll R. IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease. Dig. Dis. Sci. 43: 706-714 (1998). *
Lumsden JM, McCarty T, Petiniot LK, Shen R, Barlow C, Wynn TA, Morse HC 3rd, Gearhart PJ, Wynshaw-Boris A, Max EE, Hodes RJ. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 200: 1111-1121 (2004). *
Lun SW, Wong CK, Tam LS, Li EK, Lam CW. Decreased ex vivo production of TNF-alpha and IL-8 by peripheral blood cells of patients with rheumatoid arthritis after infliximab therapy. Int. Immunopharmacol. 7: 1668-1677 (2007).
Lundberg A, Wikberg LA, Ilonen J, Vaarala O, Fageras Bottcher M. Lipopolysaccharide induced immune responses in relation to TLR4 Asp299Gly gene polymorphism. Clin. Vaccine Immunol. 15: 1878-1883 (2008). *
Lundberg S, Holst M, Hellstrom PM. Expression of iNOS mRNA associated with suppression of colonic contraction in rat colitis. Acta Physiol. (Oxf.) 187: 489-494 (2006). *
Lunin SM, Khrenov MO, Novoselova TV, Parfenyuk SB, Novoselova EG. Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines and heat shock protein hsp70 in inflammation-bearing mice. Immunol. Invest. 37: 858-870 (2008). *
Lunz JG 3rd, Specht SM, Murase N, Isse K, Demetris AJ. Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 46: 1946-1959 (2007). *
Luo L, Wang Y, Feng Q, Zhang H, Xue B, Shen J, Ye Y, Han X, Ma H, Xu J, Chen D, Yin Z. Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice. Mol. Immunol. 46: 848-857 (2009). *
Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley M, Montaner LJ. Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages. J. Biol. Chem. 279: 18451-18456 (2004). *
Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. J. Neurochem. 97: 435-448 (2006).
Lutz W, Stetkiewicz J. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation. Int. J. Occup. Med. Environ. Health 17: 245-254 (2004).
Luyendyk JP, Maddox JF, Green CD, Ganey PE, Roth RA. Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats. Hepatology 40: 1342-1351 (2004). *
Luyendyk JP, Schabbauer GA, Tencati M, Holscher T, Pawlinski R, Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J. Immunol. 180: 4218-4226 (2008). *
Luyendyk JP, Shores KC, Ganey PE, Roth RA. Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: benchmark dose analysis for markers of liver injury. Toxicol. Sci. 68: 220-225 (2002). *
Luyer MD, Buurman WA, Hadfoune M, Jacobs JA, Dejong CH, Greve JW. High-fat enteral nutrition reduces endotoxin, tumor necrosis factor-alpha and gut permeability in bile duct-ligated rats subjected to hemorrhagic shock. J. Hepatol. 41: 377-383 (2004). *
Luyer MD, Buurman WA, Hadfoune M, Jacobs JA, Konstantinov SR, Dejong CH, Greve JW. Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock 21: 65-71 (2004). *
Lv K, Chen R, Cai Q, Fang M, Sun S. Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-alpha. Scand. J. Immunol. 64: 164-169 (2006). *
Lv X, Li Q, Huang SD, Wu FX, Yang LQ, Yu WF. Isoflurane pretreatment reduced liver injury induced by ischemia/reperfusion combined with lipopolysaccharide in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 20: 271-274 (2008).
Lye E, Dhanji S, Calzascia T, Elford AR, Ohashi PS. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses. Eur. J. Immunol. 38: 870-876 (2008). *
Lyu SY, Park WB. Mistletoe lectin modulates intestinal epithelial cell-derived cytokines and B cell IgA secretion. Arch. Pharm. Res. 32: 443-451 (2009). *
Ma C, Xu C, Duan L, He W. The intestinal intraepithelial lymphocytes with T cell receptor alphabeta express Toll-like receptor 4 and are responsive to lipopolysaccharide. Int. Arch. Allergy Immunol. 141: 401-407 (2006).
Ma J, Nakajima T, Iida H, Iwasawa K, Terasawa K, Oonuma H, Jo T, Morita T, Imuta H, Suzuki J, Hirose K, Okuda Y, Yamada N, Nagai R, Omata M. Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. Eur. J. Pharmacol. 464: 79-86 (2003). *
Ma W, Gee K, Lim W, Chambers K, Angel JB, Kozlowski M, Kumar A. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors. J. Immunol. 172: 318-330 (2004). *
Ma W, Mishra S, Gajanayaka N, Angel JB, Kumar A. HIV-1 Nef inhibits lipopolysaccharide-induced IL-12p40 expression by inhibiting JNK-activated NFkappa B in human monocytic cells. J. Biol. Chem. 284: 7578-7587 (2009). *
Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R, Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46: 1519-1529 (2007). *
Ma YG, Cho MY, Zhao M, Park JW, Matsushita M, Fujita T, Lee BL. Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J. Biol. Chem. 279: 25307-25312 (2004). *
Macagno A, Molteni M, Rinaldi A, Bertoni F, Lanzavecchia A, Rossetti C, Sallusto F. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J. Exp. Med. 203: 1481-1492 (2006). *
MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J. Gastroenterol. 31: 907-916 (1996).
Macdonald KL, Speert DP. Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells. Cell. Microbiol. 10: 2138-2149 (2008). *
Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM. Hepatitis C virus induces Toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J. Virol. 80: 866-874 (2006). *
Madi L, Cohen S, Ochayin A, Bar-Yehuda S, Barer F, Fishman P. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kB in mediating receptor level. J. Rheumatol. 34: 20-26 (2007).
Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Minireview. Neuro. Endocrinol. Lett. 29: 287-291 (2008).
Maes M, Coucke F, Leunis JC. Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro. Endocrinol. Lett. 28: 739-744 (2007).
Maestroni GJ. Sympathetic nervous system influence on the innate immune response. Ann. N. Y. Acad. Sci. 1069: 195-207 (2006). *
Magder S, Neculcea J, Neculcea V, Sladek R. Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells. J. Vasc. Res. 43: 447-461 (2006). *
Mages J, Dietrich H, Lang R. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 212: 723-737 (2008).
Maggi LB Jr, Sadeghi H, Weigand C, Scarim AL, Heitmeier MR, Corbett JA. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49: 346-355 (2000). *
Magness ST, Jijon H, Van Houten Fisher N, Sharpless NE, Brenner DA, Jobin C. In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J. Immunol. 173: 1561-1570 (2004). *
Mahadeva R, Dunn AC, Westerbeek RC, Sharples L, Whitehouse DB, Carroll NR, Ross-Russell RI, Webb AK, Bilton D, Lomas DA, Lockwood CM. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin. Exp. Immunol. 117: 561-567 (1999). *
Mahanonda R, Sa-Ard-Iam N, Eksomtramate M, Rerkyen P, Phairat B, Schaecher KE, Fukuda MM, Pichyangkul S. Cigarette smoke extract modulates human beta-defensin-2 and interleukin-8 expression in human gingival epithelial cells. J. Periodontal Res. Mar 7 [Epub ahead of print] (2009).
Maher JJ. How does estrogen enhance endotoxin toxicity? Let me count the ways. Hepatology 28: 1720-1721 (1998). *
Mahmud N, Weir DG. The urban diet and Crohn's disease: is there a relationship? Eur. J. Gastroenterol. Hepatol. 13: 93-95 (2001). *
Maitraie D, Hung CF, Tu HY, Liou YT, Wei BL, Yang SC, Wang JP, Lin CN. Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors. Bioorg. Med. Chem. 17: 2785-2792 (2009). *
Makino A, Yamada S, Okuda K, Kato T. Nicotine involved in periodontal disease through influence on cytokine levels. FEMS Immunol. Med. Microbiol. 52: 282-286 (2008). *
Malagutti N, Aimoni C, Balboni A, Stignani M, Melchiorri L, Borin M, Pastore A, Rizzo R, Baricordi OR. Decreased production of human leukocyte antigen G molecules in sinonasal polyposis. Am. J. Rhinol. 22: 468-473 (2008).
Malo MS, Biswas S, Abedrapo MA, Yeh L, Chen A, Hodin RA. The pro-inflammatory cytokines, IL-1beta and TNF-alpha, inhibit intestinal alkaline phosphatase gene expression. DNA Cell Biol. 25: 684-695 (2006).
Maltseva IA, Fleiszig SM, Evans DJ, Kerr S, Sidhu SS, McNamara NA, Basbaum C. Exposure of human corneal epithelial cells to contact lenses in vitro suppresses the upregulation of human beta-defensin-2 in response to antigens of Pseudomonas aeruginosa. Exp. Eye Res. 85: 142-153 (2007). *
Mancek M, Pristovsek P, Jerala R. Identification of LPS-binding peptide fragment of MD-2, a Toll-receptor accessory protein. Biochem. Biophys. Res. Commun. 292: 880-885 (2002). *
Mancuso G, Midiri A, Biondo C, Beninati C, Gambuzza M, Macri D, Bellantoni A, Weintraub A, Espevik T, Teti G. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via Toll-like receptor 4. Infect. Immun. 73: 5620-5627 (2005). *
Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect. Immun. 72: 6446-6454 (2004). *
Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation? J. Hepatol. 50: 1258-1266 (2009).
Mandron M, Aries MF, Boralevi F, Martin H, Charveron M, Taieb A, Davrinche C. Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J. Invest. Dermatol. 128: 882-889 (2008). *
Mangano K, Sardesai NY, Quattrocchi C, Mazzon E, Cuzzocrea S, Bendtzen K, Meroni PL, Kim JJ, Nicoletti F. Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats. Br. J. Pharmacol. 155: 722-730 (2008). *
Mangell P, Mihaescu A, Wang Y, Schramm R, Jeppsson B, Thorlacius H. Critical role of P-selectin-dependent leukocyte recruitment in endotoxin-induced intestinal barrier dysfunction in mice. Inflamm. Res. 56: 189-194 (2007). *
Mangoni ML, Epand RF, Rosenfeld Y, Peleg A, Barra D, Epand RM, Shai Y. Lipopolysaccharide, a key molecule involved in the synergism between temporinsin inhibiting bacterial growth and in endotoxin neutralization. J. Biol. Chem. 283: 22907-22917 (2008). *
Manni M, Maestroni GJ. Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: involvement of beta-adrenoceptors and relevance in inflammatory diseases. Brain Behav. Immun. 22: 80-88 (2008).
Mant TG, Borozdenkova S, Bradford DB, Allen E, Amin DM, Toothaker RD, Collins RW, Hargreaves RE, Jurcevic S. Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers. Int. Immunopharmacol. 8: 701-707 (2008).
Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA, Coppel RL, Shimoda S, Ishibashi H, Gershwin ME. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42: 802-808 (2005). *
Marantos C, Mukaro V, Ferrante J, Hii C, Ferrante A. Inhibition of the lipopolysaccharide-induced stimulation of the members of the MAPK family in human monocytes/macrophages by 4-hydroxynonenal, a product of oxidized omega-6 fatty acids. Am. J. Pathol. 173: 1057-1066 (2008). *
Mares D, Simoes JA, Novak RM, Spear GT. TLR2-mediated cell stimulation in bacterial vaginosis. J. Reprod. Immunol. 77: 91-99 (2008).
Margenthaler JA, Ku G, Flye MW. Interleukin-12 regulates natural killer cell-dependent Propionibacterium acnes-primed, lipopolysaccharide-induced liver injury. Hepatol. Res. 38: 183-193 (2008). *
Margenthaler JA, Landeros K, Kataoka M, Eilers M, Ku G, Flye MW. Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury. J. Surg. Res. 112: 102-110 (2003). *
Mariani CL, Rajon D, Bova FJ, Streit WJ. Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas. J. Neurooncol. 85: 231-240 (2007).
Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218 (2004). *
Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130: 2800-2815 (2007). *
Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94: 8093-8098 (1997). *
Maris NA, Dessing MC, de Vos AF, Bresser P, van der Zee JS, Jansen HM, Spek CA, van der Poll T. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur. Respir. J. 28: 622-626 (2006).
Markova S, Nakamura T, Sakaeda T, Makimoto H, Uchiyama H, Okamura N, Okumura K. Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation. Drug Metab. Pharmacokinet. 21: 194-200 (2006). *
Marks GB. Environmental factors and gene-environment interactions in the aetiology of asthma. Clin. Exp. Pharmacol. Physiol. 33: 285-289 (2006).
Marra MN, Thornton MB, Snable JL, Leong S, Lane J, Wilde CG, Scott RW. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins. Blood Purif. 11: 134-140 (1993).
Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J. Immunol. 144: 662-666 (1990).
Marriott I, Bost KL, Huet-Hudson YM. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. J. Reprod. Immunol. 71: 12-27 (2006).
Marriott I, Rati DM, McCall SH, Tranguch SL. Induction of Nod1 and Nod2 intracellular pattern recognition receptors in murine osteoblasts following bacterial challenge. Infect. Immun. 73: 2967-2973 (2005). *
Marsh CB, Wewers MD. The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection. Clin. Chest Med. 17: 183-197 (1996).
Marshall JC. Lipopolysaccharide: an endotoxin or an exogenous hormone? Clin. Infect. Dis. 41 Suppl. 7: S470-S480 (2005). *
Marshall TG, Marshall FE. Sarcoidosis succumbs to antibiotics-implications for autoimmune disease. Autoimmun. Rev. 3: 295-300 (2004).
Martin AC, Laing IA, Zhang G, Brennan S, Winfield K, Sly PD, Stick SM, Goldblatt J, LeSouef PN. CD14 C-159T and early infection with Pseudomonas aeruginosa in children with cystic fibrosis. Respir. Res. 6: 63 (2005). *
Martin AI, Lopez-Menduina M, Castillero E, Granado M, Villanua M, Lopez-Calderon A. Ptgs2 activation by endotoxin mediates the decrease in Igf1, but not in Igfbp3, gene expression in the liver. J. Endocrinol. 198: 385-394 (2008). *
Martin J, Dufour JF. Cholestasis shuts down calcium signaling in cholangiocytes. Hepatology 39: 248-249 (2004). *
Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Durr C, Heimesaat MM, Bereswill S, Fejer G, Vassileva R, Jakob T, Freudenberg N, Termeer CC, Johner C, Galanos C, Freudenberg MA. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 205: 2151-2162 (2008). *
Martinelli C, Reichhart JM. Evolution and integration of innate immune systems from fruit flies to man: lessons and questions. J. Endotoxin Res. 11: 243-248 (2005). *
Martinesi M, Treves C, d'Albasio G, Bagnoli S, Bonanomi AG, Stio M. Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients. Inflamm. Bowel Dis. 14: 597-604 (2008). *
Martinez FD. CD14, endotoxin, and asthma risk: actions and interactions. Proc. Am. Thorac. Soc. 4: 221-225 (2007). *
Martinon F, Agostini L, Meylan E, Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14: 1929-1934 (2004). *
Martins AJ, Colquhoun P, Reid G, Kim SO. Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease. Inflamm. Bowel Dis. 15: 515-525 (2009).
Martins J, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. Insulin inhibits LPS-induced signaling pathways in alveolar macrophages. Cell. Physiol. Biochem. 21: 297-304 (2008). *
Martins JO, Zanoni FL, Martins DO, Coimbra R, Krieger JE, Jancar S, Sannomiya P. Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through NF-kappaB activation in lipopolysaccharide-induced acute lung injury in rats. Shock 31: 404-409 (2009).
Martins PS, Brunialti MK, Martos LS, Machado FR, Assuncao MS, Blecher S, Salomao R. Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit. Care 12: R25 (2008).
Maruyama K, Sano G, Matsuo K. Murine osteoblasts respond to LPS and IFN-gamma similarly to macrophages. J. Bone Miner. Metab. 24: 454-460 (2006). *
Masamune A, Kikuta K, Watanabe T, Satoh K, Satoh A, Shimosegawa T. Pancreatic stellate cells express Toll-like receptors. J. Gastroenterol. 43: 352-362 (2008). *
Masanaga T, Watanabe Y, Van de Water J, Leung PS, Nakanishi T, Kajiyama G, Ruebner BH, Coppel RL, Gershwin ME. Induction and persistence of immune-mediated cholangiohepatitis in neonatally thymectomized mice. Clin. Immunol. Immunopathol. 89: 141-149 (1998). *
Mascanfroni I, Del Mar Montesinos M, Susperreguy S, Cervi L, Ilarregui JM, Ramseyer VD, Masini-Repiso AM, Targovnik HM, Rabinovich GA, Pellizas CG. Control of dendritic cell maturation and function by triiodothyronine. FASEB J. 22: 1032-1042 (2008). *
Masoud H, Perry MB, Brisson JR, Uhrin D, Li J, Richards JC. Structural elucidation of the novel core oligosaccharide from LPS of Burkholderia cepacia serogroup O4. Glycobiology 19: 462-471 (2009). *
Mastroeni D, Grover A, Leonard B, Joyce JN, Coleman PD, Kozik B, Bellinger DL, Rogers J. Microglial responses to dopamine in a cell culture model of Parkinson's disease. Neurobiol. Aging Mar 4 [Epub ahead of print] (2008).
Masubuchi Y, Enoki K, Horie T. Down-regulation of hepatic cytochrome P450 enzymes in rats with trinitrobenzene sulfonic acid-induced colitis. Drug Metab. Dispos. 36: 597-603 (2008). *
Masubuchi Y, Horie T. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Drug Metab. Dispos. 32: 437-441 (2004). *
Masumi A, Tamaoki S, Wang IM, Ozato K, Komuro K. IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett. 531: 348-353 (2002). *
Matalka KZ, Ali DA. Stress-induced versus preovulatory and pregnancy hormonal levels in modulating cytokine production following whole blood stimulation. Neuroimmunomodulation 12: 366-374 (2005).
Matera G, Liberto MC, Joosten LA, Vinci M, Quirino A, Pulicari MC, Kullberg BJ, Van der Meer JW, Netea MG, Foca A. The Janus face of Bartonella quintana recognition by Toll-like receptors (TLR): a review. Eur. Cytokine Netw. 19: 1-6 (2008).
Mathew JS, Sharma RP. Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int. J. Immunopharmacol. 22: 693-706 (2000).
Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32: 1008-1017 (2000). *
Matitau AE, Scheid MP. Phosphorylation of MEKK3 at threonine 294 promotes 14-3-3 association to inhibit nuclear factor-kappaB activation. J. Biol. Chem. 283: 13261-13268 (2008). *
Matricardi PM, Ronchetti R. Are infections protecting from atopy? Curr. Opin. Allergy Clin. Immunol. 1: 413-419 (2001).
Matsuda H, Ninomiya K, Morikawa T, Yasuda D, Yamaguchi I, Yoshikawa M. Protective effects of amide constituents from the fruit of Piper chaba on D-galactosamine/TNF-alpha-induced cell death in mouse hepatocytes. Bioorg. Med. Chem. Lett. 18: 2038-2042 (2008). *
Matsuda N, Nishihira J, Takahashi Y, Kemmotsu O, Hattori Y. Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia. Am. J. Respir. Cell. Mol. Biol. 35: 198-205 (2006). *
Matsuda N, Yamazaki H, Takano KI, Matsui K, Takano Y, Kemmotsu O, Hattori Y. Priming by lipopolysaccharide exaggerates acute lung injury and mortality in responses to peptidoglycan through up-regulation of Toll-like receptor-2 expression in mice. Biochem. Pharmacol. 75: 1065-1075 (2008). *
Matsui K, Wirotesangthong M, Nishikawa A. Analysis of signaling pathways involved in peptidoglycan-induced RANTES production from murine Langerhans cells. Int. Arch. Allergy Immunol. 149: 167-172 (2009).
Matsumoto A, Kinoshita M, Ono S, Tsujimoto H, Majima T, Habu Y, Shinomiya N, Seki S. Cooperative IFN-gamma production of mouse liver B cells and natural killer cells stimulated with lipopolysaccharide. J. Hepatol. 45: 290-298 (2006). *
Matsumoto K, Kanmatsuse K. Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy. Scand. J. Urol. Nephrol. 37: 164-171 (2003).
Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A, Sata M. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 140: 417-426 (2005). *
Matsumura N, Takeyama Y, Ueda T, Yasuda T, Shinzeki M, Sawa H, Nakajima T, Kuroda Y. Decreased expression of Toll-like receptor 2 and 4 on macrophages in experimental severe acute pancreatitis. Kobe J. Med. Sci. 53: 219-227 (2007). *
Matsushima N, Tanaka T, Enkhbaya P, Mikami T, Taga M, Ymada K, Kuroki Y. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate Toll-like receptors. BMC Genomics 8: 124 (2007). *
Matsushita S, Higashi T. Human Th17 cell clones and natural immune responses. Allergol. Int. 57: 135-140 (2008). *
Matto M, Raunio AR, Postila V, Huttunen K, Hirvonen MR, Pelkonen J. Human B cells and macrophages cooperate in T-cell-independent type 2 response. Scand. J. Immunol. 67: 209-217 (2008). *
Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am. J. Gastroenterol. 103: 1460-1469 (2008). *
Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 131: 410-419 (2006). *
Mayer AM, Guzman M, Peksa R, Hall M, Fay MJ, Jacobson PB, Romanic AM, Gunasekera SP. Differential effects of domoic acid and E. coli lipopolysaccharide on tumor necrosis factor-alpha, transforming growth factor-beta1 and matrix metalloproteinase-9 release by rat neonatal microglia: evaluation of the direct activation hypothesis. Mar. Drugs 5: 113-135 (2007).
Mayer K, Kiessling A, Ott J, Schaefer MB, Hecker M, Henneke I, Schulz R, Guenther A, Wang J, Wu L, Roth J, Seeger W, Kang JX. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am. J. Respir. Crit. Care Med. 179: 474-483 (2009). *
Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J. Immunol. 171: 4837-4843 (2003). *
Mayer K, Seeger W. Fish oil in critical illness. Curr. Opin. Clin. Nutr. Metab. Care 11: 121-127 (2008).
Mayo KH, Haseman J, Ilyina E, Gray B. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities. Biochim. Biophys. Acta 1425: 81-92 (1998). *
Mazurak VC, Lien V, Field CJ, Goruk SD, Pramuk K, Clandinin MT. Long-chain polyunsaturated fat supplementation in children with low docosahexaenoic acid intakes alters immune phenotypes compared with placebo. J. Pediatr. Gastroenterol. Nutr. 46: 570-579 (2008). *
McAleer JP, Rossi RJ, Vella AT. Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF. J. Immunol. 182: 5322-5330 (2009).
McAlindon ME, Hawkey CJ, Mahida YR. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 42: 214-219 (1998). *
McCombe PA. Recombinant EPF/chaperonin 10 promotes the survival of O4-positive pro-oligodendrocytes prepared from neonatal rat brain. Cell Stress Chaperones 13: 467-474 (2008).
McFarlin BK, Flynn MG, Campbell WW, Craig BA, Robinson JP, Stewart LK, Timmerman KL, Coen PM. Physical activity status, but not age, influences inflammatory biomarkers and Toll-like receptor 4. J. Gerontol. A. Biol. Sci. Med. Sci. 61: 388-393 (2006).
McGhee JR, Michalek SM, Kiyono H, Eldridge JH, Colwell DE, Williamson SI, Wannemuehler MJ, Jirillo E, Mosteller LM, Spalding DM, et al. Mucosal immunoregulation: environmental lipopolysaccharide and GALT T lymphocytes regulate the IgA response. Microbiol. Immunol. 28: 261-280 (1984).
McGuinness J, Byrne J, Condron C, McCarthy J, Bouchier-Hayes D, Redmond JM. Pretreatment with omega-3 fatty acid infusion to prevent leukocyte-endothelial injury responses seen in cardiac surgery. J. Thorac. Cardiovasc. Surg. 136: 135-141 (2008).
McInturff JE, Modlin RL, Kim J. The role of Toll-like receptors in the pathogenesis and treatment of dermatological disease. J. Invest. Dermatol. 125: 1-8 (2005). *
McKenna SD, Feger G, Kelton C, Yang M, Ardissone V, Cirillo R, Vitte PA, Jiang X, Campbell RK. Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist. J. Pharmacol. Exp. Ther. 322: 822-828 (2007). *
McMaster SK, Paul-Clark MJ, Walters M, Fleet M, Anandarajah J, Sriskandan S, Mitchell JA. Cigarette smoke inhibits macrophage sensing of Gram-negative bacteria and lipopolysaccharide: relative roles of nicotine and oxidant stress. Br. J. Pharmacol. 153: 536-543 (2008). *
McMichael JW, Roghanian A, Jiang L, Ramage R, Sallenave JM. The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses. Am. J. Respir. Cell. Mol. Biol. 32: 443-452 (2005). *
McMillian M, Nie AY, Parker JB, Leone A, Kemmerer M, Bryant S, Herlich J, Yieh L, Bittner A, Liu X, Wan J, Johnson MD. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem. Pharmacol. 67: 2141-2165 (2004). *
McMullen MR, Pritchard MT, Wang Q, Millward CA, Croniger CM, Nagy LE. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 128: 2066-2076 (2005). *
McNaught CE, Woodcock NP, Anderson AD, MacFie J. A prospective randomised trial of probiotics in critically ill patients. Clin. Nutr. 24: 211-219 (2005).
McVicker BL, Tuma DJ, Kharbanda KK, Kubik JL, Casey CA. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat kupffer cells in the presence of apoptotic cells. Alcohol Clin. Exp. Res. 31: 122-129 (2007). *
Medvedev AE, Piao W. Analysis of the functional role of Toll-like receptor-4 tyrosine phosphorylation. Methods Mol. Biol. 517: 1-23 (2009). *
Medvedev AE, Piao W, Shoenfelt J, Rhee SH, Chen H, Basu S, Wahl LM, Fenton MJ, Vogel SN. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J. Biol. Chem. 282: 16042-16053 (2007). *
Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin Res. 12: 133-150 (2006). *
Mehra MR, Lavie CJ, Ventura HO, Milani RV. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J. Heart Lung Transplant. 25: 834-838 (2006).
Meiler C, Muhlbauer M, Johann M, Hartmann A, Schnabl B, Wodarz N, Schmitz G, Scholmerich J, Hellerbrand C. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J. Gastroenterol. 11: 6031-6037 (2005). *
Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response: potential role of hepatocyte nuclear factor-1. J. Biol. Chem. 276: 30118-30126 (2001). *
Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53: 821-828 (2004). *
Mendis C, Das R, Hammamieh R, Royaee A, Yang D, Peel S, Jett M. Transcriptional response signature of human lymphoid cells to staphylococcal enterotoxin B. Genes Immun. 6: 84-94 (2005). *
Mendis E, Kim MM, Rajapakse N, Kim SK. Suppression of cytokine production in lipopolysaccharide-stimulated mouse macrophages by novel cationic glucosamine derivative involves down-regulation of NF-kappaB and MAPK expressions. Bioorg. Med. Chem. 16: 8390-8396 (2008).
Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch. Surg. 389: 475-484 (2004). *
Menon KVN, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, Shah V. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am. J. Gastroenterol. 99: 255-260 (2004). *
Mentes BB, Tatlicioglu E, Akyol G, Uluoglu O, Sultan N, Yilmaz E, Celebi M, Taneri F, Ferahkose Z. Intestinal endotoxins as co-factors of liver injury in obstructive jaundice. HPB Surg. 9: 61-69 (1996). *
Merlin T, Woelky-Bruggmann R, Fearns C, Freudenberg M, Landmann R. Expression and role of CD14 in mice sensitized to lipopolysaccharide by Propionibacterium acnes. Eur. J. Immunol. 32: 761-772 (2002). *
Mertens J, Bregadze R, Mansur A, Askar E, Bickeboller H, Ramadori G, Mihm S. Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity. J. Mol. Med. May 27 [Epub ahead of print] (2009). *
Mesotten D, Van den Berghe G, Liddle C, Coulter S, McDougall F, Baxter RC, Delhanty PJ. Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. Endocrinology 144: 4008-4017 (2003). *
Metz T, Haque T, Chen H, Prakash S, Amre D, Das SK. Preparation and in vitro analysis of microcapsule thalidomide formulation for targeted suppression of TNF-alpha. Drug Deliv. 13: 331-337 (2006).
Metzger BT, Barnes DM, Reed JD. Purple carrot (Daucus carota L.) polyacetylenes decrease lipopolysaccharide-induced expression of inflammatory proteins in macrophage and endothelial cells. J. Agric. Food Chem. 56: 3554-3560 (2008). *
Mewar D, Marinou I, Lee ME, Timms JM, Kilding R, Teare MD, Read RC, Wilson AG. Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases. Genes Immun. 7: 625-631 (2006). *
Meyer M, Huaux F, Gavilanes X, van den Brule S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Am. J. Respir. Cell. Mol. Biol. Feb 24 [Epub ahead of print] (2009). *
Michaeli B, M Berger M, Revelly JP, Tappy L, Chiolero R. Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clin. Nutr. 26: 70-77 (2007).
Michel ML, Keller AC, Paget C, Fujio M, Trottein F, Savage PB, Wong CH, Schneider E, Dy M, Leite-de-Moraes MC. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204: 995-1001 (2007). *
Michel O, LeVan TD, Stern D, Dentener M, Thorn J, Gnat D, Beijer ML, Cochaux P, Holt PG, Martinez FD, Rylander R. Systemic responsiveness to lipopolysaccharide and polymorphisms in the Toll-like receptor 4 gene in human beings. J. Allergy Clin. Immunol. 112: 923-929 (2003). *
Michlewska S, Dransfield I, Megson IL, Rossi AG. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB J. 23: 844-854 (2009). *
Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Masciana R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49: 1877-1887 (2009).
Mikami KI, Otaka M, Goto T, Miura K, Ohshima S, Yoneyama K, Lin JG, Watanabe D, Segawa D, Kataoka E, Odashima M, Watanabe S. Induction of a 72-kDa heat shock protein and protection against lipopolysaccharide-induced liver injury in cirrhotic rats. J. Gastroenterol. Hepatol. 19: 884-890 (2004). *
Miksa M, Amin D, Wu R, Jacob A, Zhou M, Dong W, Yang WL, Ravikumar TS, Wang P. Maturation-induced down-regulation of MFG-E8 impairs apoptotic cell clearance and enhances endotoxin response. Int. J. Mol. Med. 22: 743-748 (2008).
Miller LC, Sharma A, McKusick AF, Tassoni JP, Dinarello CA, Kaplan MM. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression. Hepatology 22: 518-524 (1995).
Milward EA, Trinder D, Wilcox CE, Britton RS, Ramm GA, Olynyk JK. Is HFE involved in increased hepcidin expression and hypoferremia in inflammation and anemia of chronic disease? Hepatology 41: 936-938 (2005). *
Minami M, Shimizu K, Okamoto Y, Folco E, Ilasaca ML, Feinberg MW, Aikawa M, Libby P. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappa B1 and attenuates macrophage activation. J. Biol. Chem. 283: 9692-9703 (2008). *
Mingam R, Moranis A, Bluthe RM, De Smedt-Peyrusse V, Kelley KW, Guesnet P, Lavialle M, Dantzer R, Laye S. Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur. J. Neurosci. 28: 1877-1886 (2008).
Mishra KP, Chauhan UK, Naik S. Effect of lead exposure on serum immunoglobulins and reactive nitrogen and oxygen intermediate. Hum. Exp. Toxicol. 25: 661-665 (2006). *
Mitamura M, Nakano N, Yonekawa T, Shan L, Kaise T, Kobayashi T, Yamashita K, Kikkawa H, Kinoshita M. T cells are involved in the development of arthritis induced by anti-type II collagen antibody. Int. Immunopharmacol. 7: 1360-1368 (2007).
Mitchell JA, Paul-Clark MJ, Clarke GW, McMaster SK, Cartwright N. Critical role of Toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J. Endocrinol. 193: 323-330 (2007). *
Mitsuyama K, Suzuki A, Matsumoto S, Tomiyasu N, Takaki K, Takedatsu H, Masuda J, Handa K, Harada K, Nishida H, Toyonaga A, Sata M. Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis. Clin. Exp. Immunol. 141: 130-140 (2005). *
Miwatashi S, Arikawa Y, Kotani E, Miyamoto M, Naruo K, Kimura H, Tanaka T, Asahi S, Ohkawa S. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent. J. Med. Chem. 48: 5966-5979 (2005). *
Miyake A, Murata Y, Okazawa H, Ikeda H, Niwayama Y, Ohnishi H, Hirata Y, Matozaki T. Negative regulation by SHPS-1 of Toll-like receptor-dependent proinflammatory cytokine production in macrophages. Genes Cells 13: 209-219 (2008). *
Miyake K. Roles for accessory molecules in microbial recognition by Toll-like receptors. J. Endotoxin Res. 12: 195-204 (2006). *
Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol. 19: 3-10 (2007). *
Miyake K. Endotoxin recognition molecules MD-2 and Toll-like receptor 4 as potential targets for therapeutic intervention of endotoxin shock. Curr. Drug Targets Inflamm. Allergy 3: 291-297 (2004).
Miyake K. Endotoxin recognition molecules, Toll-like receptor 4-MD-2. Semin. Immunol. 16: 11-16 (2004). *
Miyaso H, Morimoto Y, Ozaki M, Haga S, Shinoura S, Choda Y, Iwagaki H, Tanaka N. Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes. J. Gastroenterol. Hepatol. 20: 1859-1866 (2005). *
Miyatake K, Inoue H, Hashimoto K, Takaku H, Takata Y, Nakano S, Yasui N, Itakura M. PKC412 (CGP41251) modulates the proliferation and lipopolysaccharide-induced inflammatory responses of RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 360: 115-121 (2007). *
Miyazaki A, Kitaichi N, Ohgami K, Iwata D, Jin XH, Iwabuchi K, Morohashi T, Ohno S, Onoe K. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats. Graefes Arch. Clin. Exp. Ophthalmol. 246: 747-757 (2008).
Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J. Med. Virol. 80: 980-988 (2008). *
Mizoguchi Y, Kodama C, Sakagami Y, Seki S, Kobayashi K, Yamamoto S, Morisawa S. Effects of bile acids on liver cell injury by cultured supernatant of activated liver adherents cells. Gastroenterol. Jpn. 24: 25-30 (1989).
Mizutori Y, Saitoh O, Eguchi K, Nagayama Y. Lack of effect of methimazole on dendritic cell (DC) function and DC-induced Graves' hyperthyroidism in mice. Autoimmunity 40: 397-402 (2007).
Mnasria K, Lagaraine C, Velge-Roussel F, Lebranchu Y, Baron C. Anti-CD25 antibodies decrease the ability of human dendritic cells to prime allogeneic CD4 T cells. Transplant. Proc. 41: 695-697 (2009).
Moezi L, Shafaroodi H, Sarkar S, Emami-Razavi SH, Sanatkar M, Mirazi N, Dehpour AR. Involvement of nitrergic and opioidergic systems in the hypothermia induced by cholestasis in rats. Pathophysiology 13: 227-232 (2006).
Mofarrahi M, Nouh T, Qureshi S, Guillot L, Mayaki D, Hussain SN. Regulation of angiopoietin expression by bacterial lipopolysaccharide. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L955-L963 (2008). *
Mohammad Alizadeh AH, Ranjbar M, Hajilooi M, Fallahian F. Association of promoter polymorphism of the CD14 C (-159) T endotoxin receptor gene with chronic hepatitis B. World J. Gastroenterol. 12: 5717-5720 (2006). *
Mole DJ, McFerran NV, Diamond T. Differential preservation of lipopolysaccharide-induced chemokine/cytokine expression during experimental pancreatitis-associated organ failure in rats shows a regulatory expressed phenotype. Pancreatology 8: 478-487 (2008).
Moller S, Laigaard F, Olgaard K, Hemmingsen C. Effect of 1,25-dihydroxy-vitamin D(3) in experimental sepsis. Int. J. Med. Sci. 4: 190-195 (2007). *
Mollinedo F, Gajate C, Morales AI, Del Canto-Janez E, Justies N, Collia F, Rivas JV, Modolell M, Iglesias A. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis. J. Pharmacol. Exp. Ther. 329: 439-449 (2009). *
Mollnes TE, Christiansen D, Brekke OL, Espevik T. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Adv. Exp. Med. Biol. 632: 253-263 (2008).
Molnarfi N, Brandt KJ, Gruaz L, Dayer JM, Burger D. Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions. Mol. Immunol. 45: 3419-3427 (2008). *
Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, Tytgat GN, Van Deventer SJ. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology 110: 733-739 (1996). *
Monteleone G, Parrello T, Monteleone I, Tammaro S, Luzza F, Pallone F. Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC). Clin. Exp. Immunol. 117: 469-475 (1999). *
Montosi G, Corradini E, Garuti C, Barelli S, Recalcati S, Cairo G, Valli L, Pignatti E, Vecchi C, Ferrara F, Pietrangelo A. Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 41: 545-552 (2005). *
Mookherjee N, Rehaume LM, Hancock RE. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 11: 993-1004 (2007).
Moon EY, Lee JH, Oh SY, Ryu SK, Kim HM, Kwak HS, Yoon WK. Reactive oxygen species augment B-cell-activating factor expression. Free Radic. Biol. Med. 40: 2103-2111 (2006).
Moon EY, Pyo S. Lipopolysaccharide stimulates Epac1-mediated Rap1/NF-kappaB pathway in Raw 264.7 murine macrophages. Immunol. Lett. 110: 121-125 (2007).
Moon Y, Yang H, Park SH. Hypo-responsiveness of interleukin-8 production in human embryonic epithelial intestine 407 cells independent of NF-kappaB pathway: new lessons from endotoxin and ribotoxic deoxynivalenol. Toxicol. Appl. Pharmacol. 231: 94-102 (2008). *
Moore CC, Martin EN, Lee GH, Obrig T, Linden J, Scheld WM. An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine septic shock models. BMC Infect. Dis. 8: 141 (2008). *
Moran AP, Prendergast MM. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J. Autoimmun. 16: 241-256 (2001).
Moran AP, Prendergast MM, Appelmelk BJ. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16: 105-115 (1996). *
Moreau R, Barriere E, Tazi KA, Lardeux B, Dargere D, Urbanowicz W, Poirel O, Chauvelot-Moachon L, Guimont MC, Bernuau D, Lebrec D. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Hepatology 36: 1070-1078 (2002). *
Moreira LO, Smith AM, Defreitas AA, Qualls JE, El Kasmi KC, Murray PJ. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2. Vaccine 26: 5808-5813 (2008).
Moreno C, Merino J, Ramirez N, Echeverria A, Pastor F, Sanchez-Ibarrola A. Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14. Microbes Infect. 6: 990-995 (2004). *
Mormann M, Rieth H, Hua TD, Assohou C, Roupelieva M, Hu SL, Kremsner PG, Luty AJ, Kube D. Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun. 5: 246-255 (2004). *
Morre SA, Ouburg S, Klinkenberg-Knol EC, Mulder CJ, Pena AS. The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: a schematic representation of ligand-receptor interactions and NF-kappa B activation. Gastroenterology 126: 371-373 (2004). *
Mortensen NP, Fowlkes JD, Sullivan CJ, Allison DP, Larsen NB, Molin S, Doktycz MJ. Effects of colistin on surface ultrastructure and nanomechanics of Pseudomonas aeruginosa cells. Langmuir. 25: 3728-3733 (2009).
Moseley RH. Sepsis and cholestasis. Clin. Liver Dis. 8: 83-94 (2004).
Moss RB. Hypergammaglobulinemia in cystic fibrosis. Role of Pseudomonas endobronchial infection. Chest 91: 522-526 (1987). *
Moss RL, Amii LA. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin. Pediatr. Surg. 8: 140-147 (1999).
Motegi SI, Okazawa H, Murata Y, Kanazawa Y, Saito Y, Kobayashi H, Ohnishi H, Oldenborg PA, Ishikawa O, Matozaki T. Essential roles of SHPS-1 in induction of contact hypersensitivity of skin. Immunol. Lett. 121: 52-60 (2008).
Motomura K, Ohata M, Satre M, Tsukamoto H. Destabilization of TNF-alpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease. Am. J. Physiol. Endocrinol. Metab. 281: E420-E429 (2001). *
Motomura K, Sakai H, Isobe H, Nawata H. All-trans retinoic acid suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats. J. Gastroenterol. Hepatol. 12: 887-892 (1997).
Motomura K, Sakai H, Isobe H, Nawata H. Effects of retinoids on the production of tumour necrosis factor-alpha and nitric oxide by lipopolysaccharide-stimulated rat Kupffer cells in vitro: evidence for participation of retinoid X receptor signalling pathway. Cell. Biochem. Funct. 15: 95-101 (1997). *
Mottino AD, Catania VA. Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents. World J. Gastroenterol. 14: 7068-7074 (2008). *
Mou HB, Lin MF, Cen H, Yu J, Meng XJ. TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression. J. Zhejiang Univ. Sci. 5: 1239-1244 (2004). *
Moulin F, Copple BL, Ganey PE, Roth RA. Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1423-G1431 (2001). *
Mount JA, Karrow NA, Caswell JL, Boermans HJ, Leslie KE. Assessment of bovine mammary chemokine gene expression in response to lipopolysaccharide, lipotechoic acid + peptidoglycan, and CpG oligodeoxynucleotide 2135. Can. J. Vet. Res. 73: 49-57 (2009).
Mueller M, Lindner B, Dedrick R, Schromm AB, Seydel U. Endotoxin: physical requirements for cell activation. J. Endotoxin Res. 11: 299-303 (2005). *
Mueller M, Stamme C, Draing C, Hartung T, Seydel U, Schromm AB. Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein. J. Biol. Chem. 281: 31448-31456 (2006). *
Muhlbauer M, Chilton PM, Mitchell TC, Jobin C. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23p19 gene expression in IL-10-/- mice. J. Biol. Chem. 283: 14182-14189 (2008). *
Muhlfeld A, Kubitz R, Dransfeld O, Haussinger D, Wettstein M. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis. Arch. Biochem. Biophys. 413: 32-40 (2003). *
Mulcahy H, O'rourke KP, Adams C, Molloy MG, O'Gara F. LST1 and NCR3 expression in autoimmune inflammation and in response to IFN-gamma, LPS and microbial infection. Immunogenetics 57: 893-903 (2006). *
Mulero V, Searle S, Blackwell JM, Brock JH. Solute carrier 11a1 (Slc11a1; formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic, but not transferrin-receptor-mediated, iron uptake. Biochem. J. 363: 89-94 (2002). *
Mullen A, Loscher CE, Roche HM. Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J. Nutr. Biochem. May 7 [Epub ahead of print] (2009). *
Muller C, Zielinski CC. Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis. J. Hepatol. 15: 372-377 (1992).
Mullins GE, Sunden-Cullberg J, Johansson AS, Rouhiainen A, Erlandsson-Harris H, Yang H, Tracey KJ, Rauvala H, Palmblad J, Andersson J, Treutiger CJ. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand. J. Immunol. 60: 566-573 (2004). *
Munakata W, Liu Q, Shimoyama T, Sawaya M, Umeda T, Sugawara K. Ecabet sodium attenuates reactive oxygen species produced by neutrophils after priming with bacterial lipopolysaccharides. Luminescence 18: 330-333 (2003). *
Munford RS. How do animal phagocytes process bacterial lipopolysaccharides? APMIS 99: 487-491 (1991).
Munford RS. Detoxifying endotoxin: time, place and person. J. Endotoxin Res. 11: 69-84 (2005). *
Munford RS, Hall CL. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234: 203-205 (1986). *
Munford RS, Hunter JP. Acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides, has phospholipase, lysophospholipase, diacylglycerollipase, and acyltransferase activities in vitro. J. Biol. Chem. 267: 10116-10121 (1992). *
Munoz C, Lopez M, Olivares M, Pizarro F, Arredondo M, Araya M. Differential response of interleukin-2 production to chronic copper supplementation in healthy humans. Eur. Cytokine Netw. 16: 261-265 (2005).
Murakami K, Bujo H, Unoki H, Saito Y. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes. Eur. J. Pharmacol. 561: 206-213 (2007). *
Murakami M, Ohta T, Ito S. Lipopolysaccharides enhance the action of bradykinin in enteric neurons via secretion of interleukin-1beta from enteric glial cells. J. Neurosci. Res. 87: 2095-2104 (2009).
Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Arthritis Rheum. 60: 1615-1623 (2009). *
Murch O, Abdelrahman M, Kapoor A, Thiemermann C. Muramyl dipeptide enhances the response to endotoxin to cause multiple organ injury in the anesthetized rat. Shock 29: 388-394 (2008).
Murch O, Collin M, Thiemermann C. Lysophosphatidic acid reduces the organ injury caused by endotoxemia - a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma. Shock 27: 48-54 (2007). *
Murohisa G, Kobayashi Y, Kawasaki T, Nakamura S, Nakamura H. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. Liver 22: 394-403 (2002).
Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J. Invest. Dermatol. 114: 602-608 (2000). *
Murphy TJ, Paterson HM, Kriyonovich S, Zang Y, Kurt-Jones EA, Mannick JA, Lederer JA. Linking the "two-hit" response following injury to enhanced TLR4 reactivity. J. Leukoc. Biol. 77: 16-23 (2005). *
Muthu K, He LK, Szilagyi A, Stevenson J, Gamelli RL, Shankar R. Propranolol restores the tumor necrosis factor response of circulating inflammatory monocytes and granulocytes after burn injury and sepsis. J. Burn Care Res. 30: 8-18 (2009).
Muthukuru M, Cutler CW. Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance. Infect. Immun. 76: 477-485 (2008). *
Myhre AE, Aasen AO, Thiemermann C, Wang JE. Peptidoglycan - an endotoxin in its own right? Shock 25: 227-235 (2006). *
Myhre AE, Agren J, Dahle MK, Tamburstuen MV, Lyngstadaas SP, Collins JL, Foster SJ, Thiemermann C, Aasen AO, Wang JE. Liver X receptor is a key regulator of cytokine release in human monocytes. Shock 29: 468-474 (2008).
Na KS, Kim TH, Rahman P, Peddle L, Choi CB, Inman RD. Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population. Rheumatol. Int. 28: 627-630 (2008). *
Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J. Biol. Chem. 274: 7674-7680 (1999). *
Na SY, Kim HJ, Lee SK, Choi HS, Na DS, Lee MO, Chung M, Moore DD, Lee JW. IkappaBbeta interacts with the retinoid X receptor and inhibits retinoid-dependent transactivation in lipopolysaccharide-treated cells. J. Biol. Chem. 273: 3212-3215 (1998). *
Na YJ, Han SB, Kang JS, Yoon YD, Park SK, Kim HM, Yang KH, Joe CO. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int. Immunopharmacol. 4: 1187-1199 (2004).
Nachamkin I, Allos BM, Ho T. Campylobacter species and Guillain-Barre syndrome. Clin. Microbiol. Rev. 11: 555-567 (1998). *
Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, Takatsu K, Kincade PW. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24: 801-812 (2006). *
Nagaki M, Moriwaki H. Implication of cytokines: roles of tumor necrosis factor-alpha in liver injury. Hepatol. Res. 38 (s1: The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan): S19-S28 (2008).
Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J. Immunol. 167: 3329-3338 (2001). *
Nagata K, Suzuki H, Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J. Toxicol. Sci. 32: 453-468 (2007). *
Nah SS, Ha E, Mun SH, Won HJ, Chung JH. Effects of melittin on the production of matrix metalloproteinase-1 and -3 in rheumatoid arthritic fibroblast-like synoviocytes. J. Pharmacol. Sci. 106: 162-166 (2008). *
Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J. Pediatr. Gastroenterol. Nutr. 32: 449-453 (2001). *
Naito Y, Takagi T, Mizushima K, Ueta M, Kinoshita S, Handa O, Kokura S, Ichikawa H, Yoshida N, Yoshikawa T. Gene expression clusters of a lipopolysaccharide-stimulated pathway in peripheral blood monocytes of Japanese patients with Crohn's disease. Aliment. Pharmacol. Ther. 24 Suppl. 4: 256-265 (2006).
Nakamura N, Yoshida M, Umeda M, Huang Y, Kitajima S, Inoue Y, Ishikawa I, Iwai T. Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis 196: 59-67 (2008).
Nakamura T, Kawagoe Y, Ueda Y, Koide H. Polymyxin B-immobilized fiber hemoperfusion in a patient with active ulcerative colitis. ASAIO J. 51: 471-473 (2005).
Nakamura Y, Yokoyama H, Higuchi S, Hara S, Kato S, Ishii H. Acetaldehyde accumulation suppresses Kupffer cell release of TNF-alpha and modifies acute hepatic inflammation in rats. J. Gastroenterol. 39: 140-147 (2004). *
Nakanishi H, Kaibori M, Teshima S, Yoshida H, Kwon AH, Kamiyama Y, Nishizawa M, Ito S, Okumura T. Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1beta at a step of NF-kappaB DNA binding in hepatocytes. J. Hepatol. 41: 730-736 (2004). *
Nakashima K, Hirota T, Obara K, Shimizu M, Jodo A, Kameda M, Doi S, Fujita K, Shirakawa T, Enomoto T, Kishi F, Yoshihara S, Matsumoto K, Saito H, Suzuki Y, Nakamura Y, Tamari M. An association study of asthma and related phenotypes with polymorphisms in negative regulator molecules of the TLR signaling pathway. J. Hum. Genet. 51: 284-291 (2006). *
Nakashima K, Hirota T, Suzuki Y, Akahoshi M, Shimizu M, Jodo A, Doi S, Fujita K, Ebisawa M, Yoshihara S, Enomoto T, Shirakawa T, Kishi F, Nakamura Y, Tamari M. Association of the RIP2 gene with childhood atopic asthma. Allergol. Int. 55: 77-83 (2006). *
Nakata K, Inagawa H, Nishizawa T, Honda T, Kohchi C, Tonomoto Y, Yoshimura H, Nagasue N, Natori S, Terada H, Soma GI. Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages. Int. J. Colorectal Dis. 21: 339-347 (2006). *
Nakata K, Inagawa H, Nishizawa T, Kohchi C, Soma G. Suppression of response to foreign substances by intestinal macrophages. Anticancer Res. 27: 3723-3727 (2007).
Nakayama Y, Shimizu Y, Hirano K, Ebata K, Minemura M, Watanabe A, Sugiyama T. CTLA-4Ig suppresses liver injury by inhibiting acquired immune responses in a mouse model of fulminant hepatitis. Hepatology 42: 915-924 (2005). *
Nan JX, Jin XJ, Lian LH, Cai XF, Jiang YZ, Jin HR, Lee JJ. A diterpenoid acanthoic acid from Acanthopanax koreanum protects against D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice. Biol. Pharm. Bull. 31: 738-742 (2008). *
Nan YH, Jeon YJ, Park IS, Shin SY. Antimicrobial peptide P18 inhibits inflammatory responses by LPS- but not by IFN-gamma-stimulated macrophages. Biotechnol. Lett. 30: 1183-1187 (2008). *
Nanji AA. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 34: 21-25 (2004). *
Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G321-G327 (2003). *
Nanji AA, Su GL, Laposata M, French SW. Pathogenesis of alcoholic liver disease - recent advances. Alcohol Clin. Exp. Res. 26: 731-736 (2002). *
Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J. Assoc. Res. Otolaryngol. 10: 151-160 (2009).
Nath B, Szabo G. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity. Semin. Liver Dis. 29: 166-177 (2009).
Nath N, Khan M, Paintlia MK, Hoda MN, Giri S. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J. Immunol. 182: 8005-8014 (2009).
Nathanson MH, Burgstahler AD, Mennone A, Dranoff JA, Rios-Velez L. Stimulation of bile duct epithelial secretion by glybenclamide in normal and cholestatic rat liver. J. Clin. Invest. 101: 2665-2676 (1998). *
Nathens AB, Rotstein OD, Dackiw AP, Marshall JC. Intestinal epithelial cells down-regulate macrophage tumor necrosis factor-alpha secretion: a mechanism for immune homeostasis in the gut-associated lymphoid tissue. Surgery 118: 343-350 (1995).
Nautiyal KM, McKellar H, Silverman AJ, Silver R. Mast cells are necessary for the hypothermic response to LPS-induced sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R595-R602 (2009). *
Nde CW, Jang HJ, Toghrol F, Bentley WE. Toxicogenomic response of Pseudomonas aeruginosa to ortho-phenylphenol. BMC Genomics 9: 473 (2008). *
Necela BM, Su W, Thompson EA. Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages. Immunology 125: 344-358 (2008). *
Negut EA. Role of the liver in detoxification of endotoxins. Rev. Ig Bacteriol. Virusol. Parazitol. Epidemiol. Pneumoftiziol. Bacteriol. Virusol. Parazitol. Epidemiol. 21: 1-10 (1976).
Nemazee D, Gavin A, Hoebe K, Beutler B. Immunology: Toll-like receptors and antibody responses. Nature 441: E4 (2006). *
Nemeth ZH, Bleich D, Csoka B, Pacher P, Mabley JG, Himer L, Vizi ES, Deitch EA, Szabo C, Cronstein BN, Hasko G. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J. 21: 2379-2388 (2007). *
Nesbitt A, Fossati G, Bergin M, Stephens P, Stephens S, Foulkes R, Brown D, Robinson M, Bourne T. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents. Inflamm. Bowel Dis. 13: 1323-1332 (2007). *
Nessa BN, Tanaka T, Kamino K, Sadik G, Ansar AB, Kimura R, Tanii H, Okochi M, Morihara T, Tagami S, Kudo T, Takeda M. Toll-like receptor 3 mediated hyperphosphorylation of tau in human SH-SY5Y neuroblastoma cells. Psychiatry Clin. Neurosci. 60 Suppl. 1: S27-S33 (2006).
Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, Dinarello CA. Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 3: e277 (2006). *
Netea MG, Hijmans A, van Wissen S, Smilde TJ, Trip MD, Kullberg BJ, de Boo T, Van der Meer JW, Kastelein JJ, Stalenhorf AF. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur. J. Clin. Invest. 34: 94-99 (2004).
Neuman MG. Cytokines - central factors in alcoholic liver disease. Alcohol Res. Health 27: 307-316 (2003). *
Neve BP, Corseaux D, Chinetti G, Zawadzki C, Fruchart JC, Duriez P, Staels B, Jude B. PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation 103: 207-212 (2001). *
Newman B, Silverberg MS, Gu X, Zhang Q, Lazaro A, Steinhart AH, Greenberg GR, Griffiths AM, McLeod RS, Cohen Z, Fernandez-Vina M, Amos CI, Siminovitch K. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am. J. Gastroenterol. 99: 306-315 (2004). *
Neyrinck AM, Mouson A, Delzenne NM. Dietary supplementation with laminarin, a fermentable marine beta (1-3) glucan, protects against hepatotoxicity induced by LPS in rat by modulating immune response in the hepatic tissue. Int. Immunopharmacol. 7: 1497-1506 (2007).
Nhu QM, Cuesta N, Vogel SN. Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2). J. Endotoxin Res. 12: 285-295 (2006). *
Ni L, Acevedo G, Muralidharan B, Padala N, To J, Jonakait GM. Toll-like receptor ligands and CD154 stimulate microglia to produce a factor(s) that promotes excess cholinergic differentiation in the developing rat basal forebrain: implications for neurodevelopmental disorders. Pediatr. Res. 61: 15-20 (2007). *
Nielsen SE, Vainer B, Nielsen OH. Comparative studies of superoxide production by microbial wall product-primed neutrophils in ulcerative colitis. Dig. Dis. Sci. 49: 878-882 (2004). *
Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 116: 2043-2052 (2007). *
Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G, Goronzy JJ, Weyand CM, Kopp CW, Huber K, Wolzt M, Wojta J. Simvastatin suppresses endotoxin-induced upregulation of Toll-like receptors 4 and 2 in vivo. Atherosclerosis 189: 408-413 (2006).
Nigo YI, Yamashita M, Hirahara K, Shinnakasu R, Inami M, Kimura M, Hasegawa A, Kohno Y, Nakayama T. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc. Natl. Acad. Sci. U.S.A. 103: 2286-2291 (2006). *
Nijveldt RJ, Siroen MP, Teerlink T, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int. 24: 510-518 (2004). *
Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67: 593-656 (2003). *
Nikulina M, Habich C, Flohe SB, Scott FW, Kolb H. Wheat gluten causes dendritic cell maturation and chemokine secretion. J. Immunol. 173: 1925-1933 (2004).
Nilsson K, Dahlgren UI, Hanson LA. Different origins of IgA antibodies with various antigen specificities appearing in rat bile. Scand. J. Immunol. 28: 547-551 (1988).
Ninomiya Y, Yasuda T, Kawamoto M, Yuge O, Okazaki Y. Liver X receptor ligands inhibit the lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 and diminish prostaglandin E(2) production in murine peritoneal macrophages. J. Steroid Biochem. Mol. Biol. 103: 44-50 (2007).
Nisapakultorn K, Makrudthong J, Sa-Ard-Iam N, Rerkyen P, Mahanonda R, Takikawa O. Indoleamine 2,3-dioxygenase expression and regulation in chronic periodontitis. J. Periodontol. 80: 114-121 (2009).
Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, Funahashi T, Shimomura I. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131: 853-861 (2006). *
Nishimura H, Gogami A, Miyagawa Y, Nanbo A, Murakami Y, Baba T, Nagasawa S. Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface. Immunology 103: 519-525 (2001). *
Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22: 291-302 (2002). *
Nishitani C, Mitsuzawa H, Sano H, Shimizu T, Matsushima N, Kuroki Y. Toll-like receptor 4 region GLU24-LYS47 is a site for MD-2 binding: importance of CYS29 and CYS40. J. Biol. Chem. 281: 38322-38329 (2006). *
Nishiya T, Kajita E, Miwa S. Ligand-independent oligomerization of TLR4 regulated by a short hydrophobic region adjacent to the transmembrane domain. Biochem. Biophys. Res. Commun. 341: 1128-1134 (2006). *
Nita IM, Serapinas D, Janciauskiene SM. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro. Int. J. Biochem. Cell Biol. 39: 1165-1176 (2007). *
Niyonsaba F, Nagaoka I, Ogawa H. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit. Rev. Immunol. 26: 545-576 (2006).
No authors listed. In this issue. Eur. J. Immunol. 38: 9-10 (2008). *
Nogai A, Siffrin V, Bonhagen K, Pfueller CF, Hohnstein T, Volkmer-Engert R, Bruck W, Stadelmann C, Kamradt T. Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells. J. Immunol. 175: 959-966 (2005). *
Noguchi F, Kitamura C, Nagayoshi M, Chen KK, Terashita M, Nishihara T. Ozonated water improves lipopolysaccharide-induced responses of an odontoblast-like cell line. J. Endod. 35: 668-672 (2009).
Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1: 458-465 (1981).
Nolan JP. The role of endotoxin in liver injury. Gastroenterology 69: 1346-1356 (1975).
Nolan JP. The contribution of gut-derived endotoxins to liver injury. Yale J. Biol. Med. 52: 127-133 (1979).
Nolan JP, Camara DS. Intestinal endotoxins and macrophages as mediators of liver injury. Trans. Am. Clin. Climatol. Assoc. 100: 115-125 (1989).
Nolan JP, Camara DS. The importance of intestinal endotoxins in liver disease. Prog. Clin. Biol. Res. 189: 347-367 (1985).
Nolan JP, Camara DS. Intestinal endotoxins as co-factors in liver injury. Immunol. Invest. 18: 325-337 (1989).
Nolan JP, DeLissio MG, Camara DS, Feind DM, Gagliardi NC. IgA antibody to lipid A in alcoholic liver disease. Lancet 1: 176-179 (1986).
Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc. Natl. Acad. Sci. U.S.A. 106: 3883-3888 (2009). *
Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203: 425-435 (2006). *
Novoselova EG, Lunin SM, Novoselova TV, Khrenov MO, Glushkova OV, Avkhacheva NV, Safronova VG, Fesenko EE. Naturally occurring antioxidant nutrients reduce inflammatory response in mice. Eur. J. Pharmacol. May 19 [Epub ahead of print] (2009).
Nunez C, Barreiro M, Dominguez-Munoz JE, Lorenzo A, Zapata C, Pena AS. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population. Am. J. Gastroenterol. 99: 450-456 (2004). *
Nunez Miguel R, Wong J, Westoll JF, Brooks HJ, O'Neill LA, Gay NJ, Bryant CE, Monie TP. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE. 2: e788 (2007). *
Nupponen I, Turunen R, Nevalainen T, Peuravuori H, Pohjavuori M, Repo H, Andersson S. Extracellular release of bactericidal/permeability-increasing protein in newborn infants. Pediatr. Res. 51: 670-674 (2002). *
O'Neill LA, Dunne A, Edjeback M, Gray P, Jefferies C, Wietek C. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors. J. Endotoxin Res. 9: 55-59 (2003). *
Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand. J. Gastroenterol. 37: 699-704 (2002). *
Ock J, Jeong J, Choi WS, Lee WH, Kim SH, Kim IK, Suk K. Regulation of Toll-like receptor 4 expression and its signaling by hypoxia in cultured microglia. J. Neurosci. Res. 85: 1989-1995 (2007).
Ock J, Kim S, Suk K. Anti-inflammatory effects of a fluorovinyloxyacetamide compound KT-15087 in microglia cells. Pharmacol. Res. 59: 414-422 (2009). *
Odeh M. A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome. Gut 37: 441-443 (1995). *
Odenbreit S, Linder S, Gebert-Vogl B, Rieder G, Moran AP, Haas R. Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter 11: 196-207 (2006). *
Oesterreicher C, Pfeffel F, Petermann D, Muller C. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J. Hepatol. 23: 396-402 (1995). *
Oeth P, Yao J, Fan ST, Mackman N. Retinoic acid selectively inhibits lipopolysaccharide induction of tissue factor gene expression in human monocytes. Blood 91: 2857-2865 (1998). *
Ofek K, Krabbe KS, Evron T, Debecco M, Nielsen AR, Brunnsgaad H, Yirmiya R, Soreq H, Pedersen BK. Cholinergic status modulations in human volunteers under acute inflammation. J. Mol. Med. 85: 1239-1251 (2007). *
Ogasawara M, Yamauchi K, Satoh YI, Yamaji R, Inui K, Jonker JW, Schinkel AH, Maeyama K. Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism. J. Pharmacol. Sci. 101: 24-30 (2006). *
Ogawa T, Asai Y, Makimura Y, Tamai R. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front. Biosci. 12: 3795-3812 (2007).
Ogawa T, Veinot JP, Kuroski de Bold ML, Georgalis T, de Bold AJ. Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis. Am. J. Physiol. Heart Circ. Physiol. 294: H2596-H2603 (2008). *
Ogimoto K, Harris MK Jr, Wisse BE. MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide (LPS) and interleukin-1beta (IL1beta). Endocrinology 147: 4445-4453 (2006). *
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606 (2001). *
Ohata M, Suzuki H, Sakamoto K, Hashimoto K, Nakajima H, Yamauchi M, Hokkyo K, Yamada H, Toda G. Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-alpha. Alcohol Clin. Exp. Res. 28: 139S-144S (2004).
Ohhira M, Motomura W, Fukuda M, Yoshizaki T, Takahashi N, Tanno S, Wakamiya N, Kohgo Y, Kumei S, Okumura T. Lipopolysaccharide induces adipose differentiation-related protein expression and lipid accumulation in the liver through inhibition of fatty acid oxidation in mice. J. Gastroenterol. 42: 969-978 (2007). *
Ohta S, Bahrun U, Shimazu R, Matsushita H, Fukudome K, Kimoto M. Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the Toll-like receptor 4/MD-2 complex. Clin. Vaccine Immunol. 13: 1131-1136 (2006). *
Ohta S, Bahrun U, Tanaka M, Kimoto M. Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling. Biochem. Biophys. Res. Commun. 323: 1103-1108 (2004). *
Ohtami S, Kobayashi O, Ohtami H. Analysis of intractable factors in chronic airway infections: role of the autoimmunity induced by BPI-ANCA. J. Infect. Chemother. 7: 228-238 (2001).
Ohtani T, Mizuashi M, Nakagawa S, Sasaki Y, Fujimura T, Okuyama R, Aiba S. TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 126: 485-499 (2009). *
Ohya M, Nishitani C, Sano H, Yamada C, Mitsuzawa H, Shimizu T, Saito T, Smith K, Crouch E, Kuroki Y. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 45: 8657-8664 (2006). *
Okada Y, Tsuzuki Y, Hokari R, Komoto S, Kurihara C, Kawaguchi A, Nagao S, Miura S. Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-IkappaB and SOCS gene expression. Int. J. Exp. Pathol. 90: 131-140 (2009).
Okajima K. Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications. Clin. Chem. Lab. Med. 42: 132-141 (2004).
Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91 (1995). *
Okayama N, Fujimura K, Suehiro Y, Hamanaka Y, Fujiwara M, Matsubara T, Maekawa T, Hazama S, Oka M, Nohara H, Kayano K, Okita K, Hinoda Y. Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J. Clin. Lab. Anal. 16: 56-58 (2002). *
Okoko T, Oruambo IF. Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells. Food Chem. Toxicol. 47: 809-812 (2009).
Okopien B, Krysiak R, Herman ZS. Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance. J. Clin. Endocrinol. Metab. 91: 1770-1778 (2006). *
Okumura A, Saito T, Otani I, Kojima K, Yamada Y, Ishida-Okawara A, Nakazato K, Asano M, Kanayama K, Iwakura Y, Suzuki K, Yamagoe S. Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis. Arthritis Rheum. 58: 413-421 (2008). *
Olas K, Butterweck H, Teschner W, Schwarz HP, Reipert B. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin. Exp. Immunol. 140: 478-490 (2005). *
Olleros ML, Martin ML, Vesin D, Fotio AL, Santiago-Raber ML, Rubbia-Brandt L, Spahr L, Hadengue A, Garcia I. Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines. Cytokine 44: 118-125 (2008).
Olleros ML, Vesin D, Lambou AF, Janssens JP, Ryffel B, Rose S, Fremond C, Quesniaux VF, Szymkowski DE, Garcia I. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette-Guerin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis. J. Infect. Dis. 199: 1053-1063 (2009). *
Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U.S.A. 105: 10113-10118 (2008). *
Onodera S, Ohshima S, Tohyama H, Yasuda K, Nishihira J, Iwakura Y, Matsuda I, Minami A, Koyama Y. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum. 56: 521-530 (2007). *
Ooi CE, Weiss J, Doerfler ME, Elsbach P. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J. Exp. Med. 174: 649-655 (1991). *
Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, van der Linde K, Te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm. Bowel Dis. 11: 567-575 (2005). *
Opal SM, Palardy JE, Marra MN, Fisher CJ Jr, McKelligon BM, Scott RW. Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 344: 429-431 (1994).
Openshaw PJ. Crossing barriers: infections of the lung and the gut. Mucosal Immunol. 2: 100-102 (2009).
Orellana RA, Suryawan A, Kimball SR, Wu G, Nguyen HV, Jefferson LS, Davis TA. Insulin signaling in skeletal muscle and liver of neonatal pigs during endotoxemia. Pediatr. Res. 64: 505-510 (2008).
Ornatowska M, Azim AC, Wang X, Christman JW, Xiao L, Joo M, Sadikot RT. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1377-L1384 (2007). *
Ospelt C, Brentano F, J�ngel A, Rengel Y, Kolling C, Michel BA, Gay RE, Gay S. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 60: 355-363 (2009). *
Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D. Overexpression of Toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 58: 3684-3692 (2008). *
Ota A, Mori K, Kaneko YS, Nakashima A, Nagatsu I, Nagatsu T. Peripheral lipopolysaccharide administration affects the olfactory dopamine system in mice. Ann. N. Y. Acad. Sci. 1148: 127-135 (2008). *
Ott LW, Resing KA, Sizemore AW